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viii. Abstract 
Background: The identification of the vulnerable carotid plaque is of paramount importance in order 
to prevent the significant stroke-related mortality and morbidity. Currently the clinical decision-
making around this condition is based on the traditional ultrasound evaluation of the degree of 
stenosis. However, there is emerging evidence supporting that this is not sufficient for all patients. 
Aim of this thesis: The evaluation of novel carotid plaque features for the characterisation of plaque 
composition, volume and motion using 2 and 3 dimensional ultrasound technology. The ultimate 
goal is to identify novel sensitive imaging markers for carotid plaque characterisation and stroke-risk 
stratification. 
Methods: The Asymptomatic Carotid Stenosis and Risk of Stroke (ACSRS) Study was a large 
prospective multicentre trial that was recently completed. A post-hoc analysis of the sonographic 
and clinical data from this study was performed in order to evaluate the effectiveness of novel 
ultrasound texture features, such as second order statics, on stroke-risk prediction. In addition, the 
change of specific texture features and degree of stenosis during the ACSRS follow-up time (8 years) 
and their importance for stroke prediction was evaluated. In order to assess the potential of 3D 
ultrasound carotid imaging we also developed a special methodology using a 3D broadband, linear 
array probe and the Q-lab software. This methodology was then applied in a clinical, cross-sectional 
study of patients with symptomatic and asymptomatic carotid disease. Finally we developed a 
carotid plaque motion analysis methodology that we tested on a feasibility study. 
Results: The post-hoc analysis of more than 1, 000 patients from the ACSRS database showed that 
there are novel ultrasound features of plaque homogeneity that can contribute to plaque 
characterisation and improve stroke-risk prediction. Similarly our results suggest that the change of 
degree of stenosis or plaque’s composition through time might have significant predictive value 
when combined with the above novel features. The study in 3D ultrasound prospectively assessed 
more than 80 people with symptomatic and asymptomatic carotid disease with both 2 and 3D 
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carotid ultrasound without, though, revealing any significant benefit from the use of 3D imaging in 
terms of stroke-risk prediction. Finally, our feasibility study on plaque motion analysis showed that it 
is possible to objectively characterise plaque motion, using ultrasound and dedicated software 
without complicated reconstructions. 
Conclusion: The use of novel 2D ultrasound texture features in combination with traditional ones 
can improve the stroke-risk stratification. 3D ultrasound is a promising new approach, however, the 
current technology does not appear to offer a significant benefit in comparison to cheaper 
traditional 2D ultrasound for carotid plaque evaluation. Further research is warranted on this issue.  
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Carotid plaque pathogenesis, biomechanics and imaging 
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1.1 Introduction 
Carotid plaque disease is considered to be one of the main of cerebrovascular events such as stroke 
and transient ischemic attacks. The incidence of cerebrovascular events is continuously rising in the 
developed world and poses a significant source of morbidity and mortality, which is globally 
associated with rising socioeconomic costs.  
The midterm overall risk reduction with carotid endarterectomy (CEA) in patients with asymptomatic 
carotid stenosis is minimal. The ACAS study reported that in patients with stenosis >60%, CEA 
reduced the annual risk of stroke from 2% to 1%, which implies that approximately 20 procedures 
need to be performed to prevent one stroke in 5 years. [Executive Committee for the Asymptomatic 
Carotid Atherosclerosis Study, 1995] For this reason, there is considerable debate on the 
appropriateness of this procedure in all patients with asymptomatic carotid stenosis, and restriction 
to patients who are at high risk of developing neurologic events might be more cost-effective.  
There has been significant effort in the past in the direction of developing new diagnostic algorithms 
that would enable physicians to distinguish between high and low risk patients according to the 
degree of stenosis of carotid lumen [Barnett HJ,1998] [European Carotid Surgery Trialists 
Collaborative Group,1998], or the intima-media thickness (IMT) [Hollander M, 2003], or even 
according to the grey scale median (GSM) of the atheromatic plaque.[Kakkos SK & Stevens JM,2007] 
As a result of this, plaque classifications -such as the Geroulakos’ classification [Geroulakos G& 
Ramaswami G,1993] -have been developed in order to provide us with more specific and clinically 
orientated algorithms that could be used in the daily routine. However, there is still a grey area of 
asymptomatic patients that cannot be adequately stratified with regard to their risk due to 
insufficient evidence.  
 
The current advances in medical imaging, image analysis and biomechanics provide us with 
promising new tools in the quest for more sensitive markers of plaque vulnerability. 
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The development of an atherosclerotic plaque as well as its rupture can be illustrated and explained 
as a complicated, dynamic system that involves a thixotropic fluid (blood) that flows within an elastic 
tube –with various and interacting properties- and encounters a surface irregularity along its course 
(plaque) and a variety of physical forces that interrelate and cause structural changes on both the 
wall of the tube and the surface of the plaque.  
 
In bioengineering terms plaque rupture is equivalent to the structural failure of a certain material 
upon which a number of different forces are applied. The prediction of the amount of stress that a 
certain material can withstand before it reaches the crucial “break-limit” is a problem commonly 
encountered in the development of improved industrial materials.  
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1.2 Basic principles 
1.2.1 Rheological and mechanical properties of carotid blood flow 
Blood is a non-Newtonian fluid whose flow properties are not described by a single constant value of 
viscosity. It is widely accepted that blood is a shear thinning fluid whose viscosity increases non-
linearly with reduction in shear rate. While in a Newtonian fluid the relation between shear stress 
and shear rate is linear – and the constant of proportionality is the coefficient of viscosity- that is not 
the case for non-Newtonian fluids. Nevertheless, the effect of non-Newtonian behaviour on blood 
flow in large arteries is insignificant and hence has been ignored in the majority of carotid 
hemodynamics studies. 
 
Blood flow is usually described by Navier-Stokes equations, which describe the motion of fluid 
substances. They are differential equations that do not explicitly establish a relation among the 
variables of interest (such as pressure and velocity) but instead establish relations among the rates 
of changes. This is in contrast to a simple case of an ideal fluid (not compressible or viscid) flowing 
through a rigid tube for which equations can state that the rate of change of velocity (acceleration) is 
proportional to the pressure gradient in the direction of flow. 
 
The arterial wall of medium and large arteries has elastic properties that resemble that of an elastic 
tube.  However, factors such as hypertension, diabetes, smoking and aging cause significant changes 
to the arterial wall through time. (Milio G & Corrado E, 2006) These contribute to the dynamic and 
changing nature of this tube, which cannot be easily simulated. The Young’s elastic modulus and the 
brachial-ankle pulse wave velocity (baPWV) (Hung CS & Lin JW, 2008) have been used to assess the 
arterial stiffness. The Young’s modulus can be measured as the ratio of the uniaxial stress over the 
uniaxial strain in the range of stress in which Hooke's Law holds and the baPWV can be measured 
automatically using a volume plethysmographic apparatus.   
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 The structure of atherosclerotic plaques is variable and may consist of different predominant 
substances. For example some plaques are more lipid-rich and, thus, unstable whereas others are 
more fibrotic and stable. Different types of plaque are associated with different biomechanical 
behaviour to stress and interact differently to the blood flow and changes in shear stress during the 
cardiac circle. In addition, due to the local stenosis and according to Bernoulli’s principle there is an 
associated pressure gradient with energy loss, which is responsible for additional local stress. (Milio 
G & Corrado E, 2006) 
 
1.2.2 Biomechanical parameters of carotid arteries 
In the literature, a number of hemodynamic parameters have been used to describe the 
biomechanical behaviour of the carotid arteries. These include:  
• the circumferential wall tension (CWT) which can be estimated from the systolic blood 
pressure and the internal diameter of the common carotid artery (CCA),  
• the tensile stress (TS) which is proportionate to the CWT and inversely related to intima 
media thickness,  
•  the wall shear stress (WSS) which, in the simplest cases, is considered proportional to the 
blood viscosity and blood velocity and inversely associated with the internal diameter of the 
CCA and  
• the Young’s elastic modulus (YEM) which is representative of the  stiffness of the artery 
(Carallo C , 1999) (Table 1.1) 
 
 Considering the above it is clear that each spot of the arterial wall and atherosclerotic plaque is 
subjected to a load of stresses with different directions and magnitude at different times within a 
cardiac cycle. The Von Mises criterion is a formula, which can be used to calculate whether the stress 
combination at a given point will cause failure. This theory is simply one of the several structural-
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failure theories that combine principle stresses (in the x, y, or z direction) into an equivalent applied 
stress, which is compared to the tolerable stress of the material.   
 
The complexity of the above described interactions between rheological and structural factors –like 
blood, arterial wall and plaque- and biomechanical factors –such as CWT, TS, and WSS- is obvious 
and calculations without using over-simplifying assumptions demand increased technical knowledge 
and powerful software. Fluid-structure interactions (FSI) describe the interactions of a deformable 
structure with an internal or surrounding fluid flow and can be achieved using the recent advances in 
computational fluid dynamics (CFD) and finite element analysis (FEA). CFD is one of the branches of 
fluid mechanics that uses numerical methods and algorithms to solve and analyse problems that 
involve fluid flows. Computers are used to perform the millions of calculations required to simulate 
the interaction of fluids and gases with the complex surfaces used in engineering. Finite element 
analysis method (FEA) is a numerical technique for solution of boundary-value problems. In its 
application, the system is represented by a geometrically similar model consisting of multiple but 
linked representations of discrete regions—i.e. finite elements. (Birchall D,2006). 
 
The previously mentioned techniques have been combined with magnetic resonance imaging (MRI) 
to simulate the blood flow and provide us with information about the morphological features and 
the hemodynamic effect within stenotic carotid arteries (Birchall D,2006). 
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1.3 Mechanical stress and the association with the carotid plaque pathogenesis 
The right and left carotid arteries are not affected to the same extent by atherosclerosis and 
investigations of the pathological process have revealed that these lesions are most commonly 
encountered in areas of low wall shear stress. (Gnasso A, 1997) Areas of bifurcation or curved 
arteries are portrayed as areas where low or oscillatory shear stresses occur (Cheng C, 2006) and this 
observation corresponds with the clinical experience of plaque disposition mainly at these sites. The 
theory behind the mechanisms of plaque creation, indicates that it is the oscillatory shear stress in 
combination with the low shear stress that is mainly responsible for the endothelial dysfunction, 
whereas the unidirectional shear stress may be protective for the endothelial layer (Gambillara 
V,2006; Melchionna R,2005 and Slager CJ, 2005). 
 
1.3.1 Effect of stress on the arterial endothelium 
It is possible that the key factor is the interaction between low or/and oscillatory shear stress and 
the subjacent endothelium, which responds by up-regulation of vaso-occlusive agents and down-
regulation of vasodilating agents such as endothelial nitric oxide synthetase (eNOS) gene expression 
(Gambillara V,2006; Melchionna R,2005 and Slager CJ, 2005). In porcine carotid artery models that 
were exposed for three days to unidirectional high and low shear stress or to oscillatory shear stress 
there was an increase in the expression levels of metalloproteinase-2,-9 and a decrease in the 
plasminogen activator inhibitor-1 expression in the latter group  (Gambillara V,2005) These results 
indicate that such a plaque-prone hemodynamic setting may cause wall remodeling of the artery 
and this is also supported by other experimental studies. (Cheng C, 2006)  High shear stress is 
generally considered as an important destabilizing factor through the induced changes to the 
endothelium and smooth muscle cells of the plaque matrix as they are summarized in figure 1.2. 
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Table 1.1: Simplified formulas of the various types of stresses encountered during the wall stress 
analysis. (Makris GC, 2010; doi: 10.1259/bjr/49957752.) 
Type of stress Simplified formula Description of action 
1. Circumferential Wall 
Tension (CWT)  
CWT (dynes/cm) = SBP x 
(ID/2) 
 
adjacent parts of the material tend 
to press against each other   through 
a typical stress plane 
2. Tensile Stress (TS)  TS (dynes/cm2) = CWT/IMT 
 
two sections of material on either 
side of a stress plane tend to pull 
apart or elongate 
3. Wall Shear Stress (WSS)  
 
WSS = 8 x μ x (MV/ID) two parts of a material tend to slide 
across each other in any typical 
plane of shear upon application of 
force parallel to that plane 
4. Young’s Elastic Modulus 
(YEM)  
YEM (dynes/cm3) = 
(SBP-DBP) x (IDM / [(IDT-IDR) 
x IMT] 
describes arterial wall stiffness  
5. Stress Phase Angle (SPA)  SPA= CWS/WSS combination of CWS and WSS 
SBP: systolic blood pressure, ID: Internal diameter in cm, IMT: Internal media thickness ,   μ: blood viscosity, 
MV: mean velocity DBP: diastolic blood pressure, IDM: IDR + (IDT − IDR)/3, IDR: Internal diameter during R wave 
of cardiac cycle, IDT: internal diameter during T wave of cardiac cycle, CWS: circumferential wall stress/strain.  
 
 
 
 
 
 
 37 
Figure 1.1 Summary of the effect of Wall Shear Stress on atherosclerotic plaque development. 
(Makris GC, 2010; doi: 10.1259/bjr/49957752.)  
 
 
 
 
 
 
 
 
 
 
 
 
 
The effect of low wall shear stress on plaque 
pathogenesis 
The effect of high wall shear stress on plaque 
instability 
Enhancement of lipid oxidation and accumulation in 
the intima 
Stimulation of endothelium proliferation and 
production of TGF-β /NO/plasmin 
Endothelial dysfunction and decreased function of 
NO synthetase 
NO will stimulates macrophages to secrete promatrix 
metalloproteinases (MMPs) which will be further 
activated by plasmin to transform to active MMPs 
Smooth muscle cell proliferation and matrix 
synthesis 
Increased smooth muscle apoptosis 
Decrease of anti-oxidant proteins and increase of 
oxidative stress. 
Increased expression of antioxidant enzymes 
Increase of vascular cell adhesion molecules and 
increased recruitment of inflammatory cells 
Gene activation and vessel remodeling (if low WSS 
being sustained) 
Eccentric atherosclerotic plaque build-up 
and 
Outward vessel remodelling 
 
Fibrous-cap matrix breakdown combined with 
increased vulnerability (upstream of plaque) 
Plaque progression is delayed or absent 
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1.3.2 Effect of stress on plaque progression and severity 
Apart from the effect of wall stress on the initial mechanisms of plaque formation there is clinical 
evidence suggesting its important role in plaque progression and the observed severity of carotid 
atherosclerosis. Lee and his colleagues evaluated the IMT and plaque burden in bilateral CCA 
bifurcations, external and internal carotid arteries using duplex ultrasound in 80 untreated 
hypertensive patients. (Lee MY, 2008). They presented evidence suggesting that circumferential wall 
stress (CWS) and tensile stress (TS) are related to the severity of carotid plaque disease in this 
specific patient group. Additionally, Tang and colleagues combined in vivo MRI-based 2D/3D multi-
component models with fluid structure interactions to study twenty-one human carotid plaques. 
(Tang D,2008)  Lower plaque wall stress and lower flow wall shear stress were shown to contribute 
significantly to continued eccentric plaque progression.  
 
Intraluminar stresses are affected by a variety of different factors. The carotid geometry itself was 
found to have an important effect on blood flow and on the magnitude of wall shear stress. (Nguyen 
KT,2008) Moreover in a previous study it was also shown that flow, diameter and blood viscosity 
have significant effect on wall shear stress. (Box FM, 2005). Finally factors like age, blood pressure, 
body mass index and IMT have been independently associated with changes in wall shear and 
circumferential wall stress (O’Leary DH,1999  and Zhao SZ,2002). 
 
The combined effect of low wall shear stress and high tensile stress has also been evaluated by 
different groups and is believed to pose an important determinant of carotid plaque formation. 
(Zhao SZ,2002) This combined effect can be expressed using the phase difference between the solid 
circumferential stress/strain (CS) and the fluid wall shear stress curves or in other words the stress 
phase angle. (Tada S,2005)  
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 1.4 Mechanical stress and carotid plaque vulnerability: the clinical evidence  
It has been generally accepted that the degree of carotid lumen stenosis is not a sufficient marker 
for the underlying risk of plaque rupture. (Johnsen SH,2009) A number of trials have been recently 
launched in order to identify more reliable markers based on the plaque morphology and 
hemodynamic properties. Baseline evidence originating from in vitro (animal or artificial models) or 
even from computational simulation studies suggest that there are certain plaque characteristics 
that could be incriminated for plaque destabilization. The geometrical features of a stenotic lumen –
such as eccentricity [Steinman DA,2000 and Tang D,2004 ] and lumen curvature- [Steinman 
DA,2000], the lipid pool size [Tang D,2004] and the fibrous cap thickness [Li ZY,2006] have been 
associated with instability in these experimental settings. Histological data from CEA specimens 
suggest that a combination of cap thickness of less than 500μm and minimum cap thickness of less 
than 200μm can be independently associated with cap rupture according to the Oxford plaque 
study. [Redgrave JN,2006] 
 
1.4.1 The effect of carotid plaque characteristics on stress distribution in clinical settings 
The application of the results of the above studies in clinical practice might be more challenging than 
initially expected due to the complexity and the dynamic nature of the carotid system. The current 
clinical evidence is rather limited but corresponds well to the previous experimental evidence. 
Fibrous cap thickness appears to be strongly associated with the stress levels applied on the plaque 
and consequently with the risk for rupture and thromboembolic events. [Gao H,2008; Li ZY,Tang T, 
2008; Kock SA,2008] Lumen curvature was another characteristic associated with instability [Li ZY, 
Tang T,2008] in clinical settings. In addition, the presence of calcium deposition within plaque [Li ZY, 
Howarth S,2007] or the presence of ulceration [Groen HC,2007] may alter the local stress patterns or 
become altered by them, respectively, affecting the structural behaviour of the plaque. 
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1.4.2 The effect of different types of stress on carotid plaque stability  
Attempts have been made to evaluate the effect of different types of stress in clinical and 
experimental settings.  The current clinical evidence suggests that the various types of hemodynamic 
stress (WSS, TS, and CWT) may have a different association with plaque stability.  High shear stress 
especially on the upstream of the plaque is several times lower in magnitude than tensile stress but 
it is possibly the factor leading to the formation of unstable plaque characteristics. [Groen HC,2007; 
Trivedi RA,2007; Slager CJ, 2005 ] High tensile stress [Tang D, Yang C, 2003], induced by blood-
pressure pulse, is proposed as the most important factor eventually causing plaque rapture; 
repetitive inward bending [Paini A,2007; Beaussier H, 2008] of stiff carotid arteries may also be 
considered among potential contributors to the plaque structural fatigue and thrombogenic 
complications. However, so far there is limited or sometimes even conflicting clinical evidence about 
whether one of these factors poses a more important role or it is a matter of combined effect.  
 
1.5 Limitations of the clinical evidence 
Despite the number of experimental and computational studies there are still doubts with regard to 
the clinical implications of these novel and promising biomechanical characteristics. The current 
clinical evidence is rather limited and the number of studied patients is insufficient to help us reach 
safe conclusions. In addition, there is considerable variation in the type of stresses or wall/plaque 
characteristics analysed as well as to the methods applied for the stress analysis and imaging. In the 
majority of the studies magnetic resonance imaging has been used combined with fluid-structure 
interactions simulations contributing to the increased cost and complexity of the studies.  
 
Finally each study –apparently due to the technical complexity- focused on a different type of stress 
or arterial wall/plaque characteristic and thus the potential combined effect of various stress types 
on an anisotropic carotid plaque model has not been adequately explored.    
 
 41 
1.6 New techniques  
The increased cost and technical complexity of 3-dimension MRI reconstruction for the analysis of 
the wall-stress relation is an important limitation of this approach. Other non-invasive ultrasound-
based techniques could be applied, taking into consideration the recent technological progress. Non-
invasive vascular elastography, motion plaque analysis and 3-dimension ultrasound imaging could be 
alternative potential approaches.  
 
Non-invasive vascular elastography is a method to evaluate the vulnerability and the composition of 
a plaque creating elasticity maps, potentially enabling investigators to differentiate lipid pools and 
fibrotic plaques. [Maurice RL,2004] In contrast to the intravascular technique the radial strain and 
the ultrasound beam are not aligned in non-invasive acquisitions. [Ribbers H,2007] It has been 
suggested that in patients with non-homogenous atheromatic plaques, shear and stress elastograms 
may reveal interesting information regarding tissue composition, plaque size and mechanical 
interactions. [Schmitt C,2007] 
 
Motion analysis of carotid plaques during systole and diastole may also reveal different mechanisms 
that contribute to plaque fatigue and rupture. A computerized method that objectively analyses 
such motion patterns using ultrasound images has been developed using 2-dimensional 
displacement vector maps. Motion analysis theory advocates that distinguished plaque regions may 
present different motion patterns. This may lead to internal structural stress and thus to the 
formation of fissures and ultimately plaque disruption. [Bang J,2003] 
 
Finally there is increasing amount of evidence regarding the 3-dimensional ultrasound imaging and 
its potential applications in arterial wall and plaque image reconstruction, as well as to the direct 
evaluation of plaque volume. [Chiu B,2009; Fenster A, 2006; Ainsworth CD,2005]  The potential of 
combining 3-dimensional ultrasound imaging and computational fluid dynamic analysis has not been 
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adequately explored with regard to the clinical effect of stress patterns to plaque vulnerability and 
poses a significant challenge for future studies. However, there is preliminary evidence that wall 
shear stress patterns derived from 3-dimensional ultrasound imaging can be both well reproducible 
and potentially comparable ,if not superior,  to those acquired from MRI. [Glor FP,2004; Augst 
AD,2003] 
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1.7 Conclusions 
Carotid plaque stress analysis appears as a promising diagnostic approach based on established 
mechanic and hemodynamic properties. Prospective, clinical studies are warranted to investigate in 
depth the applicability of the different aspects of this advance into daily, clinical practice. Established 
imaging techniques –such as MRI or 2-dimensional ultrasound- could be further developed. In 
addition novel, ultrasound-based techniques like elastography, plaque motion analysis and 
especially 3-dimensional ultrasound could be investigated in order to reduce cost and complexity 
and increase the quality of information regarding wall stress-carotid plaque interactions. A 
multidisciplinary approach –including vascular surgeons, radiologists and bioengineers- is considered 
as an essential element for the accomplishment of this challenging task.
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Chapter 2 
Current status in surgical management of carotid plaque disease and 
the ACSRS study 
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2.1. The debate regarding the management of significant asymptomatic carotid plaque 
disease  
 
The debate regarding the conservative or surgical management of patients with significant 
asymptomatic carotid plaque disease [Spence JD,2010; Roffi M, 2010], has significant clinical 
implications. Current evidence suggests that the incidence of stroke is rather low at 
approximately 1% per year in individuals with asymptomatic carotid plaque disease who are 
on the appropriate medication and follow a healthy lifestyle [Abbott AL, 2009]. 
Nevertheless, the previous sentence includes 3 assumptions that generate reservations 
regarding ruling out more radical treatment options.  
 
The first assumption is the term “asymptomatic” which can be interpreted as equivalent to 
“low risk”. There is evidence to suggest that some asymptomatic carotid plaques are not as 
benign as may be assumed. A thin fibrous cap [Li ZY&Howarth SP,2006] seen on ultrasound 
as a juxtaluminal black area [Griffin MB,2010], silent embolic infracts on CT [Kakkos SK & 
Sabetai M,2009] or the detection of microemboli using transcranial Doppler [Spence JD, 
Tamayo A,2005] are associated with a 3-5 fold increase in risk of stroke. In addition, other 
factors such as decreased glomerular filtration rate <60 ml/min/1.73m2 have been 
independently related to the risk of stroke as recently reported in a meta-analysis (284,672 
participants) [Lee M, Saver JL,2010]. Novel plaque features in combination with routine 
clinical factors may provide more information in the future regarding the risk of stroke. The 
point here is that we are still underperforming in stratifying asymptomatic patients into risk 
categories, although as the Asymptomatic Carotid Stenosis and Risk of Stroke (ACSRS) Study 
highlighted, this may now be possible if both clinical and plaque features are considered. 
[Nicolaides A,Kakkos SK, 2010] 
 46 
The second assumption is that asymptomatic patients are on adequate medication (statins, 
antiplatelet agents and/or antihypertensive drugs). Nevertheless, we know that the 
effectiveness of this approach can be affected by compliance or the failure to achieve blood 
pressure or low-density lipoprotein (LDL)-cholesterol targets [Daskalopoulou SS,2008]. 
Achieving treatment goals is challenging since, as recent evidence suggests, the ability of 
statins to stabilize the carotid plaque is LDL-cholesterol level-dependant [Makris GC, Lavida 
A,2010]. In other words, poor control may result in less protection. Moreover, the 
importance of the “healthy-user” effect [Brookhart MA,2007] on trials evaluating 
pharmacological approaches should also be taken into consideration since the 
socioeconomic status of the patient may impact on the accessibility of appropriate medical 
care in the long run.  
The last assumption is achieving radical lifestyle modifications in long-term smokers and 
those who have never exercised. Smoking cessation clinics may have unsatisfactory results, 
especially in the long run [Robles GI,2008]. In addition, there is not enough data regarding 
the effect of risk factor modification clinics [Daskalopoulou SS,2008] and these are also not 
widely available. Nevertheless, there is evidence supporting a beneficial effect of risk factor 
management in patients with carotid artery disease [Liapis CD,2010].  
Conservative management for patients with significant but asymptomatic carotid plaque 
disease should always be considered first but we should keep in mind that the success of this 
decision depends on certain assumptions before becoming a reality. The introduction of 
long-term risk factor modification may be one way of ensuring a decrease in cardiovascular 
risk [Lee M, Saver JL, 2010]. We are still learning about what defines an unstable plaque. The 
presence of symptoms or just the degree of stenosis, are not perfect “markers”. Patients can 
be asymptomatic and at low-risk one day and the next they may suffer a stroke. Indeed, the 
risk category has changed but it is too late. 
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 It appears that further improvement in diagnostic approaches for risk stratification and the 
introduction of a more structured network of risk factor modification clinics is the way to be 
equally effective when we are less radical [Liapis CD,2010].  
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2.2. Can we identify the patients at increased risk of stroke? Introduction to the 
ACSRS study. 
The degree of stenosis has been for years an established measurement in order to assess the 
risk of ipsilataral embolic stroke and is a major determinant for eligibility for carotid 
endarterectomy.  Studies performed more than a decade ago illustrated that the risk for 
stroke in asymptomatic patients with internal carotid artery stenosis <75-80% (NASCET 
criteria) was 0.1-1.6% per year and 2.0-3.3% per year when the stenosis was greater. 
(European Carotid Surgery Trialists Collaborative Group, 1995; Inzitari D, 2000) 
Two randomized controlled trials, the ACAS in 1995(Executive Committee for the 
Asymptomatic Carotid Atherosclerosis Study, 1995) and ACST in 2004 (Halliday A, 2004) 
reported that in patients with asymptomatic ICA >60-70% (NASCET) carotid endarterectomy 
reduced the risk of stroke from 2% to 1% per year. This means that approximately 20 
operations need to be performed to prevent one stroke in 5 years or 100 operations to 
prevent one stroke in one year. However, even this benefit was not without risks. In these 
trials CEA was associated with 2-3% perioperative rate of stroke and death. On the other  
hand medical therapy was left to the discretion of the local research teams and only 25% 
and 80% of the patients were on statins and antiplatelet therapy, respectively, when 
recruited. The definition of best medical treatment has changed dramatically since then with 
lipid lowering and blood pressure control to predefined targets and with life style changes so 
that currently the estimated average annual risk of ipsilateral cerebral stroke is 
approximately 1%. (Abbot A, 2009) As a result many authorities are questioning the need for 
carotid endarterectomy in asymptomatic individuals. There is continuous research for the 
development of diagnostic approaches in order to identify those characteristics, which 
define the vulnerable carotid plaque. If a specific patient-subgroup with asymptomatic 
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carotid stenosis with sufficiently higher than average risk of stroke could be identified then 
carotid surgery may still be justified.  
In the past ultrasound had been the standard examination for the evaluation of patients 
with carotid disease and several studies have shown that hypoechoic and heterogenous 
plaques are more often associated with cerebrovascular symptoms than hyperechoic 
(echogenic) plaques. [Geroulakos G, Ramaswami G,1993] More recently, plaque area and 
plaque volume as well as texture features such as entropy, homogeneity and energy have 
also been shown to be associated with symptomatic plaques.[Spence JD,2006] However, the 
use of the above ultrasonic markers in combination in order to achieve better risk-
stratification has not been properly investigated. 
2.2.1. Study design and quality control 
The ACSRS study was an international, multicentre, prospective, observational natural 
history study of asymptomatic patients with ICA stenosis >50% (ECST criteria) run by our 
group and a number of international experts. It was designed to overcome fundamental 
methodological problems of the previous risk-stratification trials such as small numbers, 
short follow-up and poor reproducibility of plaque types or texture features because of lack 
of image normalisation. The principal aim of the ACSRS study was to identify subgroups of 
patients with stroke-risk less than 1% and more than 4% annually using local (plaque 
characterization and texture analysis) and systemic factors in addition to the degree of 
stenosis. 
Bilateral carotid ultrasound scanning was performed on admission and the entire duplex 
investigation was recorded on S-VHS videotape and sent to the coordinating centre. The 
degree of stenosis was graded according to established velocity criteria and expressed as 
both ECST and NASCET percentages (Mansfield A, 2004; Nicolaides A, Sabetai M,2003). A 
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high frequency linear array transducer (4 -7 MHz) was used and the following technical 
ultrasound settings were observed to ensure optimum image quality for plaque type 
classification and texture analysis.  
 
Ultrasonographers from participating centers attended for two day training at the 
coordinating center. They were trained not only on equipment settings and method of 
image recording but also on the method of image normalization. Although 
ultrasonographers were not expected to perform image analysis, it was felt that knowledge 
of how it was done would ensure that all prerequisites for image analysis described above 
would be included. A specially prepared video recording with instructions how to perform 
the examination was provided. Video recordings of the examination and frozen images of 
plaques were sent to the coordinating centre for image analysis. Continuous feedback 
ensured quality (Nicolaides A, Sabetai M,2003). 
 
Analysis of the baseline carotid plaque characteristics was performed with the use of the 
“Plaque Texture Analysis” software (version 3.2 –Incosoft International Ltd, PO Box, 
Greenford, London UB6 9ZN [Griffin M,2007]) after image normalization and segmentation. 
The primary outcome measures were ipsilateral cerebral or retinal stroke (fatal and non-
fatal), transient ischemic attacks and retinal embolic events (i.e amaurosis fugax) whereas 
secondary outcomes were death and all other neurological events. 
2.2.2. Previously published results from the ACSRS study 
A total number of 1,121 patients were recruited. The available results from a number of 
interim analyses of the ACSRS data can be summarized as follows: 
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A. Mortality-associated factors in patients with asymptomatic carotid stenosis. 
Factors such as age, cardiac failure, male gender, myocardial ischemia and left ventricular 
hypertrophy on electrocardiogram (ECG) were independent predictors of increased risk for 
cardiovascular and all cause mortality according to Cox multivariate analysis. On the other 
hand antiplatelet therapy was associated with reduced risk. [Kakkos SK, Nicolaides A,2005] 
Using the above risk factors it was possible to identify a high-risk group consisting of one 
third of the studied population with 66% all cause death rate and 40% cumulative 
cardiovascular death rate at 7 years. In comparison the other two thirds of the population 
were at low-risk with a 21% all cause mortality rate and a 10% cumulative cardiovascular 
death rate at 7 years. No significant difference in the cumulative ipsilateral stroke rate was 
observed between the two groups (Log Rank P>0.05). [Kakkos SK, Nicolaides A,2005] 
B. Severity of asymptomatic carotid stenosis and risk of ipsilateral hemispheric embolic 
events. 
The relation between the severity of ICA stenosis and other risk factors (such as serum 
creatinine levels) with the risk of ipsilateral embolic neurologic events was also reported in 
the first 1115 patients recruited with a mean follow-up period of 37.1 months. The ICA 
degree of stenosis was linearly associated with the event rate when expressed by the ECST 
method but was S-shaped when the NASCET criteria were used. Serum creatinine levels of 
more than 85 micromols/L (RR 2.1; 95%CI 1.23-3.65) and history of contralateral TIAs (RR 
3.0; 95% CI 1.90-4.73) were identified as independent predictors of ipsilateral neurologic 
events including stroke. [Nicolaides AN, Kakkos SK,2005] 
 
When these three risk factors were combined a low-risk (2.3% annual event and 0.7% annual 
stroke rates) and a high-risk group (7.3% annual event and 4.3% annual stroke rates) could 
be identified. The identification of novel risk factors in addition to the degree of ICA stenosis 
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may help one achieve a better risk stratification and refine the CEA indications. [Nicolaides 
AN, Kakkos SK,2005] 
 
C. Effect of image normalization on carotid plaque classification and the risk of ipsilateral 
hemispheric events 
One hundred and sixteen ipsilateral embolic events were documented in the first 1,115 
patients recruited to the ACSRS study (mean follow-up 37.1 months). Plaques were classified 
as type 1-5 according to the Geroulakos classification. Before normalization all types of 
plaques were associated with a high event rate. After image normalisation more than 50% of 
the plaques were reclassified mainly to a higher or lower type and 94% of the events 
occurred in patients with type of plaque 1 to 3. [Nicolaides AN, Kakkos SK,2005] Patients 
with plaque types 4 and 5 had a cumulative stroke rate of 0.9% at 7 years (0.14% per year) 
but patients with plaque types 1 to 3 had a cumulative stroke rate of 14% at 7 years (2% per 
year). These results indicate that the risk of stroke in patients with plaque types 4 and 5 is 
low irrespective of the underlying degree of stenosis. [Nicolaides AN, Kakkos SK,2005]  
D. Risk of ipsilateral hemispheric events and silent embolic infarcts on brain CT scan. 
From the 1,121 patients with asymptomatic CPD who were included in the trial, 821 had 
baseline CT-Brain scans which were reported centrally by a neuroradiologist.  In the baseline 
CT scans 17.8% of the patients (146) had silent embolic infarcts which were classified as: 15 
small cortical, 8 large cortical, 72 discrete subcortical and 51 basal ganglia ipsilateral infarcts. 
[Kakkos SK, Sabetai M, 2009] 
During the follow-up period (6 months to 8 years) 102 ipsilateral hemispheric neurologic 
events occurred (47 strokes, 38 TIAs and 16 amaurosis fugax), 24 patients were lost in 
follow-up and 134 died.  
 53 
In patients with stenosis of less than 60% (mild stenosis) (n=359) the silent embolic infarcts 
were not associated with increased risk (log-rank P=0.65). In patients with ICA stenosis 
ranging from 60% to 99% stenosis (NASCET criteria) the cumulative annual stroke rate was 
1% when silent embolic infarcts were not present and 3.6% when present (log-rank 
P=0.002). [Kakkos SK, Sabetai M,2009] Therefore the presence of silent embolic infarcts may 
prove useful in the identification of a high-risk group for TIAs and stroke and in the 
management of patient suffering from moderate ICA stenosis. 
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Chapter 3 
Medical management of atherosclerosis and current imaging of disease 
progression 
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3.1.Introduction 
In recent year the medical management of patients with carotid atherosclerotic disease has 
become the mainstay of management for stroke prevention. Especially with regard to the 
beneficial effect of statin administration to patients with cardiovascular disease, which been 
well established since the first large placebo-controlled trial was published almost fifteen 
years ago [The Scandinavian Simvastatin Survival Study Group, 1994] .Pooled data from two 
large meta-analyses provide significant evidence illustrating the beneficial effect of statin-
treatment [Baigent C,2003; Amarenco P,2004]. The relative risk reduction rate for stroke was 
21% [(OR) 0.79 (0.73-0.85)] with no heterogeneity between studies [Amarenco P,2004] while 
the 5-year incidence of major coronary events, coronary revascularization and stroke was 
reduced by about one-fifth per mmol/l reduction in LDL cholesterol [Baigent C,2003].  
 
In addition, in a recent meta-analysis of statins combined with other strategies for stroke 
prevention which included 165, 792 patients, there was a reduction in relative risk for stroke 
of 21.1% (95% CI 6.3-33.5, p=0.009) for every 1 mmol/L decrease (39 mg/dl) in LDL 
cholesterol  [Amarenco P,2009]. Reduction rates of 16% and 26% for fatal/ non-fatal strokes 
and total vascular events respectively, were also observed in another study after intensive 
treatment with atorvastatin. This was the only randomized trial (SPARCL-Stroke Prevention 
by Aggressive Reduction in Cholesterol Levels), which included patients who had suffered 
stroke or transient ischemic attacks (TIA) but without manifestations of heart disease after a 
median follow-up of 4.9 years [Amarenco P,2006].  
 
The effect of statins on peripheral artery disease (PAD) and particularly on carotid plaque 
disease has been a matter of increasing importance due to the socioeconomic burden, which 
arises from stroke or TIAs. Two systematic reviews indicate that there is clinical evidence 
supporting the beneficial effect of statins on the development of PAD, though the quality of 
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the evidence was insufficient as most of the studies were non-randomized [Stalenhoef AF, 
2009; Paraskevas KI, Liapis CD,2006]. In parallel, preliminary evidence exists with respect to 
the potential reductions of perioperative morbidity and mortality in patients undergoing 
non-cardiac vascular surgery. Further appropriately designed trials, however, are warranted 
in order to establish the true effect and define the duration and dosage of statin treatment 
needed to achieve maximum benefit [Paraskevas KI, Liapis CD,2006]. 
 
Plaque progression and vulnerability are invaluable prognostic markers of cerebrovascular 
events irrespectively of the studied vascular bed. Nevertheless the majority of studies are 
currently focused on the coronary system. The REVERSAL (Reversal of Atherosclerosis with 
Aggressive Lipid Lowering) [Nissen SE,2008] and ASTEROID (A Study to Evaluate the Effect of 
ROsuvastatin on Intravascular Ultrasound Derived Coronary Atheroma Burden) trials [Nissen 
SE,2006] are two of several randomized studies which concluded that the atheroma volume 
within the coronaries can be significantly reduced by statin therapy.  
 
In this chapter the clinical evidence on the effect of medical management with HMG-CoA 
reductase inhibitors on carotid plaque morphology (size and composition) and the related 
serum inflammatory markers is reviewed. 
 
3.2. Results from systematic review of the literature 
Our recent systematic review of the literature [Makris GC, Lavida A 2010] showed that there 
is preliminary evidence supporting the notion that statin treatment may have beneficial 
effects on plaque morphology, which may be adequately assessed by ultrasound, MRI, and 
PET scans. There is also limited, supporting data for the anti-inflammatory potential of 
statins mainly based on the down-regulation of CRP production.  
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Paraskevas and colleagues [Paraskevas KI,2007] recently published an extensive review 
about the effect of statins on carotid IMT and the incidence of cerebrovascular events. The 
presented evidence supports the fact that statins reduce the rate of progression of the IMT 
and that the perioperative outcome in symptomatic patients undergoing carotid 
endarterectomy may be improved in statin users. However, despite the extensive use of IMT 
as a surrogate marker of atherosclerosis, there is uncertainty as to whether or not it is 
currently the best marker to quantify changes in atherosclerotic plaques. The carotid plaque 
and the IMT are considered genetically and biologically different and, thus, their association 
may be weaker than originally thought [Spence JD,2006;  Coll B,2008]. 
 
3.2.1. The effect of the type of statin 
Our systematic review [Makris GC, Lavida A 2010] was the first to accumulate evidence 
supporting that statin treatment not only beneficially alters carotid IMT but also results in 
plaque remodelling and regression. The majority of the studies found, used simvastatin and 
atorvastatin, since they have been the standard treatment for lipidaemic control, although 
there was no direct comparison between them with regard to their effectiveness in plaque 
stabilization. Recently, new statins ,such as rosuvastatin, have been licensed for lipid-
lowering treatment around the world. No solid evidence supporting the superiority of a 
specific statin exists due to the lack of comparative trials and the heterogeneity between the 
existing ones. Nevertheless, a previous metanalysis from Pilote and colleagues suggested 
that simvastatin, pravastatin and atorvastatin, when used at their standard dosages, have no 
statistically significant difference in their effect on the long-term prevention of 
cardiovascular events [Zhou Z, 2006]. 
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3.2.2.The effect of statin dosage on carotid plaque imaging features 
The intensity of the statin-dosage scheme is another area of considerable controversy due to 
potential side effects. However, from a recent metanalysis of HMG-reductace inhibitor trials 
and other preventive strategies including more than 160,000 patients it was evident that the 
lower the LDL level, the lower the relative risk for stroke. [Amarenco P, 2004] The 
conclusions were the same regarding secondary prevention for non-cardioembolic stroke. 
Unfortunately, only a few studies were identified from our review, investigating the effect of 
intense statin treatment on plaque morphology and even fewer examined the effect of 
targeting LDL levels<100mg/dL. [Makris GC, Lavida A, 2010] 
 
In a recent experimental study in fat apolipoprotein E-deficient mice it was found that 
fluvastatin may have an LDL-independent, pleiotropic effect on plaque stabilization 
[Nakamura K,2009]. The methodology applied was however, debated by researchers and 
further research on this issue appears to be necessary. Until then, the existing clinical 
evidence favours the fact that it is the effective lowering of LDL rather than the aggressive 
use of statins, which stabilizes carotid plaques [Corti R,2005; Watanabe K, 2005; Kadoglou 
NP,2008; Kadoglou NP,2009]. 
 
3.2.3. The use of combined lip lowering treatment. 
Two large systematic reviews suggested that targeting higher HDL levels and/or lower 
triglyceride levels could be beneficial in terms of stroke prevention [Amarenco P, Labreuce 
J,2008;  Labreuce J,2009]. This effect could be anticipated since the atherosclerotic process is 
not only associated with LDL levels but also with the function and levels of HDL and 
triglycerides. These are also considered major determinants of cardiovascular risk [Grundy 
SM,2004; Adult Treatment Panel III, 2001]. Niacin, fibrates and omega-3 fatty acids are the 
main agents that could be considered for combination treatment with statins. This could 
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establish better total lipidaemic control. There is accumulating evidence that combined 
lipidaemic treatment with niacin [Brown BG,2001], fibrates [Corti R,2007] and/or omega-3 
fatty acids [Iso H,2001; He K,2002] may further increase plaque stability , thus,potentially 
reducing the rates of stroke. However, only two studies have reported the direct effect of 
combined treatment with statin and niacin [Zhao XQ,2001; Phan BA,2007]. In addition only 
one study measured the effect of statin and omega-3 fatty acids using carotid IMT [Mita 
T,2007]. More studies are required in order to establish if there is any clinical benefit from 
the use of lipid-lowering agents other than statins in terms of primary and secondary stroke 
prevention.  
 
3.2.4. Imaging techniques and markers for carotid plaque evaluation after medical 
treamtment. 
In the majority of the included trials in our systematic review [Makris GC, Lavidas A,2010] , 
MRI and 2-dimensional ultrasound imaging have been applied to evaluate plaque changes in 
relation to statin treatment. The imaging features that were evaluated ranged from plaque 
size to composition but only a few of them investigated the effect on both these 
characteristics [Zhao XQ,2001; Phan BA,2007; Yamagami H,2008, Underhill HR,2008]. In 
addition, information about the effect of statins on intraplaque haemorrhage, ulceration and 
neovascularisation was scarce and no significant data about the response of these 
characteristics to statin treatment was identified. Recent studies have shown that these 
characteristics are associated with plaque instability and rupture [Gao P,2007; Fisher M, 
2005; Gao P, Chen ZQ,2007] and therefore further evaluation of their relation to statin 
administration is needed. 
 
Despite the evidence that IMT is a strong predictor of future cardiovascular events [Lorenz 
MW,2007], the Tromso study showed that in a general population carotid plaque area can 
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be a stronger predictor of myocardial infarction than IMT [Johnsen SH,2007]. New markers 
of extra-coronary atherosclerosis have been proposed for the evaluation of plaque 
composition and area/volume (size). A small number of studies evaluating the effect of 
statin administration on both plaque size and composition were identified [Zhao XQ,2001; 
Phan BA,2007; Yamagami H,2008; Underhill HR,2008]. However, due to the lack of clinical 
end points, such as stroke or TIA rates and appropriate duration of the follow-up, no direct 
comparisons can be made between the predictive values of plaque size versus plaque 
composition. There are potential benefits in measuring 3-dimensional volume instead of 
composition- as significant effects of therapy can be detected in just 3 months with relatively 
small sample sizes [Ainsworth CD, 2005].  
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 3.3 Limitations of the current evidence  
There is considerable heterogeneity between the clinical studies evaluating the effect of 
medical management on carotid plaque characteristics. This heterogeneity is mostly due to 
the variation in selected patient-populations, imaging modalities used, and the duration and 
type of statin treatment. Additionally, only nine randomized studies were found, three of 
which were of high quality. The number of included patients was generally small in the 
majority of the randomized and non-randomized trials and there was no common primary 
endpoint between most of them. Although the literature search was performed 
systematically publication bias should be taken into account when interpreting the results of 
this review. [Makris GC, Lavida A 2010] 
 
Van Bortel and his group [Kips JG, 2008] reviewed the imaging techniques currently used to 
identify vulnerable plaques, including those utilized in the studies we reviewed. Each 
technique has limitations, which must be taken into consideration when evaluating the 
effects of treatments on atherosclerotic plaque. 2D ultrasound can only provide limited 
views (longitudinal and transverse), making image quality and information content highly 
variable and operator dependent. Moreover, once an image is captured, additional views in 
other planes cannot be extracted. Preliminary results from 3D ultrasound studies suggest 
that some of these issues can be addressed using this novel technique [Chiu B,2008; Landry 
A,2005]. Nevertheless, it is also a heavily operator dependent technique which warrants 
further assessment and standardization. 
 
More recently the introduction of angio-MRI (MRA) and angio-CT (CTA) have revolutionized 
volumetric vascular imaging. However their limited accessibility, increased cost, invasive 
nature, increased patient inconvenience and the possibility of contraindications (in patients 
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allergic to the contrast or with renal impairment) limit their use. Particularly with MRA, a 
major limitation is the poor spatial (400μm) and temporal resolution [Hatsukami TS,2000]. 
Plain MRA can be utilized to assess the arterial anatomy, severity of stenosis and spatial 
resolution but only high-resolution MRI can identify crucial plaque components [Fuster 
V,2005] such as calcification, haemorrhage and lipid rich core. 
 
PET may also provide us with information regarding inflammation within plaques (i.e. 
macrophage activity), a useful marker for more metabolically active vulnerable plaques 
[Landini L,2003]. Nevertheless, due to its limited resolution, an adequate description of 
anatomical information cannot be provided. Thus, it must be combined with another 
imaging technique, like MRI, with obvious cost implications. Finally the exposure to radiation 
has to be significantly decreased before long-term follow-up studies can be performed.  
 
 
 
 
 
 
 
 
 
 
 
 
\ 
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3.4.Conclusion 
The current evidence regarding the effect of medical management on carotid plaque 
morphology and serum inflammatory markers suggests that carotid plaque morphology (size 
and composition) may be beneficially affected by statin administration.  
 
However, due to the significant heterogeneity between the studies, the lack of large, high 
quality randomized trials and the possibility of publication bias, solid conclusions are hard to 
reach. In addition the clinical significance of the attributed changes in carotid plaque 
morphology remains unknown, along with the question of whether this is an LDL associated 
effect or a separate pleiotropic phenomenon of statins.  
 
Properly designed studies that will investigate the sole or combined effect of statins with 
other lipid-lowering treatments on carotid plaque features and on the rate of 
cerebrovascular events, are warranted. Advanced imaging techniques such as high-
resolution MRI and 3-dimensional ultrasound in combination with sophisticated image 
analysis software may also have a role in this direction. 
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Chapter 4 
Emerging imaging techniques for the evaluation of carotid 
atherosclerosis: The MRI advances 
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4.1. Introduction 
MR imaging is a relatively new tool that has found significant applications in vascular imaging 
due to the excellent soft tissue characterisation capabilities that it provides. A small number 
of studies have shown that vessel and plaque quantification measurement using MR can has 
be reproducible but there is still significant variability that should be taken into account in 
the design of future prognosis studies and clinical trials. This is especially true with regard to 
specific features such as the reproducibility of fibrous cap identification that needs to be 
improved. [Touzé E,2007] 
Novel MR-defined plaque features of vulnerability are emerging and appear promising for 
the identification of the vulnerable plaque. In a recent systematic review in a total of 779 
subjects it was demonstrated that the presence of plaque features such as intraplaque 
haemorrhage, lipid-rich necrotic core, and thinning/rupture of the fibrous cap is linked to an 
increased risk of future stroke or transient ischemic attack in patients with carotid 
atherosclerotic disease. Dedicated MRI of plaque composition can offer stroke risk 
information beyond measurement of luminal stenosis in carotid atherosclerotic disease. 
[Gupta A, 2013]. 
Although MRI is promising with regard to its clinical application for plaque characterisation, 
it will require further consensus regarding MRI settings and confirmation by histology. In a 
recent systematic review of the literature where more than 17 studies were included only 
two studies were performed on a high-resolution 3.0-T MRI scanner whereas the majority 
was performed on a 1.5-T scanner. This review of the available evidence suggested that it is 
probably premature for to routinely use MRI as an imaging modality to assess carotid 
atherosclerosis characteristics, which can be associated with plaque vulnerability. At the 
moment no well established predefined protocols for histology and MR imaging are in place 
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and further consensus will be needed with evidence provided by future studies.[den Hartog 
AG,2013] 
Purpose of this chapter is to review the most important recent advances in MRI technology 
allowing better imaging and modelling of carotid atherosclerosis. 
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4.2.Novel MRI techniques  
4.2.1. High resolution MR imaging above the 1.5Tesla 
Currently the majority of MR based carotid imaging is performed using 1.5T magnets. The 
continuous advances in MR technology have allowed carotid imaging at higher magnetic 
strengths. Preliminary experience with eight-channel or higher neurovascular coils at 3T 
indicates an increase in signal to noise ratio (SNR) to contrast to noise ratio (CNR) compared 
with 1.5T, which is likely to improve resolution of carotid MR angiography. In a study of 18 
subjects with carotid atherosclerosis 1.5 and 3 T systems using phased-array coils were used 
for imaging. [Young VE, 2012]  T(1) weighted (T(1)W), T(2) weighted (T(2)W) and proton 
density-weighted (PDW) images were obtained and multiple slices were prescribed to 
encompass both the carotid bifurcation and the plaque. In this study the mean improvement 
in SNR in plaque was 1.9, 2.1 and 2.1 in T(1)W, T(2)W and PDW images, respectively, which 
were statistical significant. In a similar study by Furie et al.,[ Hinton-Yates DP,2007] in a total 
of 10 subjects, the use of 3.0 T for carotid plaque imaging resulted in an  increase in SNR and 
CNR compared to 1.5 T. 
However, improved resolution may not be the most exciting application of 3T MR imaging. 
Several plaque components potentially identified on 3T MR imaging are correlated with 
recent ipsilateral carotid thromboembolic symptoms. The combination of 3T and sensitive 
surface coils can improve the evaluation of carotid plaque composition, which would 
contribute towards the shift of MR imaging away from a strict evaluation of luminal 
narrowing to a dedicated evaluation of plaque morphology and texture. This notion was 
demonstrated in a study by Demarko et al, in which 19 patients were imaged at 3T. In this 
study there were significant associations between the presence of thin/ruptured fibrous cap 
(100% versus 36%, P = .006) and lipid-rich necrotic core (100% versus 39%, P = .022), with 
marginal association with haemorrhage (86% versus 33%, P = .055). [Demarco JK,2010] 
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4.2.2. 2D versus 3D MRI 
The use of traditional 2 dimensional (D) MR imaging versus 3D for carotid plaque evaluation 
is still a matter of considerable debate. In a 2 dimensional sequence, each radiofrequency 
(RF) pulse excites a only narrow slice, while in a 3D one, each RF pulse excites the whole 
imaging volume using phase encoding to discriminate spatially. For general MR use, 3D 
sequences have shown to achieve greater sensitivity since each acquisition represents an 
average of the entire sampled volume. In a study by Balu et al, a total of 18 subjects with 
significant carotid stenosis were scanned with 2D (2-mm slice thickness) and 3D (1-mm/0.5-
mm slice thickness). [Balu N,2008] Morphological measurements, signal-to-noise ratio (SNR) 
in the wall and lumen, and wall-lumen contrast-to-noise ratio (CNR) were compared 
between 2D and 3D images. The lumen SNR, wall SNR, and CNR were comparable between 
the two methods. There was also no difference in average volumetric measurements 
between 2D/3D. In contrast the distributions of small plaque components such as 
calcification were better characterized by the 3D acquisition while there was a higher 
sensitivity to motion artifacts with 3D imaging, resulting in a small number of examinations 
with low image quality. The conclusion from this study was that 2D and 3D protocols can 
provide comparable morphometric and volumetric measurements of the carotid artery with 
the 3D imaging offering an advantage in terms of small plaque component visualization but 
with the price of lower reliability for image quality. 
In another study [Takano K, 2012], twenty-two patients scheduled for carotid 
endarterectomy underwent carotid plaque MR imaging with both 2D and 3D MR sequences 
and the quality of images as well as the SNR was evaluated. These observations were 
compared for each plaque component according to the histological category of the plaque 
between 2D and 3D sequences. No significant differences were observed among the overall 
imaging quality scores of the two modalities, although 3D sequences allowed visualization in 
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random orientations, as well as better depiction of small plaque components such as 
ulcerations and calcifications. The SNR of the plaque to the submandibular gland on T1-
weighted 3D sequence was significantly higher than that on 2D sequence. In addition it was 
shown that the SNR of the plaque to the submandibular gland of histology-defined soft 
plaque components were significantly higher on T1-weighted 3D sequence than on 2D 
sequence. There were no significant differences between the two T1-weighted sequences 
for hard components. From this study it was concluded that 3D variable-flip-angle turbo 
spin-echo is a promising tool for the diagnosis of carotid plaques and can improve the 
characterisation of certain plaque components. Further research is warranted. 
4.2.3. Dynamic contrast enhanced MR imaging 
The theory of intraplaque neovascularisation being associated with active intraplaque 
inflammation and increased risk for rupture has gained popularity the last decade. In the 
past, dynamic contrast enhanced (DCE) MRI was extensively utilised to study the vascularity 
and neovascularisation within tumours. Recently though, further applications came to light 
with delayed and dynamic contrast enhanced (CE) MRI being introduced as non-invasive 
tools to assess the extent of plaque neovascularization in animals and patients with 
atherosclerosis. [Calcagno C, 2010]. Gadolinium is a contrast agent typically administered for 
routine MR angiography and can be used to improve plaque characterization. Gadolinium 
has favourable properties that allow enhancement of the cap, more reliable vessel wall 
measurements, and better visualisation of the intraplaque neovessels. The above properties 
combined with the pre-contrast series can help in the identification of intraplaque 
haemorrhage. At the moment there is a limited number of studies evaluating the usefulness 
of these features in stroke risk prediction. 
In a study by a Yuan et al [Sun J,2013] , symptomatic patients with carotid plaque disease 
underwent bilateral carotid artery MRI examination, which included multi-contrast 
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sequences for detecting intraplaque haemorrhage (IPH)  and a DCE MRI sequence for 
characterizing adventitial perfusion. Kinetic modelling of the dynamic contrast-enhanced 
MRI time series was performed to estimate adventitial perfusion and K(trans). The presence 
of IPH was linked to a significantly higher value in adventitial K(trans) (0.142 ± 0.042 vs 0.112 
± 0.029 min(-1); P<0.001). This relationship remained significant after adjusting for other 
confounding factors. This study demonstrated an independent pathophysiological link 
between the adventitia and IPH and related it to the microcirculation of the adventitial vasa 
vasorum. Adventitial perfusion imaging may be useful in studying plaque pathogenesis, but 
further studies  are deemed as necesary. 
In another study [Gao T, Zhang Z,2009], it was shown that different types of stroke can be 
identified by brain MRI detection before invasive therapies. In this study 102 consecutive 
subjects with and without cerebrovascular event were studied with contrast-enhanced 
carotid MRI, brain MRI and magnetic resonance angiography. This study demonstrated that 
from 63 patients with mild to moderate stenosis (< or =70%), 44 (69.8%) had vulnerable 
plaques, which was significantly more than those in patients with severe stenosis (>70%; p < 
0.001).  
Finally in a study by Millon et al., sixty-nine patients scheduled for a carotid endarterectomy 
underwent a 3-T contrast enhanced MRI. [Millon A,2012] The carotid plaque enhancement 
was assessed on T1-weighted images performed pre and post contrast administration. 
Histological analysis was performed of the entire plaque and of the area with matched 
contrast enhancement on MR images. Gadolinium enhancement was observed in more than 
50% of the patients. There were three types of carotid plaques that were identified 
depending on the enhancement pattern. In other words they were grouped according to 
whether it was the shoulder region, the shoulder and fibrous cap or the central part of the 
plaque enhancing more. Fibrous cap rupture, intraplaque haemorrhage, and plaque 
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gadolinium enhancement was significantly more frequent in symptomatic than in 
asymptomatic patients (P=0.043, P<0.0001, and P=0.034, respectively). After histological 
analysis, gadolinium enhancement was significantly associated with vulnerable plaque 
(American Heart Association VI, P=0.006), neovascularization (P<0.0001), macrophages 
(P=0.030), and loose fibrosis (P<0.0001). The presence of neovessels, macrophages, and 
fibrosis in the enhancing area was 97%, 87%, and 80%, respectively, and was different 
depending on the enhancement location in the plaque. From this study it appears that the 
enhancement of carotid plaque is associated with vulnerable plaque phenotypes and related 
to an inflammatory process. 
4.2.4. Ultrasmall superparamagnetic iron oxide (USPIO) 
Sinerem is an ultrasmall superparamagnetic iron oxide (USPIO), which has significant uptake 
by macrophages and thus it, can act as a marker of inflammation. The application of USPIOs 
in MRI imaging has helped us to track the macrophage activity in carotid atherosclerosis. In a 
study Tang et al., twenty symptomatic patients underwent multi-sequence MRI before and 
36 hours after USPIO infusion. [Tang T, Howarth SP,2006]. The images were manually 
segmented into quadrants, and the signal change in each quadrant was assessed after USPIO 
administration. All symptomatic carotid plaques appear to have inflammatory components 
with an increase in USPIO uptake.  This study highlights the argument that carotid 
atherosclerosis can be a truly systemic disease. In addition, in another study by Tang et al., 
the relationship between the degree of MR-defined inflammation using USPIOs particles and 
the severity of luminal stenosis in asymptomatic carotid plaques was explored. It was shown 
that there was no significant relationship between the degree of inflammation and the 
degree of luminal stenosis, supporting the theory that the currently used as gold standard, 
degree of stenosis, is not the best marker for stroke risk evaluation. [Tang TY, Howarth 
SP,2008] 
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In another new promising application of MRI-USPIOs, it was combined with PET-FDG for the 
evaluation of the carotid atheroma inflammation. In a small feasibility study, in two patients, 
it was shown that the imaging results from the two types of imaging were complementary 
and concordant, implying that both techniques mirror similar metabolic processes. The main 
conclusion of this study was that the inflammatory activity identified by these two possibly 
complimentary methods, might act as a possible surrogate risk marker for the identification 
of patients who are suitable for carotid surgery. Obviously solid evidence is still lacking 
regarding the practical clinical outcomes and further research is warranted regarding its cost 
effectiveness. [Tang TY, Moustafa RR,2008]  
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4.3.Combination of MRI with PET for the investigation of carotid plaque disease 
In recent years hybrid scanners such as PET/CT have emerged as a useful modality in clinical 
routine as well as an important research tool. The newly developed fully integrated PET/MR 
scanners combine excellent soft tissue contrast and functional imaging capabilities. Their 
combination can quantify plaque neovascularization and inflammatory infiltrate, 
respectively. Previous studies have shown that plaque (18)F fluorodeoxyglucose (FDG) 
uptake correlates with macrophage content and that it may be an alternative modality to 
directly identify the inflamed plaque in carotid artery stenosis. In this section we are 
presenting the available evidence on the combination of these two techniques for the 
identification of the vulnerable plaque. [Davies JR,2005] 
In a study by Kwee  et al., 50 patients with symptomatic carotid stenosis were assessed with 
CT, MR and FDG-PET imaging and the agreement between them was compared. It was 
shown that correlations between (18) F-FDG PET and CT/MRI findings are weak, however, 
correlations between CT and MRI measurements appear to be moderate to strong, but with 
considerable variation in absolute differences. [Kwee RM,2009].  
Finally in a study by Davies et al.,only  in 7 out of the 12 patients waiting for an 
endarterectomy, high FDG uptake was seen in the lesion targeted for endarterectomy. In the 
remaining 5 patients, FDG uptake in the targeted lesion was low. [Davies JR,2005] In these 5 
patients, 3 had non-stenotic lesions identified on HRMRI that exhibited a high level of FDG 
uptake. All 3 of the highly inflamed non-stenotic lesions were located in a vascular territory 
compatible with the patients' presenting symptoms. This was one of the first studies to 
suggest that angiography may not always identify the culprit lesion. From this preliminary 
data it appears that combined FDG-PET and HRMRI might be able to assess the degree of 
inflammation in stenotic and non-stenotic plaques, which could potentially be used to 
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identify lesions responsible for embolic events even when the degree of stenosis is less than 
70%. 
Again it seems that the combination of MRI and PET may add significant information useful 
for plaque characterization. However, the especially high cost of these two techniques 
combined makes the evaluation of their cost effectiveness mandatory before any safe 
conclusions can be reached. Further studies are warranted. 
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4.4. Conclusion 
MR imaging has revolutionised many areas of clinical imaging and diagnosis. Lately there has 
been significant activity in the field of vascular imaging and especially that of carotid imaging 
and stroke. The identification of the vulnerable carotid plaque has proven to be a 
particularly complicated problem with many parameters and limitations. Ultrasound has 
been for years the mainstay of diagnosis and is still the basis of every management plan, 
however, there is mounting evidence to suggest that it is not enough. MR is currently the 
most sophisticated imaging method with favourable imaging properties and a wide range of 
potential “plug inns” that could be very useful for the development of a customised 
approach with regard to the identification of the vulnerable plaque. At the moment there 
are many different promising approaches which are based on MR imaging, though, most of 
them are just at their beginning and further clinical research is need to determine clinical 
outcomes and cost effectives. Until then ultrasound will remain the first line investigation of 
choice.
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PART II 
Methods for 2D and 3D ultrasound image analysis and processing 
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Chapter 5 
Established 2D ultrasound image analysis methodology for carotid plaque 
characterization 
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 5.1. Introduction 
The Asymptomatic Carotid Stenosis and Risk of Stroke (ACSRS) Study was an international, 
multicentre, natural history study of asymptomatic patients with internal carotid artery (ICA) 
stenosis >50% (ECST criteria). The principal aim of the ACSRS study was to identify subgroups of 
patients with annual stroke risk of less than 1% and more than 4% using local (plaque 
characterization and texture analysis) and systemic factors in addition to the degree of stenosis 
[Liapis CD,2009]. 
Bilateral carotid ultrasound scanning was performed on admission to the ACSRS study and the entire 
duplex investigation was recorded on VHS videotape and sent to the coordinating centre. The 
degree of stenosis was graded according to established velocity criteria and expressed as both ECST 
and NASCET percentages. Our group over the years has developed a unique methodology and 
software for objective characterisation of carotid plaque composition. 
The exact image acquisition technique will be described in this chapter.  
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 5.2.Methods  
5.2.1.Ultrasound duplex examination 
Two dimensional Ultrasound image capture Ultrasound examinations were performed using duplex 
scanning and colour flow imaging (IU2200,Phillips Ultrasound System, USA). Duplex scans and plaque 
images were recorded on S-VHS videotapes and later on DVDs discs. A S-VHS “Panasonic” video 
cassette recorder (model AG-7350-B, Matsushita electric Ind. Co. Ltd, Japan) and an external 
capturing device-frame grabber (Snappy v2, Play Inc., Ca, USA) were used to transfer the images 
from the videotapes to a computer, saved as Tag Image File Format (Aldus TIFF) files at the initial 
stages of the ACSRS study.  
5.2.2. Standard ultrasound imaging settings and degree of stenosis assessment 
The degree of stenosis was graded according to established velocity criteria and expressed as both 
ECST and NASCET percentages [Liapis CD,2009; Nicolaides AN, Kakkos SK,2010]. A high frequency 
linear array probe (4 -7 MHz) was used and the following technical ultrasound settings ensured 
optimum image quality for plaque type classification and texture analysis: 
• Maximum dynamic range was used to ensure the greatest possible display of gray scale 
values.  
• Persistence was set on low and frame rate on high, the latter ensuring good temporal scale 
values.  
• The time gain compensation curve (TGC) was sloping through the tissues but was positioned 
vertically through the lumen of the vessel because to ensure that the brightness of the 
adventitia of the anterior and posterior walls was similar. 
• The overall gain was adjusted to give optimum image quality. This was achieved by 
adjustment of the gain control to minimize but not abolish noise.  
• The ultrasound beam was at 900 to the arterial wall.  
• The minimum depth was used so that the plaque occupied a large part of the image. 
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 5.2.3. Computer-assisted plaque analysis   
Analysis of the baseline carotid plaque characteristics was performed with the use of the “Plaque 
Texture Analysis” software  (version 3.2 –Incosoft International Ltd, PO Box, Greenford, London UB6 
9ZN) after image normalization and segmentation. The black and white image and the corresponding 
colour image (using the colour or power Doppler) of the area of interest were used for the 
identification of the plaque outline during segmentation (image 5.1) as it has been shown in a recent 
publication [Fenster A, 2004]. Fifty-one histogram and ultrasound texture features of the grey tones 
were produced from the outlined carotid plaque area and were extracted (image 5.2) using the 
following algorithm methods (Appendix I): 
(i) Histogram measures. 
(ii) First order grey level parameters, including grey scale median (GSM)  
(iii) The Spatial Gray Level Dependence Matrices (SGLDM) . 
(iv) Gray level difference statistics (GLDS). 
(v) Gray level run length statistics (RUNL) . 
(vi) The Fourier power spectrum (FPS). 
Methods (iii)-(vi) are novel texture analysis algorithms used to study heterogeneity, which will be 
studied in this thesis. All methods were applied on the region of interest (ROI) selected by the expert 
physician; pixels used for the analysis were only the pixels of the ROI, and not the pixels of the 
rectangle that includes the ROI, as several other applications do.  
 
5.2.4. Visual plaque classification  
Carotid plaques were classified into five types according to their overall echodensity in: 
• Type 1 (completely echolucent lessons, sometimes a thin fibrous cap is visible) 
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 • Type 2 (predominantly echolucent lesions having less than 50% echogenic components) 
• Type 3 (predominately echogenic with less than 50% echolucent components) 
• Type 4 (uniformly dense echogenic lesions with less than 10% echolucent components)  
• And type 5 (calcified plaques with excessive acoustic shadow).  
 
The presence of discrete echogenic plaque components or the presence of 15% or more of the total 
plaque area as an echolucent plaque component near the lumen (juxta-luminal) was also recorded.  
[Kakkos SK, Griffin MB,2012] 
The above settings were essential prerequisites for plaque texture analysis, which was performed at 
the coordinating center. Participating sonographer to the ACSRS study had to attend a two-day 
training course at the coordinating center.  
 
Video-recordings of the examination and snapshot images of plaques were sent to the coordinating 
center for image analysis. Continuous feedback was provided to the participating centers to ensure 
quality [Heliopoulos J,2008]. 
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Image 5.1: B-mode and corresponding Doppler image in Inconsoft Carotid Plaque Texture analysis 
programme as they were acquired by the 2D ultrasound scan. 
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Image 5.2: Example of feature extraction from a specific carotid plaque slice using the image analysis 
software. 
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Chapter 6 
Development of the 3D image acquisition and analysis protocol 
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 6.1. Introduction 
Three-dimensional ultrasound (3DUS) may combine the advantages of volumetric vascular imaging 
of MRI with those of ultrasound imaging (increased availability, non-invasive nature and decreased 
cost) [Makris GC, 2011].  The new volumetric acquisition techniques may facilitate the storage of 
multiple, consecutive and equidistant views, which are subsequently converted in a matrix of points, 
which are representative of the volume scanned.  
 
The purpose of this study was the development of a protocol to obtain and analyse the composition 
and volume of an entire carotid plaque using 3DUS. 
 
 Our hypothesis is that 3DUS may simultaneously provide us with carotid plaque characteristics such 
as volume and composition for the entire plaque with the use of a simple, semi-automated method 
of plaque analysis and commercially available software.  
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  6.2. Methods and protocol development 
  6.2.1. 2D Ultrasound scanning 
Bilateral carotid ultrasound scanning was performed using a high frequency linear array transducer 
(4 -7 MHz, Phillips IU22). The ultrasound beam was at 90o to the arterial wall and the minimum 
depth was used so that the plaque occupied a large part of the image. This way optimum image 
quality for plaque type classification and texture analysis was obtained (image 6.1). 
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Image 6.1: Common carotid echogenic plaque in B-mode, 2 dimensional ultrasound imaging. 
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 6.2.2.Three dimensional image acquisitions  
The VL13-5, 3D broadband, linear array probe (Phillips Co) on an iU22 ultrasound system (Philips Co.) 
was used to obtain 3D images. After the carotid plaque was identified with the 2D probe the 3D 
probe was positioned above the lesion. A set of multiple B-mode and the corresponding colour 
Doppler 3D images of the carotid plaque were automatically acquired. 
 
6.2.3. Segmentation using Q-Lab software  
The Qlab software (Philips Co.) is commercially available quantification software with various 
applications in cardiac, 3D ultrasonography. However certain applications of this software can be 
applied for the analysis of carotid plaque images. The application “General Imaging 3DQ (GI -3DQ)” 
provides tools for measuring angles, 2D distance, area and volume The obtained 3D images of the 
entire carotid plaque volume were uploaded to this software using a regular personal computer. The 
inter-slice distance was set to 2mm and the number of slices to 13 in order to cover the entire 
plaque volume (Image 6.2). The software, with the use of the “iSlice” application, automatically 
produced the corresponding transverse sections for the entire plaque volume (image 6.3). The same 
procedure was followed for both the B-mode and the corresponding colour images. 
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Image 6.2: Q-lab interface: (1) longitudinal section of the carotid plaque as obtained by 3D 
ultrasound probe; the vertical lines represent the acquired transverse sections, (2) an 
example of a transverse section of the plaque as acquired by 3D ultrasound, (3) horizontal 
view of the common carotid, (4) Acquired transverse sections of the entire carotid plaque. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 2 
3 4 
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Image 6.3: Thirteen transverse sections as they were acquired from the 3D ultrasound probe. The 
inter-slice distance was 2mm. 
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 6.2.4. Image analysis 
The image analysis was performed using the commercially available “Iconsoft Carotid Plaque Texture 
analysis” software as described in the previous chapter. For each pair of the colour and the 
corresponding B-mode transverse images produced by the Qlab software, image normalisation for 
gray scale, image standardisation to 20 pixels per mm, image segmentation (cropping of the plaque) 
and texture features extraction were performed as it has been described in previous publication by 
our group [Kakkos SK, 2009]. The same procedure was repeated for all the 13 3D transverse sections 
as well as for the 2D longitudinal section. 
 
6.3. Calculation of volume and texture features of the 3D images  
Plaque Volume and Volume Texture Feature were then calculated using the following, simple, 
mathematical formulas: For transverse sections at n mm intervals:   
 
Volume = (Area1 x n) + (Area2 x n) +...+ (AreaN x n). 
 
 For the mean GSM of the entire plaque the value was calculated as follows:  
 
GSMvol = (GSM1 * Area1) + (GSM2 * Area2) +....+ (GSMn * Arean) / Area1 + Area2 +.......+Arean.  
 
The latest version of the statistical software SPSS (IBM) was used for the analysis of the data. 
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 6.4. Preliminary results and proof of concept 
To test this methodology we analysed the carotid plaque (image 6.1), which was obtained from a 
volunteer during a regular outpatient appointment and after verbal consent was obtained. 
 
6.4.1. Pilot 2D measurements 
The GSM and plaque area of the longitudinal section of the plaque were 35.82 and 59.8mm2 
respectively. According to these measurements the plaque belongs to a plaque type III. 
6.4.2. Pilot 3D measurements 
Thirteen transverse sections with an inter-slice distance of 2mm were automatically produced and 
analysed from the obtained 3D volume (Image 6.3). The mean GSM and plaque area from the 
transverse sections were 24.7 (SD: 9.5) and 18.8 mm2 (SD: 6.17) respectively. The variability of GSM 
and plaque area along the various plaque transverse segments is obvious as it is illustrated in figures 
6.1 and 6.2. For the entire plaque the GSM and plaque volume were 23 and 490.6 mm3, respectively. 
There was a significant difference between the GSM of the entire plaque as this was acquired during 
the 3D imaging and the GSM of the ultrasound slice, which was captured with the 2D probe.  The 
echogenicity of the plaque is almost doubled when the whole volume of the plaque is considered. 
This isolated finding may indicate that, indeed, there can be significant differences in plaque 
characterization when evaluating a random 2D longitudinal slice of the plaque and when the whole 
volume of the carotid plaque is being assessed using 3D ultrasound. 
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 Figure 6.1: Grey scale median (GSM) change of the transverse images long the course of the carotid 
plaque. The interslice distance is 2mm. 
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 Figure 6.2: Transverse plaque area measurements along the course of the carotid plaque. The inter-
slice distance is 2mm. 
 
 
 
 
 
 
 
?
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 6.5 Discussion 
6.5.1. The value of 2- dimensional ultrasound and the dawn of the 3D era 
For a significant number of patients with carotid plaque disease the 2D ultrasound and the 
subsequent analysis of the information that is provided are sufficient in order to determine the best 
possible plan of care. However, 2D ultrasound can only provide us with a limited number of views 
(longitudinal and transverse) and certainly their quality and information that they contain can vary 
due to its heavily operator-dependant nature. In addition, once the slices (2D) have been captured it 
is not possible to extract additional planes from the same plaque. The above may have significant 
implications if we intend to use the composition of the plaque as a risk stratification tool. 
 
The 2D ultrasound provides us with the same information as if we were taking an imaging “biopsy” 
of a certain part of the plaque, which then we consider as representative of the entire plaque. The 
reason is that atherosclerotic plaques “grow” in a 3-dimensional environment in all directions both 
in the longitudinal and transverse axis of the artery. In addition, in the case of heterogeneous 
plaques the single capturing of one 2D slice of the carotid plaque may be not really representative in 
terms of composition. Of course, as it was mentioned before, even this approach may be sufficient 
and cost-effective for a significant number of patients, however, the detrimental effects of 
cerebrovascular events urge for the investigation of every possible improvement in the diagnosis 
and management of the vulnerable carotid plaque. 
6.5.2.Principles of 3D ultrasound imaging for volumetric and composition measurements 
The basic concept behind 3DUS imaging is that by combination and juxtaposition of non-contiguous 
2 dimensional ultrasound slices to obtain a 3D volume of the image of the targeted structure. There 
are three necessary steps, which are required: 
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              i. Acquisition of a series of images through manual or mechanical scanning 
Manual scanning using a 2D ultrasound probe and a hand-free technique was utilized at the 
preliminary stages of 3D imaging development for image acquisition. This technique had an 
important limitation resulting from the uncontrolled scanning speed, which could affect the accuracy 
and reproducibility of the volume measurement. This is the reason why the new generation of 3D 
probes is able to perform mechanical scanning with constant speed. This way the acquired slices are 
deflected by the same angle and separated by a regular distance and thus there is increased 
accuracy and reproducibility of the measurements. The types of probes currently available for 
mechanical scanning are linear probes for linear scanning and convex probes for angular scanning 
both of which have peripheral vascular applications. 
            ii. Image transformation in a matrix of corresponding points and volume reconstruction. 
Each point of every acquired 2D slice is then placed in space according to specific x, y and z 
coordinates creating a 3 dimensional matrix of the image. The interslice distance (which can be 
predetermined) and the interslice spaces are filled by points, which are automatically interpolated 
from the grey-scale average levels of the 2 adjacent corresponding views.  When there is underlying 
movement of the targeted organ (i.e. during systolic and diastolic vessel movement) ECG 
synchronization may be required in order to avoid the corrugation of the image.  
iii. Computerized processing of the data and volume digitalized illustration and navigation. 
Sophisticated software such as the Q-Lab™ (Phillips) can provide us with the significant computer 
power that is essential for the analysis of the acquired 3D information. The basic concept behind this 
kind of software is the combination of surface geometric information and the 3D ultrasound 
representation of the tissue as voxels (3D) instead of pixels (2D). The main reconstructions can be 
performed off-line using a conventional, personal computer and after the scanning of the patient 
has been completed without any additional inconvenience for the patient.  
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 There are certain limitations to our methodology mainly because the technique is based on 
ultrasound principles. Thus, very calcified plaques or very tight carotid stenosis (above 90%) may 
cause image degradation and make the image analysis of the plaque impossible. In addition because 
of the bulkier 3DUS probe manoeuvring can be more challenging in patients with high bifurcations. 
In these patients the use of MRI may be appropriate in order to get compositional information about 
the underlying carotid plaque.  
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 6.6. Conclusion 
Simultaneous analysis of the composition and volume of the entire carotid plaque is feasible using 
3D ultrasound and a simple, semi-automated, computerized methodology for image analysis based 
on commercially available software.  
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Chapter 7 
Development of plaque motion analysis methodology for the identification of 
the vulnerable carotid plaque. 
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 7.1. Introduction 
It has been suggested that plaques may rupture not only as a result of inherent instability, but also 
due to excessive mechanical forces during the cardiac cycle. Hennericci  et al., proposed that plaque 
surface motion analysis maybe able to distinguish between high and low risk plaques. [Meairs,1999] 
This approach was based on reconstructions of plaque motions using temporal 3-D ultrasound 
imaging. This study showed that there were important differences in the maximal discrepant surface 
velocity motion between asymptomatic and symptomatic plaques. In another study by Murillo et al. 
a multi-scale motion approach was used to estimate 2-D plaque motion and differentiate between 
symptomatic and asymptomatic carotid plaque. [Murillo S,2012]  Finally Golemati et al. in a more 
recent study reported on the differences found between the average motion measurements 
extracted from symptomatic versus asymptomatic cases [Golemati,2012]. 
In this chapter we will describe a new image analysis methodology for quantifying discordant plaque 
motion, which is the phenomenon of different parts of the plaque moving in different directions 
with different velocities during the cardiac cycle. Concordant plaque motion on the other hand is the 
phenomenon of all parts of the plaque moving in the same direction and the same velocity. 
Obviously, discordant motion could be related to higher strains, as opposed to concordant motion, 
which is associated with lower strain values.  
Our aim is to develop this methodology for objective plaque motion analysis that will classify and 
quantify the carotid plaque motions and help clinicians to differentiate between plaques that are 
likely to rupture because of high internal strains from those with low strains. 
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 7.2.Method 
The plaque Motion Analysis (PMA) was studied using customised research software developed by   
Dr Hamed Nasrabadi and Professor Marios Pattichis from the University of New Mexico, USA.  
7.2.1. Ultrasound video acquisition and visual classification 
Before any processing the video loops were anonymised and studied blind without knowledge of 
symptoms. The size of the ultrasound videos was 568 x 448 pixels and the frame rate 40 frames per 
second (fps).  
We extracted a series of 8-10 consecutive cardiac cycles from each video loop that did not include 
motion artefacts such from neck movement or swallowing. The loops were then categorised visually 
as with concordant or discordant motion. A carotid plaque was reported as discordant if it had 
components move in different directions, at certain parts of the cardiac cycle, especially in peak 
systole. Instead, it was classified as concordant if it had all of its components simultaneously move in 
the same direction throughout the cardiac cycle.  
7.2.2 Video motion estimation  
Motion estimation was based on Farneback’s method [Farnebäck G,2002]. This method has been 
shown to perform slightly better than the method developed by Horn and Schunck’s [Horn 
BKP,1981].  Motion was computed between any two video frames, in contrast to the traditional 
Horn and Schunck’s approaches that uses the averages over several video frames [Horn BKP, 1981]. 
For this motion estimation protocol, we computed the overall motion over a time interval specified 
by the used as opposed to computing motion between successive video frames. This is specified as 
the 𝑇𝑇𝑤𝑤𝑜𝑜 𝐹𝐹𝑟𝑟𝑎𝑎𝑚𝑚𝑒𝑒𝑠𝑠 𝐶𝐶𝑜𝑜𝑚𝑚𝑝𝑝𝑎𝑎𝑟𝑟𝑖𝑖𝑠𝑠𝑜𝑜𝑛𝑛 𝐼𝐼𝑛𝑛𝑡𝑡𝑒𝑒𝑟𝑟𝑣𝑣𝑎𝑎𝑙𝑙 parameter. In this study the interval between different 
successive frames compared was set to 0.1 seconds. 
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 7.2.3. Plaque motion visualization and analysis 
Unstable plaques were those that were seen to move in different directions in peak systole. Stable 
plaques on the other hand were those that had all their parts move simultaneously in the same 
direction throughout the cardiac cycle.  
Between the different sequential frames the interval compared was 0.1 sec, the distance between 
the pixels with vectors was 10 pixels and the magnitude of pixel movement was set to 5. Histogram 
bar width was set at 6 and cut-off to peak ratio (polar-fan) at 0.5. 
For every cine-loop a plot of peak motion against fan width was obtained (Fig 7.1). From each plot, 
the maximum fan-width (MFW) corresponding to pixel movement 5 (MFW5), 4 (MFW4), 3 (MFW3) 
and 2 (MFW2) were obtained. Also, the sum of the MFWs for pixel movements 5 to 3 (SMFW5-3) 
and the sum of the MFWs for pixel movements 5 to 2 (SMFW5-2) were calculated. 
 
 
 
 
 
 
 
 
 103 
 (A) 
(B) 
(C) 
Figure 7.1. (A) Frame 61 at peak systole compared with the frame 57 (interval of 0.2 sec) shows that 
all the pixels move in the same direction. (B) The data of frame 61 show the histogram of the pixels 
and the motion amplitude. The narrow fan on the circular presentation confirms that all the pixels 
move in the same direction (C) Scattergram of peak motion against fan width. There is a 
characteristic narrow fan-width for peak motion of 7 pixels down to 2. 
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 7.3. Conclusion 
It appears that with the use of this methodology and software we can develop objective measures to 
analyse carotid plaque motion using B-mode ultrasound video loops. This way we can obtain 
dynamic information regarding plaque interaction with its surrounding environment, which might be 
useful for further plaque characterisation. The preliminary results from the further evaluation of this 
methodology will be present at Part V of this thesis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 105 
  
 
 
 
 
 
 
 
 
 
 
PART III 
The Asymptomatic Carotid Stenosis and Risk of Stroke (ACSRS) 
Study; post hoc analysis 
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Chapter 8 
The effect of novel texture features of homogeneity and echolucency on 
carotid plaque characterization; Results from the ACSRS study 
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 8.1.Introduction 
The Asymptomatic Carotid Stenosis and Risk of Stroke (ACSRS) Study was an international, 
multicentre, natural history study of asymptomatic patients with internal carotid artery (ICA) 
stenosis >50% (ECST criteria). The principal aim of the ACSRS study was to identify subgroups of 
patients with annual stroke risk of less than 1% and more than 4% using local (plaque 
characterization and texture analysis) and systemic factors in addition to the degree of stenosis 
[Nicolaides A, Sabetai M,2003].Clinical factors such as age, cardiac failure, male gender, myocardial 
ischemia and left ventricular hypertrophy on electrocardiogram (ECG) were independent predictors 
of increased risk for cardiovascular and all cause mortality according to Cox multivariate analysis 
[Kakkos SK, Nicolaides A,2005].  
 
Using the above risk factors it was possible to identify a high-risk group consisting of one third of the 
studied population with 66% all cause death rate and 40% cumulative cardiovascular death rate at 7 
years. In addition serum creatinine levels of more than 85 micromols/L, history of contralateral 
transient ischaemic attacks (TIAs) [Nicolaides AN, Kakkos SK,2005] or silent embolic infarcts on the 
CT scan [Kakkos SK, Sabetai M,2009] were identified as independent predictors of ipsilateral 
neurologic events including stroke. The final results of the ACSRS study were recently published 
indicating that the degree of stenosis, history of contralateral TIAs or stroke, grey scale median 
(GSM), plaque area, and discrete white area (DWA) were independent predictors of ipsilateral 
cerebrovascular or retinal ischemic (CORI) events. [Nicolaides AN, Kakkos SK,2010] 
 
Combinations of the above factors could stratify asymptomatic patients into different stratum of risk 
for ipsilateral CORI events with predicted risk close to observed risk. Of those 923 patients with          
≥ 70% stenosis, the predicted cumulative 5-year stroke rate was less than 5% in 495, 5% to 9.9% in 
202, 10% to 19.9% in 142, and ≥ 20% in 84 patients [Nicolaides AN, Kakkos SK, 2010]. 
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One of the limitations of 2-dimensional (2D) ultrasound is that it is operator dependent. In the past 
plaque characterisation was considered as not reliable due to the subjective measures that were 
used. However, this problem was addressed by image normalisation using two reference points 
(blood and adventitia) and linear scaling [Griffin M, Nicolaides A,2007]. As a result of this, 
reproducible measurements of i.e. gray scale median could be performed when the same patients 
were scanned by different equipment, different operators in different locations [Griffin M, 
Nicolaides A,2007]. In the ACSRS study the image analysis after normalization resulted in more than 
50% of the plaques being reclassified mainly to a higher or lower type and 94% of the events 
occurred in patients with type of plaque 1 to 3- according to the Geroulakos classification.  Patients 
with plaque types 4 and 5 had a cumulative stroke rate of 0.9% at 7 years (0.14% per year) but 
patients with plaque types 1 to 3 had a cumulative stroke rate of 14% at 7 years (2% per year). These 
results suggested that the risk of stroke in patients with plaque types 4 and 5 can be low 
irrespectively of the underlying degree of stenosis [Nicolaides AN, Kakkos SK,2005]. 
 
On the basis of these findings the ACSRS study has shown that plaque classification and grey scale 
median (GSM) can be used to stratify patient-risk. Nevertheless, a number of other computer-
generated texture features, such as first order statistics (FOS), grey level difference statistics (GLDS), 
grey level run length statistics (RUNL) and spatial gray level dependence matrices (SGLDM) have 
shown to be promising in differentiating symptomatic from asymptomatic plaques in cross-sectional 
studies [Kakkos SK, Stevens JM,2007]. Nevertheless, they have not been yet applied to prospective 
studies such as the ACSRS study. The potential for improved stratification using these novel texture 
features is due to their ability to provide combined information both for plaque composition, 
according to grey levels and plaque heterogeneity [Kakkos SK, Sabetai M,2009].  
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 Our hypothesis is that some of these texture features will be associated with the unstable carotid 
plaques providing risk-stratification over and above that provided by stenosis and GSM alone. These 
novel features will be tested on the baseline ultrasonic images of the ACSRS study.  
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 8.2.Methods 
                 8.2.1. Study population 
The study design, the quality control process as well as the baseline characteristics of the included 
population in the ACSRS study have been previously reported [Nicolaides A, Sabetai M,2003; 
Nicolaides AN, Kakkos SK,2010]. Professor Stavros Kakkos and the ACSRS collaborators’ team under 
the supervision of Professor Andrew Nicolaides performed the recruiting, ultrasound scanning and 
data collection during an 8-year period. Briefly the study design was as follows: 
8.2.2.Inclusion criteria 
Newly referred (<3 months) patients with 50-99% ICA stenosis in relation to the carotid bulb 
diameter (ECST method) without previous ipsilateral (CORI) events and without neurological 
abnormality were recruited to the study after written informed consent. Patients who had had 
contralateral cerebral hemispheric/retinal or vertebrobasilar symptoms or signs of stroke/TIA were 
included if asymptomatic for at least 6 months prior to recruitment. For patients with bilateral 
asymptomatic carotid atherosclerosis the side with the more severe stenosis was considered 
ipsilateral (the study artery). 
 
8.2.3. Exclusion criteria 
Patients who could not attend for a six monthly neurological assessment and those with a limited life 
expectancy because of conditions such as severe cardiac failure or disseminated malignancy were 
excluded. 
8.2.4.Recruitment sources and ethical approval 
The participating centres, their eligibility criteria and quality control procedures have been described 
previously (Nicolaides A, Sabetai M,2003). The Multicenter Research Ethics Committee (North 
Thames, London, UK) and local ethics committees have approved the study. 
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   8.2.5 Clinical and Biochemical Characteristics 
At baseline all patients had a history taken and a physical examination by the local neurologist, 
electrocardiographic (ECG) examination and collection of fasting blood.  
                8.2.6. Two-dimensional Ultrasound image capture 
Bilateral carotid ultrasound scanning was performed on admission to the ACSRS study and the entire 
duplex investigation was recorded on an S-VHS videotape and sent to the coordinating centre. The 
degree of stenosis was graded according to established velocity criteria and expressed as both ECST 
and NASCET percentages [The European Carotid Surgery Trialists Collaborative Group,1995; Inzitari 
D,2000]. The exact image acquisition technique has been described elsewhere [Griffin M, Nicolaides 
A, 2007] and was an essential prerequisite for plaque texture analysis, which was performed at the 
coordinating centre. Ultrasonographers from participating centres attended two day training at the 
coordinating centre. Video recordings of the examination and frozen images of plaques were sent to 
the coordinating centre for image analysis and continuous feedback ensured quality. 
8.2.7. Grading of internal carotid stenosis 
The velocities were measured at the point of maximum internal carotid stenosis and at the centre of 
the common carotid artery lumen with the beam of ultrasound at 60 degrees to the direction of 
flow. Because absolute velocity measurements could underestimate stenosis or overestimate 
stenosis the sonographers at each centre were trained to use a combination of velocity ratios and 
absolute velocity measurements [Nicolaides A, Sabetai M, 2003] (Table 8.1).  
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Table 8.1. Duplex velocity criteria used in the ACSRS study.  
 
Angiographic 
Diameter 
Stenosis 
Duplex Velocity Criteria 
N % E % PSVIC 
(18,19) 
EDVIC 
(18-20) 
PSVIC/PSVCC 
(21-23) 
PSVIC/EDVCC 
(24,25) 
EDVIC/EDVCC 
 
  <120 <40 <1.5 <7  
11 50      
<2.6 
30 60     
7-10 47 70 120-150 40-80 1.5-2 
60 77  
150-250 
80-130 2-3.2 
65 80  
3.2-4 
 
10-20 
 
2.6-5.5 70 83 >130 
82 90 >250 >4 20-30 
90 94 >30 >5.5 
95 99   Trickle Flow   
 
Abbreviations: N= NASCET; E=ECST; PSV=Peak systolic velocity; EDV= End-diastolic 
velocity; IC=Internal carotid; CC=Common carotid 
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                  8.2.8. Image analysis using dedicated software 
Analysis of the carotid plaque characteristics was performed with the use of the “Plaque Texture 
Analysis” software [Griffin M, Nicolaides A, 2007] (version 3.2 –Incosoft International Ltd, PO Box, 
Greenford, London UB6 9ZN) after image normalization and segmentation both for the baseline and 
the follow-up carotid images. More details regarding the plaque’s composition image analysis can be 
found in chapter 5 of this thesis. 
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 8.3 Statistical analysis 
Data were analyzed using SPSS 17 statistical software (SPSS Inc, Chicago, Ill). The 51 texture features 
were evaluated within groups for high correlation (>0.8) using the non-parametric Spearman’s rho in 
order to reduce multi-collinearity. Data were linearly transformed whenever possible before 
entering them into further analysis using appropriate transformations (i.e. logarithmic, square root –
Appendix II). The Kolmogorov-Smirnov test as well as normal Q-Q plots and detrended Q-Q plots 
were used to assess deviations from normality.  
 
Factor analysis was used to reduce the number of variables retaining only those with potential value 
to the model. The R-matrix determinant and the KMO and Barlett’s values were assessed for R-
matrix and sample size adequacy, respectively. Finally the Varimax orthogonal rotation was 
considered before the extraction of the final factors. Only the variables with loading factors above 
0.8 were considered. Hazard ratios for the resulting texture features for ipsilateral CORI events were 
determined using an unadjusted Cox model. Those texture features that were significant at p<0.05 in 
the unadjusted models for CORI or stroke events were considered in the multivariate proportional 
hazard models.  
 
Proportional hazards models were created including:   
• (a) Only the novel texture features to predict CORI events without any 
adjustments for stenosis  
• (b) Only the novel texture features to predict CORI events adjusted for 
the severity of ECST stenosis (mild: 50-69%, moderate: 70-89% and severe: >90%  
•  (c) Established (GSM, plaque area) or other emerging plaque features 
(discrete white areas) and the resulting novel texture features. 
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  The aim was to assess if there was any improvement in the prediction model after the inclusion 
of the novel texture features. The diagnostic value of the various texture features and regression 
models were assessed with the receiver operator curve (ROC) method and expressed as area 
under the curve (AUC). The covariates included in each model were used to calculate the linear 
predictor score βχ (Xbeta- the sum of the product of mean-centred covariate values and 
corresponding parameter estimates) for every subject. ROC curves were constructed for βχ 
against observed 5-year CORI event rates.  
These were compared between the models (a) to (c). Stratified Kaplan Meier curves were also 
constructed for the resulting texture features after they were divided into their quartiles with 
and without adjustment for stenosis. 
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 8.4. Results 
During the period 1998-2002, 1121 patients aged between 39-89 years (mean age 70±7.7SD, 61% 
male) were recruited with an average follow-up of 48 months (6-96 months). The baseline clinical 
characteristics have been previously reported [Nicolaides AN, Kakkos SK,2010]. A total number of 
130 first ipsilateral CORI events occurred out of which 59 were strokes (12 fatal), 49 were TIAs and 
22 were amaurosis fugax. The baseline ultrasound carotid images were analysed by dedicated 
software for plaque image analysis and resulted in the extraction of 51 novel ultrasound texture 
features. After multi-collinearity within the data was reduced to the minimum, 22 texture features 
were included in the analysis (Appendix II-table 1).  Factor, principal component analysis of the 
resulting, variables selected only the transformed versions of the following 10 characteristics: 
bel_30, the GSM, SGLD_ASM, SGLD_CON, GLDM_ CON, RUNL_RLD, plaque area, CL_bel30, 
SGLD_COR and SGLDINM1 (Appendix I, A-C). The remaining features had loading factors of less than 
0.8 and, thus, it was decided not to be included in the final analysis (Appendix II-table 4). 
 
Survival analysis including only ultrasound texture features of the baseline images 
The hazard ratios for each individual baseline clinical and biochemical features associated with 
patients with ipsilateral CORI , as well as their effect in the final prediction model, have been 
previously reported [Nicolaides AN, Kakkos SK,2010]. Therefore only the results from the hazard 
ratio analysis of the novel texture features will be demonstrated. The multivariate proportional 
hazard models for the resulting texture features (Table 8.2) showed that the only features that 
remained significant for this model (with and without adjustment for stenosis) were features 
SGLD_ASM (HR: 3.4 95%CI: 1.8-6.31,df:1, p<0.0001) and RUN_RLD (HR:1.02 95%CI: 1.0-1.04,df:1,  
p<0.05) . On the basis of the continuous variables the linear predictor scores xβ of this model were 
calculated for each patient resulting in Figure 8.1 with an area under the ROC curve of 0.836 
(SE:0.018, p<0.001). 
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 Table 8.2: Proportional hazards model including the resulting texture features from the factor principal 
component analysis after adjustment for the degree of stenosis. 
Features HR SE Wald Score Sig.  
GSM 1.923 3.3 0.03 0.84 
SGLD_ASM 3.450 0.3 16.13 0.000 
BEL-30 1.020 0.1 1.19 0.273 
GLDM_CON 3.576 2.3 0.30 0.581 
SGLDM_CON 0.846 0.9 0.29 0.864 
RUN_RLD 1.026 0.01 6.0 0.014 
PLAQUE AREA 0.915 0.1 0.31 0.572 
CL-BEL30 1.082 0.2 0.15 0.698 
SGLDM_COR 0.931 0.6 0.12 0.913 
SGLDM_IMC1 5.183 5.4 0.9 0.764 
Abbreviations: SE: Standard error, GSM: Grey scale median, SGLDM: Spatial Gray Level Dependence Matrices, RUN: 
Gray level run length statistics, GLDM: Gray level difference statistics, ASM: Angular Second Moment, CON: Contrast, 
RLD: Run length distribution, COR: Correlation, IMC-1: Information Measure of Correlation-1 , HR: Hazard Ratio 
 
 
 
 
 
 
 
 
 
 
 118 
 ROC Curve
1 - Specificity
1.00.75.50.250.00
S
en
si
tiv
ity
1.00
.75
.50
.25
0.00
 
 
 
Figure 8.1: ROC curve for CORI events using all novel texture features resulting from the factor analysis. The 
area under the curve is 0.836 (SE: 0.018, p<0.001) 
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 The new texture features SGLD_ASM and RUN_RLD were controlled in the same multivariable 
proportional hazard model for established plaque characteristics (such as GSM, plaque area in mm2 
and degree of ECST stenosis) and other emerging ones like the presence of discrete white area 
(DWA). The results (Table 8.3) demonstrated that both SGLD_ASM and RUN_RLD remained 
significant (HR: 3.3, 95% CI: 2.02 to 5.58, p<0.0001 and HR 1.0, 95% CI: 1.01 to 1.04, p<0.05 
respectively). It is also worth noticing that the presence of discrete white areas within the plaque 
(DWA) was also significant in this model (HR: 0.48, 95% CI: 0.29 to 0.81, p<0.05). The ROC curve 
which resulted as the linear predictor xβ of a model including GSM, degree of stenosis and the 2 
novel texture features had an AUC:0.829, SE:0.2, p<0.001. In comparison when the model included 
only the degree of stenosis and GSM the AUC was 0.746, SE: 0.2, p<0.001 (figure 8.2). 
 
The cumulative ipsilateral CORI event free survival Kaplan-Meier curves for the quartiles of the 
significant, resulting variables SGLD_ASM and RUN_RLD are shown in figures 8.3 and 8.4. The pooled 
over strata, long-rank test statistic for equality of survival distributions for SGLD_ASM and RUN-RLD 
was 102. 28 (df: 3, p<0.0001) and 21.81 (df: 3, p=0.0001), respectively.  
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 Table 8.3:  Proportional hazard model including the significant, novel texture features (SGLD_ASM,RUN_RLD) 
controlled for previously established plaque features such as GSM, plaque area, discrete white areas (DWA) 
and degree of stenosis 
 
Features HR SE Wald Score Sig.  
PLAQUE AREA 0.825 0.138 1.9 0.166 
GSM 0.140 1.774 1.2 0.268 
STENOSIS 1.013 0.008 2.9 0.085 
DWA 0.487 0.261 7.6 0.006 
RUN_RLD 1.030 0.009 9.8 0.002 
SGLD_ASM 3.343 0.262 21.2 0.000 
 Abbreviations: SE: Standard error, GSM: Grey scale median, SGLDM_ASM: Spatial Gray Level Dependence 
Matrices-Angular Second Moment, RUN_RLD: Gray levels run length statistics- Run length distribution, 
DWA: Discrete white areas, HR: Hazard Ratio 
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Figure 8.2: Comparison of the two models. The model (green line) including GSM, degree of stenosis and the 
novel texture features (SOS) appear to be superior than the model with GSM and stenosis alone (AUC:0.829, 
SE:0.2, p<0.001 vs. 0.746, SE: 0.2, p<0.001, respectively ) 
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Figure 8.3: Ipsilateral CORI event-free survival Kaplan-Meier curves for SGLD_ASM quartiles 
(ascending order) 
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Figure 8.4: Ipsilateral CORI event-free survival Kaplan-Meier curves for RUN_RLD quartiles 
(ascending order) 
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 8.5. Discussion 
Purpose of this study was to investigate if certain SOS measures (alone or in combination with FOS 
measures), the degree of stenosis and the plaque area can improve the stroke-risk stratification of 
patients with carotid plaque disease.  
 
The “Iconsoft Carotid Plaque Texture analysis” is dedicated software for carotid plaque image 
analysis [Griffin M, Nicolaides A,2007]. This software provides, apart from the GSM values (FOS 
measure) and plaque type, the above-mentioned measures of heterogeneity (SGLSM, GLDS, RUNL 
and FPS). The analysis of all these texture features of the plaque images from the ACSRS database, 
with and without adjustment for stenosis, revealed that only two of them (the SGLSM_ASM and the 
RUNL_RLD features) remained significant in the multivariate proportional hazard models for risk of 
stroke events. In addition when these two features where controlled for established plaque 
characteristics such as degree of stenosis, GSM values and plaque area (mm2), they remained 
significant and in fact improved the predictive ability of the proportional hazard model for 
cerebrovascular events when compared with GSM and stenosis alone. 
 
The SGLD_ASM feature belongs to the SOS-SGLD group and is a measure of homogeneity [Haralick 
RM,1973; Kadah YM, 1996;  Wilhjelm JE,1998]. Heterogenous images have more grey-tone 
transitions, which result into lower readings. Indeed, it was shown, that groups with the different 
SGLD_ASM levels (i.e. 1st quartile versus 4th quartile) had different rates for cerebrovascular events 
in the survival analysis. In addition, the texture feature RUN_RLD –which is also a marker of image 
heterogeneity (Appendix I)  showed potential regarding the differentiation between a high risk and 
low risk for cerebrovascular events event group. The above results in combination with the 
improved ROC curves ,when the new texture features were used, indicate that the use of both 
plaque homogeneity and echodensity features may further improve the predictive ability of the 
models for CORI events. These findings come into agreement with previous findings by Tegos and his 
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 colleagues, who showed that predominantly homogenous plaques with decreased echogenicity 
could be associated with increased incidence of cerebrovascular events [Tegos TJ,2001].   
 
Despite the large number of patients recruited and the long-term follow-up of the ACSRS study, 
there are still certain limitations especially with regard to the operator-dependant nature of the 
ultrasound. Atherosclerotic plaques are 3 dimensional structures that can occupy the whole arterial 
lumen. This represents a rather challenging environment for the conventional 2D ultrasonography, 
since different sections of the plaque maybe be captured according to the operator’s technique 
affecting the final outcome of the image analysis. In order to overcome this problem, the use of 3D 
ultrasound or MRI has been proposed since they may provide us with information regarding the 
whole volume of the plaque. However, further research is still needed in order to establish their 
cost-effectiveness [Makris GC, 2011].  
 
In addition, digital image analysis of the carotid plaque is sensitive to the baseline ulltrasound-device 
settings. In other words, even small deviations from the described protocol for image capture or the 
use of despeckling filters may ruin the original information contained in the ultrasonound capture 
and impoverish the results from the image analysis. Further research is also warranted on this issue 
to determine the exact effect of these new despeckling technologies on carotid plaque 
characterization techniques. 
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 8.6. Conclusion 
This study showed for the first time that objective, computerized evaluation of novel plaque texture 
features, that incorporates both echogenicity and homogeneity information, may improve our 
predictive ability and the risk stratification between patients with asymptomatic carotid plaque 
disease.  
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Chapter 9 
Change of novel texture features through time and implications for stroke 
risk prediction 
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 9.1.Introduction 
The current evaluation of carotid plaques only involves the assessment of the degree of stenosis and 
its progress through time to extrapolate from that the possible risk of stroke. The degree of stenosis 
though is not the best marker since it is not very sensitive and it can be difficult to accurately 
measure especially when very small changes may have occurred. [Nicalaides AN,2010] 
 
 The composition of the carotid plaque is another possible marker that may change in time and can 
be assessed using ultrasound. The use of medication, such as statins, has shown to be affecting 
plaque composition in different ways. [Makris GC, 2011]  The same may happen after plaque rupture 
when thrombus is forming on the plaque surface. These changes could potential be followed and 
documented by regular ultrasound and possibly contribute in the identification of the vulnerable 
plaque.  
 
There is very limited evidence regarding the use of monographic plaque texture change for the 
evaluation of carotid plaque vulnerability and risk of stroke.  Using data from the ACSRS study we 
will try to explore this issue. It is possible that a combination of measurements through time and 
during the various follow-up visits can be a useful marker of plaque instability. 
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 9.2.Methods 
                9.2.1. Study design 
The study design, the quality control process as well as the baseline characteristics of the included 
population in the ACSRS study have been previously reported [Nicolaides A, Sabetai M,2003] 
The significant, resulting texture features (from the above mentioned process) as well as GSM and 
the plaque area were assessed for the degree of their change during the follow-up period within a 
subgroup of the ACSRS cohort with no change in their degree of stenosis.  
 
               9.2.2. Study population 
A random sample was selected with both symptomatic and asymptomatic individuals (ratio 1:2 
respectively). Eligible for inclusion were patients participating in the ACSRS study with:  
• follow-up time > 6months, 
• follow-up ultrasound images of adequate quality and  
• with no change in the degree of stenosis between the first and last 
visit.  
The image analysis of the baseline and last follow-up visit’s images was performed as previously 
described (chapter 5). 
 
           9.2.3. Statistical analysis 
 The Wilcoxon sign test was applied for non-normal distributions and dependant variables in order to 
compare the various texture features at baseline and last follow-up visit (i.e. GSMbase -GSMlast f/u). 
In addition the Mann-Whitney U test (non-parametric) was used to compare the change (delta) of 
the various texture features between asymptomatic and symptomatic patients (independant 
variables-i.e. DeltaGSM asympt  versus DeltaGSM symptomatics). 
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9.3.Results 
Sixty patients with no change in their degree of stenosis were randomly selected from the ACSRS 
study. However, 12 had to be excluded due to inadequate follow-up time or inadequate image 
quality of the follow-up images (i.e. presence of calcification or other artefacts). The baseline and 
last follow-up image of 33 asymptomatic and 15 symptomatic patients were included in the analysis. 
The baseline features of this subgroup are summarized in table 9.1. 
 
The changes in GSM, plaque area and the resulting features SGLD_ASM and RUN_RLD were 
evaluated for a mean follow-up of 43.8 months. There was no change in the degree of internal 
carotid stenosis in this group of patients through the follow-up period. 
 
When the change of the above features was assessed in all patients with and without symptoms [i.e. 
feature (baseline)-feature (last visit)] there was a significant change only in GSM and SGLD_ASM 
(Wilcoxon Signed Rank test, p<0.05). There was no change in plaque area and RUN_RLD features 
(table 9.2). When we separately assessed the change in the symptomatic group, again only the 
change in GSM and SGLD_ASM between the first and last visit remained significant (Wilcoxon Signed 
Rank test, p<0.05) despite the small sample size. In contrast, in the asymptomatic group there were 
not significant changes in any of the texture features or plaque area. Finally, there was no 
statistically significant difference in the degree of change in any of the studied characteristics 
between the two groups (i.e. DeltaGSM asympt vs. DeltaGSM Sympt), though the small sample size 
is not sufficient to reach sold conclusions. 
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Table 9.1:Baseline characteristics of the individuals included in the subgroup-analysis 
.  
 
Abbreviations: SE: Standard error, SD: Standard deviation, GSM: Grey scale median, SGLDM_ASM: Spatial Gray Level 
Dependence Matrices-Angular Second Moment, RUN_RLD: Gray level run length statistics- Run length distribution 
 
 
 
 
 
 
 
 
 
 
 
 
Features  
(N=48) 
Mean  SD 
Statistic SE 
STENOSIS (%) 76.25 2.1 14.9 
FOLLOW-UP (MONTHS) 43.8 3.3 23.4 
GSM 22.5 2.3 16.1 
RUN_RLD 12897.6 1045.9 7246.47 
SGLDM_ASM 0.03 0.01 0.07 
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Table 9.2. Change of texture features between the first and last follow-up visit in the different groups. 
Groups  GSM Plaque area SGLD_ASM RUN_RLD 
Symptomatics 
(N=15) 
Z^ -2.215 -0.738 -3.294 -1.079 
Asymp. Sig 
(2-tailed) 
0.027* 0.46 0.001* 0.281 
Asymptomatics 
(N=33) 
Z^ -1.492 -1.188 -1.885 -0.027 
Asymp. 
Sig (2-
tailed) 
0.136 0.235 0.059 0.979 
ALL 
(N=48) 
Z^ -2.544 -1.456 -3.487 -0.595 
Asymp. Sig 
(2-tailed) 
0.011* 0.145 0.000* 0.552 
Abbreviations: ^: Wilcoxon Sign Rank Test, *: Significant change between first and last follow-up visit, GSM: 
Grey scale median, SGLDM_ASM: Spatial Gray Level Dependence Matrices-Angular Second Moment, RUN_RLD: Gray 
level run length statistics- Run length distribution 
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9.4.Discussion 
There are several natural history studies in patients with asymptomatic carotid stenosis, which 
investigated the association between stenosis progression and risk of ipsilateral cerebrovascular 
events. [Abbott AL, 2008] Despite the fact that most studies had limitations such as the small 
number of cerebrovascular events, limited duration of follow up and the lack of reporting TIAs and 
stroke as separate outcome events, they showed that progression to > 80% stenosis was linked to an 
increased risk of cerebrovascular events. However, again the majority of the included studies 
concluded that the value of serial screening to predict cerebrovascular events was limited by the low 
rates of progression but also by the low incidence rates of this outcome event. In our study we 
sought to assess the effectiveness of plaque composition progression for the characterization of 
carotid plaques. 
 
The analysis of the follow-up images from a small number of patients with and without symptoms 
suggests that even when there is no change in the degree of stenosis, certain features such as GSM 
and SGLD_ASM may be altered in the symptomatic group through time.  
 
This observation implies that composition changes may occur even when stenosis is constant leading 
to potentially more unstable plaques. The change of certain features during a short follow-up period 
instead of single, isolated measurements may be more sensitive in the identification of the 
vulnerable plaque. This observation is in contrast with the current clinical practice where the follow-
up of carotid plaque disease is based on isolated measurements of the degree of stenosis and on a 
rough estimation of plaque composition (i.e echolucent or echogenic) without usually any measure 
of actual quantification. Nevertheless, more research is needed incorporating larger samples size 
and longer follow-up 
 
 134 
  
9.5.Conclusion 
The composition of the carotid plaque, as this is expressed by the above described texture features, 
may change through time even when the degree of carotid stenosis is constant.  This observation 
may have significant implications on the way we evaluate the progression of carotid disease and the 
risk for stroke, since so far the only factor was the change in the degree of stenosis. 
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Chapter 10 
Progression of asymptomatic internal carotid artery stenosis, associated 
factors and risk of stroke 
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10.1 Introduction 
The main objective of the Asymptomatic Carotid Stenosis and Risk of Stroke (ACSRS) Study , was to 
assess the cerebrovascular risk stratification potential of combinations of baseline clinical and 
biochemical characteristics, sonographic degree of stenosis and plaque morphology. As previously 
described, indeed, the ACSRS study demonstrated that a combination of stenosis, plaque texture 
features (gray scale median-GSM, size of plaque area and presence of discrete white areas-DWA) 
and history of contralateral TIAs or stroke can stratify stroke risk from 1% to 10% per year. 
[Nicolaides AN, Kakkos SK,2010] 
 
The above was achieved by using only the baseline degree of stenosis without any information 
regarding the progression or not of the disease. However, as mentioned previously a number of 
natural history studies in patients with asymptomatic carotid stenosis investigated the association 
between stenosis progression and risk of ipsilateral cerebrovascular events [Abbot A, 2009]. These 
studies suggested that the value of follow up screening to predict cerebrovascular events was 
limited. That was due to the low observed incidence rates of these outcome events as well as to the 
low rates of disease progression.  Thus, a secondary objective of the ACSRS study was to assess the 
value of stenosis progression or regression using six monthly duplex scanning.  
 
The aim of this chapter is to determine: 
• The incidence of progression and regression, 
• The association between changes in the severity of stenosis and ipsilateral cerebral events  
• And finally the association of baseline clinical, biochemical and plaque features with change 
in the degree of stenosis. 
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10.2. Methods 
The ACSRS study methodology including quality control, inclusion and exclusion criteria, recruitment 
sources, clinical and biochemical characteristics and duplex examination and image analysis have 
already been discussed in chapter 5. Only the relevant methodology for this chapter is presented 
here. 
 
10.2.1.Grading of internal carotid stenosis 
The velocities were measured at the point of maximum internal carotid stenosis and at the centre of 
the common carotid artery lumen with the beam of ultrasound at 600 to the direction of flow. 
Because absolute velocity measurements could underestimate stenosis or overestimate stenosis the 
sonographers at each centre were trained to use a combination of velocity ratios and absolute 
velocity measurements (Chapter 5).  
 
10.2.2.Progression and regression of stenosis  
Stenosis was graded into six groups using the above criteria: 50-59%, 60-69%, 70-79%, 80-89%, 90-
95% and 95-99%. Progression or regression was considered to occur if there was progression to the 
next grade up or down of ≥10%, respectively, provided it was found on at least two consecutive 
visits. 
 
10.2.3. Statistical analysis  
Kaplan-Meier curves were initially used for the whole patient population of this study in order to 
determine the overall stenosis progression, occlusion and regression free survival over time. Then 
the hazard ratios for biochemical, clinical and ultrasonic features for progression, occlusion and 
regression were determined using an unadjusted Cox model for each variable. Continuous risk 
factors were converted to a normal distribution where possible using appropriate transformations. 
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 Kaplan-Meier curves were also constructed for risk factors that were significant in the unadjusted 
models. 
 
The risk factors that were significant at P < 0.05 in unadjusted models for progression, occlusion and 
regression were considered in multivariable Cox proportional hazards models. ROC curves were 
constructed to test the ability of each model to predict progression, occlusion or regression by using 
the linear predictor score (x*β) to construct. Kaplan-Meier curves were used for the whole cohort to 
determine overall ipsilateral cerebrovascular and in relation to the observed changes in ipsilateral 
stenosis. 
 
The stroke predictive ability of progression or regression was assessed in a multivariate Cox models 
with cerebrovascular events (stroke) as the dependent variable.  
 
SPSS statistical package (version 18, SPSS inc, Chicago, Ill, USA) was used for statistical analysis and 
production of graphs. 
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 10.3. Results 
10.3.1.Incidence of degree of stenosis change during follow-up. 
Ipsilateral regression of stenosis by 10% stenosis (ECST% of stenosis) or more occurred in 3.8%. In 
the majority there was no change (76.4% or 856 patients). Progression by 10% or more occurred in 
almost 20% of the cohort in which progression without occlusion accounted for 16.9% and 
progression to occlusion for 2.9%. Progression by more than 20% stenosis units occurred in 27 
(2.4%) patients. The incidence of progression was after one year was 4%, after 2 years 10%, after 3-4 
years 6%, after 5 years 4%, after 6 years 3% and after 7 years 2%.  
 
10.3.2.Ipsilateral stroke in relation to plaque progression. 
From 130 ipsilateral cerebrovascular events (strokes, TIAs and AF) , more than half (67.7%) occurred 
in patients whose stenosis had not changed, almost one fourth (25.4%) in those with progression but 
not occlusion, and 9 in those who developed occlusion. There were no events in those with plaque 
regression. Regarding strokes alone there was a similar picture. From the 59 ipsilateral ischemic 
strokes again more than half (67.8%) occurred in those with no change in stenosis, 25.4% in those 
with progression but not occlusion and 6.8% in those that developed occlusion. As above no stroke 
were reported in the group with carotid plaque regression. 
 
10.3.3.Incidence of stroke and the effect of stenosis and progression  
With stroke as the dependent variable in a multivariate Cox model and with ipsilateral degree of 
stenosis and stenosis progression as covariates, both covariates were significant with hazard ratios 
of 1.3 (95% CI 1.068-1.687, P=0.01) and 1.85 (95% CI 1.072-3.0202, P=0.027) respectively (Table 
10.1). With stenosis as the only covariate, the area under the ROC curve was 0.580 (95% CI 0.504 to 
0.657) whereas when progression was added to the model, the area under the ROC curve increased 
to 0.629 (95% CI 0.555 to 0.704). 
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Table 10.1 Proportional hazards model with covariates the degree of stenosis and 
progression and stroke as the dependent variable.  
 
 
Variable    β  HR  95% CI P value 
 
 
Degree of stenosis (10% increase)    0.295  1.343  1.068-1.687 .011 
Progression              0.616  1.852  1.072-3.202 .027 
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10.3.4. Factors linked to progression 
In Table 10.2 the hazard ratios for each individual baseline biochemical, clinical, and ultrasonic risk 
factors associated with ipsilateral progression of stenosis are listed.  Male gender, elevated plasma 
creatinine, increasing plaque area, age and coronary artery disease were significant risk factors 
associated with increased incidence of progression (p<0.05). Lipid lowering therapy (statins) and 
increasing severity of stenosis appeared to be significant risk factors associated with a decreased 
incidence of progression. 
 
 Model 1-Carotid stenosis progression 
In a multivariable Cox proportional hazards model with the significant features from table 2 as 
covariates, only creatinine, stenosis, plaque area, gender and lipid lowering therapy were 
independent predictors of occurrence of progression. (Table 10.3) The ROC curve constructed for 
this model had an area under the curve of 0.637 (95% CI 0.596 to 0.677); P < 0.001.  
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 Table 10.2.  Unadjusted hazard ratios (HRs) of the risk factors for ipsilateral carotid stenosis 
progression with or without occlusion, progression and regression.  
  
 
Risk Factor  Progression HR   95% CI          P   Occlusion HR 95% CI            P  
 Regression HR    95% CI   P 
 
  
Age (10 year increase)  1.19 1.01-1.41     .044        1.18               0.76-1.84     .452          
0.62  0.44-0.87 .006 
BMI (5 units increase)  1.03 0.82-1.15     .712        0.85  0.53-1.35     .486         
1.15  0.81-1.63 .424  
SBP (10 units increase)  1.08 0.99-1.16     .051        1.01  0.90-1.33     .351         
1.00  0.85-1.19 .968 
DBP (10 units increase)  1.07 0.93-1.22     .353        1.26  0.88-1.80     .214         
1.37  0.99-1.88 .055 
Creatinine (20% increase)  1.22 1.13-1.32   <.001        1.27  1.05-1.53     .013         
0.89  0.69-1.15 .386  
Ln(GSM+40)   0.78 0.51-1.20     .258        0.24  0.07-0.76     .015         
0.74  0.28-1.96 .543 
GSM < 23   1.21 0.93-1.59     .157        2.62  1.29-5.30     .008         
1.01  0.52-1.95 .972 
Plaque area 1/3 (mm2)  1.37 1.14-1.65     .001        1.46  0.90-2.38     .125         
0.82  0.53-1.26      .366 
Fibrinogen   1.01 0.87-1.18     .890        1.19  0.82-1.72     .362         
1.08  0.75-1.55 .669 
Total cholesterol   1.05 0.93-1.18     .419        1.12  0.83-1.50     .463         
1.21  0.95-1.56 .124 
LDL cholesterol   1.05 0.92-1.20     .436        1.06  0.76-1.50     .721         
1.29  0.82-1.45 .572 
HDL cholesterol   0.74 0.52-1.05     .095        0.88  0.37-2.89     .770         
1.49  0.85-2.64 .164 
Triglycerides   1.03 0.90-1.17     .683        0.93  0.62-1.39     .711         
1.11  0.84-1.47 .470 
Ipsilateral Stenosis (10% increase) 0.84 0.76-0.93     .001        2.58  1.69-3.93   <.001         
1.47  1.11-1.96 .009 
Contr. Stenosis (10% increase) 1.05 0.95-1.16     .341        1.39  1.11-1.74     .004         
1.06  0.91-1.23 .440 
Plaque type 4+5   1           1    
         1 
      3   1.16 0.77-1.75     .470        1.12  0.32-4.30     .798         
0.95  0.40-2.26 .922 
      2   1.32 0.87-2.03     .195        2.58  0.74-8.97     .137         
0.60  0.22-1.65 .322  
      1   1.57 0.89-2.76     .120        3.93  0.94-16.4     .061         
2.36  0.82-6.73 .109  
Male     1.71 1.28-2.28     .001        3.18  1.31-7.74     .011         
1.56  0.81-3.01 .179 
Smoking   0.91 0.64-1.28     .598        0.79  0.30-2.05     .631         
1.34  0.66-2.73 .416 
Coronary artery disease  1.36 1.04-1.78     .023        1.73  0.87-3.48     .120         
1.14  0.60-2.14 .699 
Atrial fibrillation   1.20 0.53-2.71     .656        1.36  0.18-10.0     .760         
2.44  0.68-10.1 .219 
Hypertension   0.86 0.66-1.13     .292        1.21  0.57-2.55     .622         
0.61  0.33-1.13 .119 
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 Diabetes    1.23 0.89-1.69     .201        0.61  0.22-1.76     .364         
0.68  0.26-1.72 .412 
History of contr. TIAs or stroke 1.26 0.92-1.72     .146        1.63  0.76-3.53     .211         
0.31  0.07-1.29 .109 
Antihypertensive therapy  0.87 0.67-1.14     .324        1.02  0.50-2.08     .959         
0.74  0.40-1.36 .329 
Antiplatelet therapy  0.87 0.60-1.27     .481        1.72  0.52-5.64     .373         
0.99  0.39-2.54 .992 
Lipid lowering therapy  0.66 0.48-0.91     .011        0.74  0.32-1.73     .494         
2.52  1.38-4.02 .003 
Contr. carotid occlusion  0.93 0.57-1.52     .774        2.07  0.80-5.36     .136         
1.89  0.66-4.32 .269 
Presence of DWA (>1)  1.22 0.92-1.63     .165        1.19  0.56-2.52     .642         
0.52  0.29-0.96 .037 
 
 
 
* Significant risk factors are in bold. 
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  10.3.5.Factors linked to occlusion 
From Table 10.2 it is apparent that only elevated creatinine levels, ipsilateral stenosis, low GSM, 
male gender and contralateral stenosis were associated with increased incidence of occlusion. 
 Model 2-Carotid occlusion (table 10.3) 
In a multivariable Cox proportional hazards model with the significant features from Table 10.2 as 
covariates, only GSM, ipsilateral stenosis, contralateral stenosis and gender were independent 
predictors of occurrence of occlusion. On the basis of model 2 the ROC curve constructed and 
produced had an area under the curve of 0.793 (95% CI 0.719 to 0.867); P < 0.001. 
 
10.3.6. Factors associated with regression 
The ipsilateral stenosis and lipid lowering therapy with statins were associated with increased 
incidence of regression whereas age and the presence of discrete white areas  (DWA) were 
associated with a decreased incidence of regression (Table 10.2).  
 Model 3- Carotid stenosis regression 
In the multivariable Cox proportional hazards model 3 with the significant factors from Table 2 as 
covariates, the presence of DWA, the degree of ipsilateral stenosis, the administration of statin 
therapy and the patients’ age were independent predictors of occurrence of regression (Table 10.3). 
On the basis of this model 3, the linear predictor scores xβ of the model were calculated for each 
patient and the ROC curve that were constructed had an area under the curve of 0.704 (95% CI 
0.620 to 0.788); P < 0.001.  
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Table 10.3:Proportional hazards models including significant variables from Table 2 with 
ipsilateral stenosis progression (model 1) and occlusion (model 2) as the dependent 
variable.  
 
  
Variable    β  HR  95% CI P value 
 
 
Model 1: Progression of carotid stenosis as dependent variable 
 
Creatinine (20% increase)  0.191  1.210  1.114-1.315 <.001 
Ipsilateral stenosis (10% increase)   - 0.193  0.824  0.742-0.916 <.001 
Plaque area 1/3 (mm2)    0.280  1.323  1.095-1.599   .004 
Male gender    0.357  1.429  1.067-1.914   .017 
Lipid lowering therapy           - 0.375  0.687  0.498-0.948       .022 
 
Model 2: Carotid occlusion as the dependent variable 
 
Log (GSM+40)             -1.296  0.274  0.084-0.894   .032 
Ipsilat. stenosis (10% increase) 0.865  2.376  1.565-3.607     <.001 
Contralat. stenosis (10% increase) 0.192  1.212  1.039-1.414   .014 
Male gender    1.130  3.094  1.271-7.534   .013 
  
Model 3: Carotid stenosis regression as the dependent variable 
 
Age (10 year increase)            -0.450  0.638  0.450-0.904   .011 
Ipsilat. stenosis (10% increase) 0.466  1.594  1.179-2.155       .002 
Lipid lowering therapy  0.820  2.272  1.232-4.189   .009 
DWA               -0.693    0.500  0.272-0.920   .026 
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 10.4. Discussion 
This study showed that the overall incidence of ipsilateral carotid stenosis progression (19.8%) is 
similar to that found in past studies with a similar follow-up duration [Abbot A, 2009]. On the other 
hand the incidence of regression was less common (3.8%). 
 
Regarding the association between carotid stenosis progression and other factors, it has been 
previously shown that coronary artery disease (Liapis C, 2000), age (Sabeti S, 2007) and hypertension 
(Bertges DJ,2003; Ballotta E,2007) were strongly associated. Although, this study also suggested that 
the incidence of progression might also be linked to male gender, elevated creatinine and plaque 
area. In addition, this is one of the first studies to show that a decrease in the incidence of 
progression was seen in patients with severe stenosis and those with statin therapy. Creatinine 
levels and their association with carotid stenosis progression was probably expected since serum 
creatinine is an independent predictor of cardiovascular risk and especially ischemic stroke as it has 
been shown by previous research. [Wannamethee SG, 1997; Sprengers RW, 2009] Unfortunately, 
though, these factors that were associated with progression did not improve the stroke-prediction 
model and thus it is unlikely to have significant clinical usefulness. 
 
In this study statin therapy was linked to an increase in the incidence of regression. The association 
between lipid lowering therapy and plaque regression in patients with carotid plaque disease has 
already been demonstrated as we have also shown in a big systematic review of the available 
literature (Makris GC, 2010; Spence JD, 2010 ). In this study the regression prediction using risk 
factors such as statin therapy, age, ipsilateral stenosis and DWA in a Cox proportional hazards model 
(Model 3; Table 10.3) was moderate as indicated by the area under the ROC curve (AUC: 0.704). 
 
Even if progression of carotid stenosis identifies a high- risk group, only 19 of the strokes occurred in 
this group whereas 40 strokes occurred in the group with no change in the degree of carotid 
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 stenosis. This finding alone implies that carotid progression is a rather poor indicator of plaque 
instability. This is also stressed by the fact that carotid plaque progression was not a significant 
covariate when added to a Cox model, which has already shown to be able to stratify patients 
according to the risk of stroke.  
 
One of the main limitations of this study was that medical therapy was left to the discretion of the 
attending physician and that was before the introduction of the today’s strict management with lipid 
lowering medications.  
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 10.5.Conclusion 
Regular interval screening for carotid stenosis progression detection in patients with asymptomatic 
carotid stenosis may improve the stroke-risk prediction based on stenosis alone. If, however, it is 
compared with stenosis combined with plaque composition analysis then it does not seem to 
contribute significantly more.  
Finally our study emphasized on the fact that regression of carotid stenosis was linked to lipid 
lowering therapy and that none of the patients with regression developed a stroke.  
 
In the future it would be worthwhile to study the effect of aggressive medical therapy on plaque 
regression by regular ultrasound scanning. If this favourable effect of plaque regression on the 
incidence of stroke is definite, then plaque regression may become an imaging marker to monitor 
the effectiveness of therapy.  
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Chapter 11 
Juxta-luminal black area in asymptomatic carotid plaques and risk of stroke 
 150 
 11.1. Introduction 
Studies evaluating histology in extracted carotid samples have shown that symptomatic plaques 
have a necrotic core, which can be twice as close to the vessel lumen compared to asymptomatic 
plaques (Bassiouny HS,1997). This observation correlates with the observations made by cross-
sectional ultrasound studies, which showed a link between juxta-luminal black (black) area (JBA) and 
the incidence of cerebrovascular events (Griffin MB,2010; Pedro LM,2002; Sztajzel R,2006). JBA in 
ultrasonic images of asymptomatic carotid artery plaques has been shown to correspond to a lipid 
core close to the lumen when histological analysis is performed (Sztajzel R,2005). A previous cross-
sectional study of patients with both symptomatic and asymptomatic carotid plaques has 
demonstrated that a JBA >8mm2 without a sonographically visible fibrous cap was associated with a 
increased prevalence of symptomatic carotid plaques (Griffin MB,2010). 
However, despite the above evidence, the predictive role of JBA in prospective studies of 
asymptomatic carotid stenosis and its contribution to stroke-risk stratification remains largely 
unclear. It has been previously suggested by our group that JBA cut-off points from cross-sectional 
studies need to be validated in longitudinal studies of asymptomatic patients (Griffin MB,2010) 
The aim of our study was to use the ACSRS imaging cohort to test the hypothesis that the presence 
and size of JBA without an obvious fibrous cap can predict future ipsilateral ischemic events. 
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 11.2.Methods 
11.2.1. Patient recruitment and image analysis. 
Briefly, inclusion criteria were newly referred patients with 50% to 99% ICA stenosis in relation to 
the carotid bulb diameter (European Carotid Surgery Trial [ECST] method) without previous 
ipsilateral cerebral or retinal ischemic (CORI) symptoms and without neurological abnormality; these 
were recruited to the study after they had provided written informed consent. Inclusion and 
exclusion criteria and recruitment sources have been previously reported. Carotid duplex scanning 
was performed on admission to the study as previously described (chapter 5). The image acquisition 
and analysis of carotid plaques have also been previously described. 
11.2.2.JBA measurement 
The largest juxta-luminal black area of the selected plaque (ie, area with pixels having a gray-scale 
value of less than 25) without a visible echogenic fibrous cap (ie, pixels with gray-scale value higher 
than 25) was outlined using the computer mouse (image 11.1). Then the JBA area was automatically 
calculated by the software. The value of the larger area was used when there were two plaque 
components with black areas. The reproducibility of JBA measurements has been reported in 
previous publication of our group (Griffin MB,2010). 
11.2.3.Outcome measures. 
 The primary outcome measure of the ACSRS study was ipsilateral cerebral ischemic stroke.  
 
 
 
 
 152 
 11.2.4.Statistical analysis. 
Receiver operating characteristic (ROC) curves for JBA was constructed with stroke as the state 
variable. The area under the curve was also calculated. Several cut-off points were tested to 
categorise JBA, including a previously suggested cut-off point (8 mm2) based on a cross-sectional 
study in order to produce stratified Kaplan-Meier plots. JBA was then entered into a multivariate 
proportional hazards model with cerebrovascular events or stroke as the dependent variable. Other 
plaque features known to be associated with increased risk such degree of ECST stenosis, presence 
of discrete white areas, GSM, plaque area and history of contralateral TIA or stroke were also include 
in the model.  
Statistical analysis was performed with PASW/SPSS Statistics 18 or later (SPSS Inc, Chicago, Ill, USA). 
 
 
 
 
 
 
 
 
 
 153 
  
Image 11.1: The segmented gray scale image of the same plaque before and after colour contouring 
according to the gray level of pixels (Gray scale: 0-25 = black; 26-50 = blue; 51-75 = green; 76-100 = 
yellow; 101-125 = orange; ≥ 125 = red).  
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 11.3.Results 
As previously reported, during follow-up, a total of 130 first ipsilateral cerebrovascular events 
occurred (59 strokes, 49 TIAs, and 22 amaurosis fugax).  
11.3.1.Ipsilateral cerebrovascular events (AF, TIA or stroke) 
Using Kaplan Meier curves, the 5-year cerebrovascular event rate was 3% in patients with JBA < 
4mm2. In patients with JBA between 4 and 8 mm2 was 21% and 36% when JBA was 8-10 mm2 .If JBA 
was above 10mm2 the 5-year cerebrovascular event rate mounted to 43% (P <0.001, Fig. 11.1.A). 
This translates to corresponding annual rates of 0.6%, 4.2%, 7.2% and 8.6%, respectively. 
In multivariate analysis using Cox proportional-hazards regression with ipsilateral cerebrovascular 
events as the dependent variable and after adjusting for other plaque features, which are known to 
be associated with increased stroke-risk (Table 11.1, Model 1), the JBA (<4, 4-8, >8, in mm2) was still 
significant whereas plaque area and GSM were not. 
11.3.2.Ipsilateral stroke 
For stroke alone and after using Kaplan Meier curves, the corresponding annual rates (mean for 5 
years) for JBA: <4, 4-8,8-10 and >10mm2 were 0.4%, 1.4%, 3.2% and 5%, respectively (P<0.001, Fig. 
11.1B).  
The ROC area under the curve for stroke using JBA as a continuous variable was 0.816 (95% CI 0.77-
0.86, P<0.001). Fatal stroke occurred in 0.2% of patients with a JBA < 8 mm2 and in 4.1% of those 
with a JBA ≥ 8mm2 (P<0.001, Fisher’s exact test, OR: 18.7, 95% CI 4.1-85.9). After 8 years of follow 
up, fatal stroke-free survival was 99.5% in those with a JBA < 8mm 2 and 90.1% in patients with a JBA 
≥ 8mm2 and (P<0.001, HR: 19.6, 95% CI 4.3-89.6).  
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 Multivariate analysis was then performed using Cox proportional-hazards regression, with ipsilateral 
stroke as the dependent variable. JBA as a categorical value (<4, 4-8, >8, in mm2) was still significant 
after adjusting for other plaque features as previously (Table 11.1, Model 2). 
Using only the significant variables from the previous models (stenosis, DWA, JBA and history of 
contralateral TIA or stroke) in the Cox model (Table 1, Model 3) the five-year stroke free and average 
annual risk of stroke was calculated for each patient. This way, patients were classified in 5 
subgroups of annual stroke risk (<1.0, 1.0-1.9, 2.0-3.9, 4.0-5.9 and ≥6) (Table 11.2 A-C).  
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Figure 11.1: Kaplan-Meier plots showing (A) ipsilateral cerebrovascular or retinal ischemic event free 
survival and (B) stroke free survival, stratified by Juxtalumunal Black Area (JBA). The number of 
patients at risk at each interval is shown at the bottom of each  
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 Table 11.1: Cox proportional hazards models including juxta-luminal black area and other plaque 
features known to be associated with increased risk. Ipsilateral cerebrovascular events (stroke, 
AF,TIAs)  was the dependent variable in Model 1 and ipsilateral ischemic stroke as the dependent 
varuable in Models 2 and 3. 
 
Variable      β HR 95% CI P value 
                                                 Model 1 
JBA (4, 4-8, 8-10, >10)    0.816 2.26 1.84 to 2.78  < 0.001 
Stenosis (50-69, 70-89, 90-99)   0.241 1.27 0.98 to 1.66     0.073 
DWA (present, absent)    0.883 2.42 1.52 to 3.85  < 0.001 
History of contr. TIA or stroke (present, absent) 0.518 1.68 1.14 to 2.47     0.008 
GSM (<15, 15-30, >30)              -0.041 0.96 0.72 to 1.27     0.776 
Plaque area (<40, 40-80, >80)   0.099 1.04 0.83 to 1.47     0.502 
 
                                               Model 2 
JBA (4, 4-8, 8-10, >10)    0.773 2.16 1.58 to 2.97  < 0.001 
Stenosis (50-69, 70-89, 90-99)   0.465 1.59 1.06 to 2.38     0.025 
DWA (present, absent)    0.619 1.86 0.98 to 3.51     0.057 
History of contr. TIA or stroke (present, absent) 0.793 2.21 1.28 to 3.61     0.004 
GSM (<15, 15-30, >30)    0.163 1.18 0.75 to 1.83     0.471 
Plaque area (<40, 40-80, >80)   0.051 1.05 0.68 to 1.62     0.818 
 
                                              Model 3 
JBA (4, 4-8, 8-10, >10)    0.853 2.34 1.89 to 2.91  < 0.001 
Stenosis (50-69, 70-89, 90-99)   0.462 1.59 1.06 to 2.37     0.023 
DWA (present, absent)    0.582 1.90 0.98 to 3.27     0.059 
History of contr. TIA or stroke (present, absent) 0.788 2.20 1.27 to 3.79     0.005 
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 Table 11.2.A: Stenosis 90-99% ECST (83-99% NASCET) (n=325) and predicted annual stroke risk 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
History of 
Contralateral 
TIAs or Stroke 
Absent 
 
 
 
History of 
Contralateral 
TIAs or Stroke Present 
 
 
 
DWA 
(+) 
n  = 
2.8 
140 
10.3 
38 
 4.6 
28 
18.6 
12 
 
 (-) 
n  = 
1.8 
60 
6.8 
26 
 3.3 
16 
12.6 
4 
 
 
  <8 >8  < 8 >8  
  JBA  
(mm2) 
   
 
JBA  
(mm2) 
 
 
Stroke 
Rate/year 
(%) 
≥ 6 
4.0-5.9 
2.0-3.9 
1.0-1.9 
< 1.0 
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 Table 11.2.B: Stenosis 70-89% ECST (50-82% NASCET) (n=598) and predicted annual stroke risk  
 
 
 
 
 
 
 
 
 
 
 
 
 
 History of Contralateral 
TIAs or Stroke Absent (%) 
History of Contralateral 
TIAs or Stroke Present (%) 
 
 
DWA 
Present 
n = 
2 
270 
7.2 
64 
  
 
3.4 
32 
14.2 
17 
      
 
 Absent 
n = 
1.3 
148 
4 
43 
  
 
2.3 
13 
8.8 
10 
     
 
  < 8 >8   <8 >8       
  JBA  (mm2 )   JBA  (mm2 )  
 
Stroke 
Rate/year 
(%) 
≥ 6 
4.0-5.9 
2.0-3.9 
1.0-1.9 
< 1.0 
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 Table 11.2.C: Stenosis 50-69% ECST (< 50% NASCET) (n=198) and predicted annual stroke risk 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Stroke 
Rate/year 
(%) 
≥ 6 
4.0-5.9 
2.0-3.9 
1.0-1.9 
< 1.0 
 
 
 History of Contralateral 
TIAs or Stroke Absent (%) 
History of Contralateral 
TIAs or Stroke Present (%) 
 
 
DWA 
Present 
n = 
1.0 
78 
4.2 
14 
  
 
2 
20 
8.4 
4 
      
 
 Absent 
n = 
0.5 
57 
2.4 
9 
  
 
1.3 
13 
5.3 
3 
     
 
  < 8 >8   <8 >8       
  JBA  (mm2 )   JBA  (mm2 )  
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 11.4. Discussion 
This is one of the first studies to show that the size of juxta-luminal black carotid plaque area (JBA) 
on ultrasound can stratify the risk of for patients with asymptomatic carotid artery disease.  
Even though JBA was associated with the occurrence of ipsilateral carotid symptoms in two previous 
studies (Pedro LM, 2002; Kakkos SK, Nicolaides AN,2011) the cross-sectional nature of them 
precluded the findings from stroke-risk assessment modelling.  That is why prospective studies, like 
the ACSRS were necessary. Indeed, in this study we demonstrated that the presence of a JBA 
without a visible fibrous cap was linked to ipsilateral neurological events in patients with 
asymptomatic carotid artery stenosis. This link was still significant after adjusting for other 
significant factors associated with plaque vulnerability.  
Another important finding from our study was that JBA size was a very strong predictor of stroke, 
with the area under the ROC curve being 0.816. In addition the finding that not only neurological 
events as a whole, but also ispilateral ischemic stroke, a hard endpoint, is associated with the size of 
JBA increases the validity of our results. 
Finally, another interesting association from our study was that between JBA and fatal stroke. The 
possible explanation behind this is that a larger JBA is able to produce a larger ulcer on the carotid 
surface, which can attract a large amount of thrombus, which in turn can cause a large, fatal brain 
infarct. 
The main limitation of this study was that there was no assessment of optimum GSM cut-off points 
for JBA determination. However, as indicated in the method section the black area was defined as an 
area with gravy pixel values equal to or less than 25. The theory behind this, based on a previous 
study by our group (Griffin MB,2010) is that the human eye is unlikely to distinguish shades of grey 
within the range of 0-25. However, regarding JBA area the 8mm2 cut-off value was proved to be 
optimum.   
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 11.5.Conclusion 
The juxta-luminal black area size appears to be linearly related to the risk of stroke and could be 
useful in risk stratification models. Of course our findings have to be validated in future prospective 
studies or in the medical arm of randomized trials and in the presence of best medical treatment. 
 
 
 
 
 
 
 
. 
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PART IV 
Clinical 3D Ultrasound Studies 
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Chapter 12 
  3D ultrasound for the evaluation of carotid plaque disease; a systematic 
approach to the available evidence. 
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 12.1. Introduction 
Two dimensional (2D) ultrasound imaging has been a powerful tool for the diagnosis and 
management of carotid plaque atherosclerosis. Ultrasound imaging provides the vascular surgeon 
with a valuable asset due to its non-invasive nature, its low cost and its undoubted effectiveness in 
identifying and evaluating the carotid anatomy and associated pathologies such as the formation of 
atherosclerotic plaque [U-King-Im JM,2009].  Even today, in the era of advanced imaging techniques 
such as angio-MRI and angio-CT , 2D ultrasound remains our first choice imaging for the initial 
investigation of patients with carotid plaque disease. 
 
Indeed, for a significant number of patients with carotid plaque disease, 2D ultrasound investigation 
and its subsequent analysis are sufficient to determine the best possible plan of care. Nevertheless, 
2D ultrasound can only provide us with a limited number of views (longitudinal and transverse) the 
quality of which can vary since it is an operator-dependent technique. Moreover, once the 2D slices 
have been captured, images of other planes can no longer be extracted [Fenster A, Landry A,2004; 
Fenster A, Downey DB,2001]. This may affect the accuracy of plaque characterization since 
information is only sampled from one section, which is then assumed to be representative of the 
entire plaque. 
Furthermore, there is accumulating evidence that plaque composition [Grønholdt ML,2001; Kakkos 
SK, Stevens JM,2007], morphology [Prabhakaran S,2006; Rothwell PM,2000] and size [Spence 
JD,2002] may significantly impact plaque vulnerability. The 2D approach may not be sufficient to 
accurately evaluate these features for the entire plaque volumes since a large number of carotid 
plaques have variable compositions with some of their components being more echolucent than 
others. Thus, in heterogeneous carotid plaques, 2D ultrasound imaging may not provide with an 
accurate assessment of the composition or size, with obvious implications in risk stratification. 
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 Traditional 2D ultrasound imaging is an adequate and cost-effective method for a significant 
proportion of patients with carotid plaque disease, although, there exists a need for a more sensitive 
means of identifying the subgroup of high-risk asymptomatic patients who may benefit from more 
radical management [Makris GC, Nicolaides AN,2011]. The development of angio-MRI and angio-CT 
introduced a new era in volumetric vascular imaging. Following the use of highly sophisticated 
reconstruction software and the acquisition of images containing volume information in three 
dimensions, the visualization of vascular structures in different planes from different angles is 
possible. Thus, a more holistic evaluation of the plaque properties can be achieved. Nevertheless, 
these modalities have their own limitations including limited accessibility, increased cost, exposure 
to radiation, a more invasive nature, increased patient inconvenience and contraindication in 
patients with contrast-allergy or renal impairment. 
3D ultrasound may represent an alternative option combining the advantages of volumetric vascular 
imaging using MRI or CT with those of ultrasound imaging (increased availability, non-invasive 
nature and decreased cost).  Cardiology and obstetrics are among the first medical fields where 3D 
ultrasound already had significant applications [Lang RM,2006]. The new volumetric acquisition 
techniques facilitate the storage of multiple, consecutive and equidistant views which are 
subsequently converted in a matrix of points (voxels) representative of the volume scanned. The 
navigation and the 3D reconstruction of the underlying structures can then be performed by 
sophisticated software. 
In this chapter we sought to identify and critically review the clinical evidence regarding the 
reproducibility and effectiveness of 3D ultrasound in carotid plaque characterization.  
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 12.2.Methods 
The PubMed, Scopus and Cochrane databases were searched for clinical studies evaluating the 
reproducibility and effectiveness of 3D ultrasound on carotid plaque characterization in terms of 
plaque size, volume, morphology or composition. The search terms used were: “3-dimensional”, 
“ultrasound”, “carotid plaque” AND “volume” OR “composition” OR “morphology” OR “stenosis” OR 
“flow velocities” in various combinations. Two independent reviewers Dr. G Makris and Dr. A Lavida 
performed the literature search and data extraction. The selected studies were manually searched 
for relevant publications out of their reference lists.  
 
All clinical studies which reported results on the reproducibility of 3D ultrasound measurements or 
its effectiveness in evaluating the carotid plaque progression post medical treatment were retrieved 
and included in the final analysis. In vitro or animal only studies using 3D ultrasound were excluded 
from the analysis. Case report studies were also excluded. There was no language or time limit to 
our search.  
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 12.3.Results 
                  12.3.1.Reproducibility of 3D carotid measurements of volume and stenosis 
The sample size in most studies was small and ranged from 10 to 105 carotid plaques in total. The 
majority of the studies evaluated the total plaque volume (TPV) and only one the vessel wall volume 
(VWV). (Table 12.1) All studies concluded that there was good intra- and inter-observer 
reproducibility of 3D ultrasound in carotid plaque volume measurements ranging from 2.8-6.0% and 
4.2-7.6%, respectively. The effect of the distance between the studied slices (ISD) as well as the 
effect of the initial plaque size in the volume reproducibility measurements was assessed by 2 
studies. Both studies concluded that volume measurement variability can be smaller for larger 
plaques, while Fenster et al., suggested a possible effect of the ISD on the observed variability. 
[Landry A,2004]  
 
The reproducibility of the degree of stenosis using 3D ultrasound was investigated by four studies. In 
two of the studies 2D and 3D ultrasound were used to assess the degree of stenosis while Yao et al.[ 
Yao J,1998], used carotid angiography and Wessels et al. [Wessels T,2004] used digital subtraction 
angiography to evaluate stenosis. All studies suggested good agreement between the compared 
methods (Table 12.1). Lastly, the peak systolic velocities (PSV) were evaluated by Needleman et al., 
[Forsberg F,2008] who showed good correlation between the measurements obtained by 3D and 2D 
ultrasound  (r >or= 0.32; P < .002). 
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                      12.3.2. Reproducibility of 3D ultrasound for the evaluation of plaque composition 
Only 2 studies [Heliopoulos J,2009;  Schminke U,2000] were identified investigating the clinical use 
of 3D ultrasound for the evaluation of carotid plaque morphology. Morphology features such as 
plaque surface irregularity [Heliopoulos J,2009] or the presence of ulceration [Heliopoulos J,2009;  
Schminke U,2000] were mainly evaluated. Good intra- and inter-observer reproducibility in the 
characterization of plaque morphology was demonstrated by those studies ranging from 8.9- 9.4% 
and 9.7-2.3%, respectively , suggesting that 3D ultrasound can be used for the evaluation of carotid 
plaque surface. In the study by Heliopoulos et al., [Heliopoulos J,2000] it was also shown that 3D 
ultrasound was superior to 2D in detecting ulceration in a sample of 62 plaques which were 
evaluated by both 3 and 2D ultrasound and by 2 independent observers (16.1% and 14.5% of 
plaques, for observers 1 and 2, respectively, versus 6.5% and 9.7% of plaques, for observers 1 and 2, 
respectively, p= 0.125 and p= 0.063, for observers 1 and 2, respectively).  
Three studies reported reproducibility data and apart from the study by Heliopoulos et al., 
[Heliopoulos J,2009] which included 214 patients, the remaining two [Denzel C,2009; Seabra 
JC,2009] included only 19 and 5 patients respectively. Grey scale median (GSM) and mean grey 
values (MGV) from the image grey scale histogram were used for the evaluation of plaque 
composition with no reference to other texture features. Fine intra and inter-observer 
reproducibility was reported with intra-and inter-observer correlation coefficients of >0.935 and 
>0.89, respectively [Heliopoulos J,2009; Denzel C,2009]. All studies concluded that 3D ultrasound 
could adequately evaluate plaque echodensity. Particularly Denzel et al., [Denzel C,2009] who 
studied 24 endarterectomy samples using both 2D and 3D ultrasound, suggested that 3D imaging 
can be equivalent to 2D in the assessment of plaque echodensity (p < 0.001, r = 0.8), although, these 
results were supported by a small sample. (Table 12.2) 
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                    12.3.3. Effectiveness of 3D ultrasound in the evaluation of carotid plaque progression  
Eleven studies were identified regarding the use of 3D ultrasound for the evaluation of carotid 
plaque progression with or without treatment (Table 12.2). Two of these studies evaluated the 
plaque progression without any treatment, five studies evaluated the effect of statins on various 
plaque characteristics and three studies the effect of other medication such as anti-hypertensives. 
The study design, as well the follow-up time varied significantly between the studies, ranging from 7 
years to 3 months. Only five studies of these studies were randomized control trials. The sample size 
also varied from a maximum of 165 to 7 patients. (Table 12.1) 
 
The majority of studies used plaque volume or vessel wall volume changes and four of them 
assessed changes in plaque composition. All studies concluded that 3D ultrasound could be a useful 
tool for the evaluation of various carotid plaque characteristics and their progression through time, 
with or without the effect of any particular treatment. In addition two studies showed that 3D 
ultrasound can be sensitive enough to detect plaque changes in short periods of time or in small 
sample sizes and thus can be particularly useful for the evaluation of new treatments. Finally it 
should be noted that no studies were identified evaluating both carotid plaque volume and 
composition changes (Table 12.2).  
 
A comparison between the sensitivity of 2D and 3D ultrasound measurements as a response to 
treatment was only performed in 4 studies (Table 12.2).  In these studies the change of 3D US 
volume measurements as a response to treatment was compared to the changes of the intima 
media thickness (IMT) of the internal carotid artery, which is one-dimensional. All studies concluded 
that 3D volume measurements are more sensitive than IMT measurement for the evaluation of 
carotid plaque progression post-treatment. More specifically, while there was significant change in 
3D plaque volume during the follow-up period there was no change in IMT. However, no studies 
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 were found comparing the 3D plaque volume or composition (i.e. grey scale median) changes with 
the 2D plaque area or composition features post-medical treatment.  
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 Author 
/year 
Study design and 
number of 
patients 
3D US specifications Reproducibility outcomes Conclusion 
VOLUME STENOSIS/ FLOW VELOCITIES  
Delcker A, 
/ 1994  
 
Repeated 
measurements were 
performed at weekly 
intervals using three 
different evaluation 
procedures/ N= 70 
 
Three newly developed 
evaluation procedures of plaque 
volumes (manual tracing, 
threshold procedure, watershed 
algorithm) were assessed.  
 
Intraexaminer variability ranged from 2.8% (watershed 
algorithm) to 4.1% (threshold procedure).  
Interexaminer variability ranged from 4.2% (manual 
tracing) to 7.6% (threshold procedure) 
Follow-up measurements ranged from 5.2% (watershed 
algorithm) to 9.4% (threshold procedure). 
Pearson correlation coefficients for interexaminer 
agreement and for the three measurement procedures 
were all highly significant (p<0.01). 
 
- 3D computer based image 
reconstruction provides with highly 
reliable quantification of moderate 
atherosclerosis. 
Griewing 
B,  et al./ 
1997  
 
Conventional colour 
coded Doppler US 
and 3D US 
angiography were 
used to evaluate 
carotid artery 
atherosclerosis, PV 
ranged from 0.053 to 
0.685 ml./ N=21  
 
Conventional color-coded 
Doppler ultrasound and 3D 
ultrasound angiography Data 
collection for 3D imaging 
required five minutes per patient 
The intraobserver and interobserver variabilities were 
4.16 and 5.87%, respectively (r = 0.96, p < 0.0001; r = 
0.89, p < 0.0001). 
3D Color Doppler and 3D ultrasound angiography 
(power mode) assessments of plaque volume differed by 
8.5%. 
Plaques were more easily differentiated using 3D US 
and quantification of plaque volume was less affected by 
echo shadowing after 3D reconstruction. 
 
- 3D ultrasound angiography offers a 
more precise quantitative method 
for the quantification of 
atherosclerotic lesion than other 
techniques for prospective, clinical 
studies. 
Palombo C,  
et al./ 1998 
[13] 
 
In vitro quantitive 
analysis of known 
test phantoms and in 
vivo reproducibility 
of plaque volume (2 
observers )/ N=27 
phantoms (range, 100 
to 600 mm3) and 
N=47 fibroadipous 
plaques (range, 7 to 
450 mm3) 
Controlled sequential 
tomographic data acquisition  
performed by scanning in a 
fanlike motion with a linear array 
of the high-frequency transducer 
(7.5/10 MHz) +/-ECG 
synchronization  
 
In vitro: Excellent correlation between the volume of 
plaque phantoms measured using the 3D data and the 
true volume (r=0.99;  y=0.96x+12.38,  P<0.01) 
 
In vivo: High reproducibility was found for 
measurement of carotid plaque volume (mean difference 
between two observers: 0.6±11.2 mm3 and correlation 
(r=0.99, Y=1.02x-2.03; P<0.01).  
 
- 3D US imaging of carotid artery is 
an accurate and highly reproducible 
means for measuring atherosclerotic 
PV.  
Table 12.1: Clinical evidence regarding the reproducibility of 3D ultrasound on carotid plaque volume and stenosis/flow measurements 
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 Yao et al./ 
1998  
 
Symptomatic pts 
with severe carotid 
artery stenosis 
(>70%) imaged with 
3D US and 
angiography before 
endarterectomy, and 
12 of the operated 
carotids were imaged 
aftewards by two 
observers/ N=14. 
 
|Commercially available 
ultrasound system (AU3 Partner, 
Esaote Biomedica, SpA) 
incorporated with a 3D prototype 
probe (linear array transducer 
operating at dual frequencies of 
10/7.5 MHz) +/-ECG 
synchronization 
 
3D US showed good reproducibility as the intra and 
inter observer variability was SEE=1.9 r=.99 and 
SEE=2.3 r=.99 respectively in plague length 
measurement and SEE=42.9 r=.99 and SEE=54.4 r=.99 
respectively in plaque volume measurement..  
 
Good correlation between the percentage of 
carotid stenosis measured by angiography 
and 3D US was observed ( SEE=12.4%, 
r=0.76, and mean difference=7.0+/-12.3% 
with the diameter method; SEE=10.5%, 
r=0.82, and mean difference=1.8+/-10.5% 
with the area method) 
The quantitative and qualitative 
analyses possible using 3D US 
(especially volumetric) may have 
important clinical implications in 
following plaque progression or 
regression and assessing the 
outcomes of clinical interventions 
due to its excellent reproducibility. 
 
Keberle M, 
et al./2000  
 
Prospectively 
screened pts for CAD 
using power 3D US 
and 2D US; the 3D 
data was analyzed by 
two independent 
reviewers/ N=75 
Doppler US and 3D power 
Doppler sonography, utilizing a 
7.5-MHz linear-array transducer 
combined with tissue harmonic 
imaging. 
 
- 
 
 
 
 
 
 
 
 
 
The degree of stenosis determined by the 
conventional Doppler highly correlated 
with that determined using 3D US (r = 
0.982-0.998). 
 
Good correlation of measurements of length 
of lesion and distance from the bulb using 
conventional and 3D US (r = 0.986). For 
3D US the interobserver variability rate was 
3.7% +/- 0.5%.   
3D power Doppler US provides 
with an easy and accurate method 
for screening atherosclerotic lesions 
of the carotids and the excellent 
volume surveys produced may be 
helpful in planning surgical 
intervention. 
Wessels T 
et al./2004 
[16] 
 
Evaluate agreement 
of ICA stenosis using 
3D US  compared 
with DSA /N=49  
Color-coded duplex system using 
the power mode was applied. 3D 
system consisted of an 
electromagnet that induces a low-
intensity magnetic field near the 
patient's head. 
- High agreement between two observers was 
found in 3D US (weighted kappa 
coefficient of 0.88). 3D US slightly 
underestimated the mean stenotic degree 
(mean 3D CDS 68.47+/-10.5 vs. DSA 
71.3+/-10.0). 
Good agreement between DSA and 3D US 
Mean sensitivity of 3D CDS= 93%, mean 
specificity=82.5%, mean positive predictive 
value=82%, and mean negative predictive 
value=98%. 
3D CDS findings demonstrated 
good agreement compared with the 
DSA, yielding higher accuracy than 
CDS alone. 
Landry A,  
et al./ 2004 
[17] 
Multiple-observer 
study investigating 
observer variability 
and reliability in the 
Mechanical linear 3D scanning 
system (LIS Inc) with a 3D 
image transducer (50 mm; L12–
5, Philips) while video frames 
Intraobserver and interobserver measurement reliabilities 
were 94% and 93.2%, respectively.  
 
PV measurement variability decreased as PV increased 
- 3D US provides with an accurate 
and reliable means of measuring 
plaque volume which is affected by 
plaque size and chosen ISD. 
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  measurement of 
plaque volume. / 
N=40 plaques (range, 
37.43 to 604.10 
mm3) 
 
 
from an US machine (ATL HDI 
5000, Philips) were digitized and 
saved to a computer workstation.  
 
(ranging from 27.1% to 2.2%).  
 
ISDs between 1.0 and 3.0 mm did not affect PV 
measurement precision, but PV measurement variability 
increased with ISD. 
 
Repeated 3D US scan measurements gave the same 
values as single-scan measurements (p=0.867). 
 
Egger M, 
et al./ 2007 
[18] 
 
3D US images 
acquired from the 
right and left ICA of 
subjects with carotid 
atherosclerosis 
scanned twice within 
a period of two wks 
(two observers) / 
N=10 
3D US images by ultrasound 
transducer (L12-5,50 mm, 
Philips, Bothell, WA, USA) 
along the neck of the patient 
every 4.0 cm (ATL HDI 5000, 
Philips, Bothell, WA, USA) 
COV and ICC for VWV measurements (scan COV = 
4.6% ICC = 0.95, rescan COV = 3.4%, ICC = 0.96) 
(COV = 5.7%, ICC = 0.85) and TPV measurements 
(intraobserver variability scan COV = 22.7% ICC = 
0.85, rescan COV = 21.1% ICC = 0.88 and interscan 
variability, COV = 31.1%, ICC = 0.83), indicated higher 
intraobserver and interscan reproducibility for VWV.  
- 3D US VWV measurements show 
higher intraobserver and interscan 
reproducibility than TPV 
measurements and thus VWV 
measurements may provide with 
additional information about the 
plaques.   
Ludwig et 
al. / 2008 
[19] 
 
N=45 plaques used to 
assess PV intra- and 
inter- observer 
reproducibility (three 
sonographers) and  
N=60  plaque images 
used to assess  the 
effects of plaque size 
and number of slices 
(5 vs. 10 ) in manual 
planimetry 
3D US high-resolution Voluson 
530 D MT, 2D-/3D CFM-
Ultrasound System (Kretz-
Technik AG, Zipf, Austria)  
ICC for intraobserver variability was 0.985, 0.967, and 
0.969 respectively for each of the appointed observers. 
The interobserver ICC= 0.964, thus both intra- and inter- 
observer variability were small, AND smaller for larger 
(PV>60µl) than smaller plaques (PV<60µl).  
Using 5 or 10 slices did not have a significant effect on 
the variability (mean CV= 3.4 and 3.1 for 5 and 10 slices 
respectively).  
Mean CVs for the larger plaques (40-60µl) were smaller 
than for smaller plaques (20-40µl) for both the 5 and 10 
slide methods   
- 
 
 
 
3D US can produce highly reliable 
and reproducible re-quantification 
of plaque volume  
In smaller plaques, a 10 slice 
procedure as opposed to a 5 slice, 
can prove more reliable. 
Forsberg 
F,  et 
al/2008 [20] 
 
compare PSV and 
degree of stenosis 
measurements 
obtained using a real-
time 3D Doppler US 
scanner and a 
conventional Doppler 
US scanner/N=59  
3D Doppler US (Encore PV; 
VueSonix Sensors Inc, Wayne, 
PA) and conventional Doppler 
US 
- The methods for measuring stenosis 
showed good agreement using ICA PSV 
(ICC= 0.83; P < .0001) and to a lightly 
lesser extent using ICA/CCA PSV ratio 
(ICC = 0.65; P < .0001).  
 
PSV measurements obtained using 
conventional US and 3D US correlated if 
all vessels (r >or= 0.32; P < .002). 
The semi-automated 3D Doppler 
device is comparable to 
conventional 2D US in the 
measurement of PSV and thus the 
assessment of carotid stenosis. 
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Abbreviations :3D: three-dimensional; US: ultrasound; PV: plaque volume; ml: millilitres; mm:  millimetres; MHz: Megahertz; ECG: echocardiogram  pts: patients; CAD: carotid artery disease; 2D: 
two-dimensional; LIS: life imaging Systems Inc,; ATL: Advance Technology Laboratories; HDI: high definition imaging; ISD: interscile distance; ICA: internal carotid artery;  DSA: digital subtraction 
angiography; vs.: versus; CDS: color Doppler sonography; wks: weeks; cm: centimetre; WA: Washington; USA: United States of America; COV: coefficients of variation; ICC: intraclass correlation coefficient; 
VWV: Vessel Wall Volume; TPV: Total Plaque Volume; CFM: color flow mode; CV: coefficient of variation; PSV: peak systolic velocities; PA: Pennsylvania; CCA: common carotid artery 
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 Table 12.2. Evaluation of carotid plaque progression using 3D ultrasound with or without treatment  
Author/Year Number of patients/Study 
Design/ Type of treatment 
Evaluated plaque 
characteristics/ Follow up 
Study Outcome Comments 
Hennerici M, 
et al./1991 
[29] 
 
N=7/ four flat and 17 soft carotid 
plaques were investigated during, and 
after heparin-induced extracorporeal 
LDL precipitation (HELP).  
Plaque volume progression 
and regresion/ Average f/u 
was 17 months (minimal=7; 
maximal=24 months) 
 
During treatment, plaque regression was seen in all subjects within 6 
(n=6) or 12 (n=l) months of f/u. 
 
After this, during continuous HELP treatment the vessel wall changes 
persisted in all patients spare one who experienced plaque progression 
 
Specially designed quantitative 3D US 
analysis, provides with a useful way to 
evaluate significant plaque volume 
reduction in all subjects. 
Schminke  et 
al./ 2000 [30] 
 
N=32/ Carotid artery plaques were 
examined using 3D reconstruction of 
parallel 2D gray scale b-mode US with 
power mode./No treatment was given, 
3D power Doppler used to 
measure PV and its 
progression/regression at 
baseline and after an average 
of 18.9 months 
Carotid plaque progression was observed in 15% of cases, while plaque 
volume stayed constant (a change less than 20%) in 85%. 
Progressive plaques were usually hypoechoic (3/5), while those which 
were progressive and hyperechoic had an ulcerated surface.  
There was a significant increase in plaque volume in symptomatic 
patients (p<0.05) and patients with carotid stenosis of >50% (p<0.05). 
Drug therapy and other risk factors showed no correlation to plaque 
progression, probably due to the small number of plaques with 
progression 
 
3D reconstruction of atherosclerotic 
carotid artery plaques enables the 
reproducible quantification of plaque 
volume thus making it an excellent 
technique for longitudinal trials assessing 
progression or regression of plaques. 
Kessler et al./ 
2002 [31] 
 
N=23 / Patients (mean age = 61.7 +/- 
7.5 years) with hypercholesterolemia 
were treated with statins and the 
progression of 31 carotid artery 
plaques was assessed  
Quantitative measurements of 
carotid artery PV using 3D 
reconstruction of exactly 
parallel transverse duplex 
ultrasound scans (slice 
distance = 0.1 mm) over 15.1 
+/- 4.5 months. 
 
Plaques significantly less frequently progressive if hypoechoic (11%, n 
= 9 vs. 64%, n = 14; P = .016) or if the baseline serum cholesterol 
levels were above 8.0 mmol/L (9%, n = 11 vs. 75%, n = 12;   P = .002). 
3D US allows the measurement of the  
volume of an entire atherosclerotic plaque 
rather than the arterial wall thickness and 
plaque morphology and configuration 
may be analyzed. 
Pollex RL,  et 
al./2005 [32] 
 
N=98/ case-control study included 49 
Oji-Cree adults with diabetes or 
impaired glucose tolerance, aged 21-
69, and 49 sex- and age-matched 
normoglycaemic subjects 
Carotid arterial IMT and total 
PV were assessed at baseline 
and 7 years later. 
Total PV (P = 0.037), though not IMT were higher in subjects with 
diabetes/impaired glucose tolerance vs. normoglycaemic controls at f/u. 
Correlation between IMT and total PV was moderate (r = 0.524) 
To achieve power >0.7 using IMT measurements for diabetic vs. non 
diabetic subjects, thousands of subjects are required, while only 
Total PV appears to capture the 
atherosclerotic disease burden more 
effectively in subjects with type 2 
diabetes than IMT, and thus would be an 
appropriate outcome measure for studies 
aimed at changing assessing these 
patients. 
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 hundreds are needed when using total PV. 
For  total PV, intra- and inter-observer reliability were 0.94 [n = 40] 
and 0.93 [n = 40], respectively (both P < 0.01). 
 
 
Ainsworth et 
al./ 2005  
N=38/ Patients with carotid stenosis  
>60%, age ±SD: 69.42±7.87 years 
randomly assigned in a double-blind 
fashion to 80 mg atorvastatin daily 
(n=17) vs. placebo (n=21)  
 
3D plaque volume at 
baseline and after 3 months of 
treatment 
Plaque regression of  -90.25± 85.12 mm3 seen in patients taking 
atorvastatin vs. plaque progression of 16.81±74.10 mm3 in those taking 
placebo (P<0.0001). 
3D PV measurements can be used to 
demonstrate the large effects of therapy 
on atherosclerosis in 3 months in sample 
sizes of 20 patients per group and over a 
short period of time (3-6 months).  
Stumpe et al./ 
2007  
 
N=165/MORE RCT/ patients  
randomized to olmesartan (20-40 
mg/day) or atenolol (50-100 mg/day) 
and were investigated using 2D and 
3D US in order to compare the two 
treatments 
 
 
Change from baseline (Delta) 
in CC-IMT assessed by 2D 
US. Secondary outcomes 
included Delta PV assessed by 
3D US and blood pressure 
(BP)/ US performed at 
baseline and 28, 52 and 104 
wks 
 
The two treatments produced similar significant reductions in CCA 
IMT. Mean Delta PV (SEM) was -4.4 (2.3) microl and 0.1 (1.5) microl 
in the olmesartan and atenolol treated subjects, respectively, without 
significant between-treatment differences.  
In patients with baseline PV > or = median (33.7 microl), there were 
significant between-treatment differences in Delta PV (p = 0.023), as 
PV regressed significantly with olmesartan (Delta PV: -11.5 (4.4) 
microl) but not with atenolol ( Delta PV: 0.6 (2.5) microl 
While carotid IMT and BP decreased 
similarly with olmesartan and atenolol, 
only olmesartan reduced the volume of 
larger atherosclerotic plaques. 
 
Mallett et al./ 
2009  
 
N=77/ Longitudinal, placebo 
controlled study where patients were 
randomized to receiving vitamin B9, 
B6 and cobalamin (group A) vs. 
Placebo (group B). 
Analysed the sensitivity of 
three US phenotypes, B mode 
derived IMT and TPA and 3D 
US derived VWVCCA+ICA./ 
subjects  blindly scanned at 
baseline and 2.3+/-  1 year 
later (range: 0.5 to 4.5 y) 
The VWV rate of change for CCA and ICA, was significantly greater 
than 0 for group B (53 +/- 110 mm3/y) (p=0.008), but not significantly 
different than 0 for group A (-12 +/- 137 mm3/y) (p=0.6).  
 
A significant difference between the VWV rates of change between 
treatment groups was seen (p=0.034).  
 
There was a significant relationship between deltaVWV and deltaIMT. 
In group A they were positively correlated (r=0.44, p<0.05) and in 
group B negatively correlated (r=-0.44, p<0.01). 
 
3D US measured VWV seems to be more 
sensitive to temporal changes in carotid 
atherosclerosis of pts with diabetic 
nephropathy than IMT of TPA. 3D US 
VWV is  adequate for longitudinal studies 
of atherosclerosis providing the necessary 
sensitivity and specificity 
Yamada K, et 
al./ 2009  
 
N=40/  consecutive non- or slightly 
hypercholesterolemic pts with 
moderate carotid artery stenosis 
randomly assigned to diet group (n = 
20) or atorvastatin group (n = 20) 
IMT and 3D IBS values 
measured at baseline and after 
6 months. 
 
Relative lipid volume of carotid plaques significantly decreased from 
58.4 +/- 25.6 to 47.8 +/- 23.5% in the statin group (p < 0.01), whereas 
no significant decrease was seen in the diet group. 
IBS values and relative lipid volume between baseline and 6 months 
were correlated with the change in LDL (r = 0.31, p < 0.05, and r = 
0.34, p < 0.05, respectively) 
Quantitative assessment of carotid 
plaques using 3D IBS analysis was a 
clinically useful method for monitoring 
atherosclerotic lesion progression 
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 Krasinski A, 
et al./ 2009 
 
 
N=35/ RCT/pts with carotid stenosis 
>60% were randomized  to receive 
either 80 mg atorvastatin (16 subjects, 
nine male, mean age 68+/-8.6 y) or 
placebo (19 subjects, 15 male, mean 
age 70+/-9.4 y) daily 
3D US VWV was manually 
segmented by a single 
observer. Individual lumen 
and wall segmentation 
contours used to generate 
carotid atherosclerosis 
thickness difference maps/ Pts 
evaluated at baseline and 3m 
VWV increased by 70+/-140 mm3 (+4.9+/-10.3%) in the placebo group 
and decreased by 30+/-110 mm3 (-1.4+/-7.7%) in the atorvastatin group 
(p<0.05). 
3D US VWV provides with a quantitative 
measure of atherosclerosis burden 
including the IMT and plaque, and has 
sensitivity to detect changes over short 
periods of time. VWV thickness 
difference maps can provide visual 
evidence of the spatial and temporal 
dynamics of carotid artery changes. 
Awad J,  et 
al./ 2010  
 
N=53 with ICA stenosis>60% were 
enrolled and 38 subjects completed the 
study (17 subjects on atorvastatin and 
21 on placebo)/ cross-sectional study 
Using 3D US images 270 
texture features from seven 
texture techniques were 
extracted from manually 
segmented carotid arteries 
based on the IMT boundary / 3 
months 
Texture features improved the detection of statin-related changes using 
DBC to 0.5199, using WRS to 0.002, and ACC to 63.87%, 
respectively.  
The texture techniques that most differentiated between atorvastatin 
and placebo classes were Fourier power spectrum and Laws texture 
energy measures. 
The use of specific texture features resulted in the AUC value of 
0.9988 +/- 0.0069 compared to 0.617 +/- 0.15 using carotid VWV. 
Texture features derived from 3D US can  
be more sensitive in detecting statin-
related changes in carotid atherosclerosis 
than VWV. 
Abbreviations: LDL: low density lipoprotein; f/u:follow-up;  3D:3-dimensional, US:  ultrasound, 2D: two dimensional; PV: plaque volume; mm: millimetre; vs.: versus; 
mmol/L: millimol per litre; IMT: intima-media thickness; SD: standard deviation; mg: milligram; mm: millimetre; MORE: Multicentre Olmesartan atherosclerosis Regression 
Evaluation; RCT: randomized control trial; CCA: Common Carotid; SEM: standard error of the mean; BP: blood pressure;  TPA: total plaque area; VWV: vessel wall volume; 
ICA: Internal carotid artery; y: year;  Delta: change from baseline; pts: patients; IBS: integrated backscatter analysis., DBC: distance between classes; WRS: Wilcoxon rank 
sum; ACC: median accuracy measures; AUC: Area under the receiver-operator characteristic curve
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                    12.3.4. 3D ultrasound for carotid plaque disease, in patients with or without stroke 
Only one study [Heliopoulos J,2008] was identified investigating the potential differences in 3D 
ultrasound features between patients with symptomatic or asymptomatic carotid plaque disease. The 
investigators evaluated the cases of 110 symptomatic and 104 asymptomatic patients using 3D 
ultrasound. They assessed the echodensity of the plaques by means of 3D imaging using the mean 
grey values of the whole plaque without any information regarding plaque volume or morphology 
changes. They concluded that, especially, at moderate degrees of ICA stenosis (less than 60-70%), 
lower mean grey values can be an important factor, indicating plaque vulnerability and increased risk 
for a stroke. Finally, there were no studies regarding the use of 3D ultrasound for the evaluation of 
carotid-restenosis after stenting, while there was only one regarding carotid artery changes post-
endarterectomy [Yao J,1998]. 
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 12.4.Discussion 
The purpose of this chapter was to systematically review the available clinical evidence regarding the 
reproducibility and effectiveness of 3D ultrasound in the evaluation of carotid plaque disease. A 
number of studies were identified evaluating various plaque characteristics such as volume, 
morphology (i.e. presence of ulceration), composition or degree of stenosis. All studies concluded in 
favour of the good reproducibility of 3D ultrasound. The majority of them (Table 12.1) focused on the 
reproducibility of plaque volume measurements (>90% for both inter- and intra observer variability), 
although there were also studies suggesting good reproducibility in the assessment of plaque 
morphology or composition. There were studies suggesting equal [Forsberg F,2008] or sometimes 
better results than 2D ultrasound [Heliopoulos J,2009; Pollex RL,2005] regarding plaque 
characterization within small samples or short follow-up periods [Ainsworth CD,2005]. However, there 
was one study that failed to show any additional benefit from the use of 3D ultrasound for the 
evaluation of carotid plaque echodensity when compared to 2D [Denzel C, 2009]. 
 
Only a small number of studies evaluated the reproducibility and effectiveness of 3D ultrasound on 
the evaluation of carotid plaque composition and morphology.  Ulceration [Fisher M,2005] or the 
presence of a heterogenous, echolucent plaque [Grønholdt ML,2001; Kakkos SK, Stevens JM,2007] 
with increased lipid component has been recently associated with increased risk of cerebrovascular 
events. All the studies in this review suggested that 3D ultrasound could be a reliable method for the 
evaluation of both plaque morphology and composition in terms of presence of ulceration or grey 
scale levels, respectively. However, despite the encouraging data, due to the small number of the 
available studies more research is warranted in order to define the exact potential of 3D ultrasound on 
the evaluation of plaque composition and morphology. 
 
Total plaque volume (TPV) was the most commonly evaluated characteristic for the assessment of 
alterations in plaque burden and evaluation of treatment effects (Table 12.2). While TPV is a useful 
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 measurement for the quantitative assessment of plaque burden, it does not provide information 
regarding the location of the plaque in the artery, where the volume changes occur [Landry A,2002; 
Zahalka A,2001]. Moreover, measurement of total plaque volume from 3D images can be more 
technically challenging, since it requires trained observers who are able to distinguish plaque 
boundaries from vessel wall, although it must be pointed out that good reproducibility was reported 
by all studies, which evaluated total plaque volume (table 12.1). Vessel wall volume (VWV) is a 
measurement of vessel wall thickness and plaque within the internal and common carotid. It is 
considered to be a more reproducible method of volume evaluation since it only requires the 
segmentation of the media-adventitia and lumen-intima (plaque) boundaries in the 3D images. These 
boundaries can be more regular and identifiable by an automated or semi-automated segmentation 
method. Nevertheless the VWV measurement was less reported [Egger M,2007] but was also well 
reproducible. 
 
In addition it should be noted, that despite the preliminary data which suggest that 3D plaque volume 
measurements are more sensitive than one-dimensional IMT measurements in identifying plaque 
changes post treatment [Pollex RL,2005; Mallett C,2009], this has to be interpreted with caution. The 
IMT is a vessel-related parameter and is not the best marker to assess plaque changes since the intima 
media complex and the carotid plaque are two biologically distinct structures [43]. In addition the 
mean increase of IMT in untreated individuals is 0.015 mm per year [Bots ML,2003] when the 
resolution of the ultrasound is ~0.3 mm. In contrast, carotid plaque volume has been shown to 
increase by 50 mm3/year and plaque area by 5 mm2/year and, thus, potential change can be more 
easily detected [Spence JD,2005]. Two-dimensional measurements of plaque area and GSM have 
shown significant potential in identifying vulnerable plaques [Nicolaides AN, Kakkos SK,2010] and thus 
their predictive ability should be compared with that of 3D volume or composition measurement. 
Unfortunately no such studies were identified.  
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 Moreover, there was only one study comparing the 3D plaque composition findings between two 
groups with or without cerebrovascular symptoms. The study by Heliopoulos et al., showed that at 
moderate degrees of stenosis (between 60-70%), lower total plaque echogenicity might be a 
significant risk factor for the development of cerebrovascular events [Heliopoulos J,2008]. Lower grey 
scale levels can be attributed to echolucent material within the plaque such as lipids, haemorrhage or 
thrombus. This finding may have significant implications in the re-stratification of asymptomatic 
patients with moderate degree of stenosis. According to the current guidelines these patients are not 
suitable for any intervention, apart from optimization of their medical management [Liapis CD,2010]. 
Nevertheless, more studies are needed in order to clarify if 3D composition or morphology evaluation 
is more sensitive than 2D in the identification of the high-risk individuals within the asymptomatic 
group. In addition the use of novel texture features, such as second order statistics [Kakkos SK, 
Stevens JM,2007] for 3D plaque- characterization of both echodensity and heterogeneity, was only 
explored in one cross-sectional study [Awad J,2010]. Fenster and his colleagues suggested in this study 
that these features could be more sensitive in the detection of pharmacological changes to plaque 
than volume measurements. Some of these features have been previously associated with ipsilateral 
embolic brain infraction [Kakkos SK, Stevens JM,2007]. More data is also needed to clarify the 
potential of these novel features when used in combination with 3D imaging. 
 
A recent systematic review of the literature also showed that other novel diagnostic approaches for 
the identification of vulnerable carotid plaques, such as stress wall analysis of the plaque’s 
biomechanical properties, may have promising clinical potential [Makris GC,2010]. Currently, 2D 
ultrasound and MRI imaging can be combined with fluid–structure interaction (FSI) techniques to 
create maps of the stress variation upon the plaque’s surface, with increased cost and complexity. 3D 
ultrasound could potentially simplify this process since it combines the increased availability of 
ultrasound with optimized volumetric information for the whole plaque similar to that provided by 
MRI [Augst AD,2003].In their study, Gao and Long et al., using 3D ultrasound and FSI simulation- 
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 showed that areas of increased stress on the fibrous cap of the plaque can be identified [Gao H,2008]. 
However, no studies were identified comparing the volumetric information obtained by 3D ultrasound 
and that by MRI. Further research on this issue is also warranted. 
 
The main limitation of this systematic review of the available evidence is the heterogeneity between 
the evaluated studies, which made the meta-analysis of the data unfeasible. Various techniques of 3D 
image acquisition and analysis were utilized as a result of the technological advances in 3D technology 
occurring between the publication of the first 3D studies and the latest available reports in the last 20 
years. The development of 3D ultrasound probes and the introduction of sophisticated image- analysis 
software have simplified the 3D imaging process providing us with the opportunity to study more 
plaque characteristics at the same time and thus to obtain more information for the identification of 
vulnerable plaques.  
 
Another limitation is the small sample size in most studies and the heterogeneity in outcome 
measures and follow-up. Most studies evaluated 3D plaque volume whereas only a small number 
evaluated plaque composition. No studies evaluating both plaque composition and volume were 
identified. In addition, there was only one study comparing 3D composition between symptomatic and 
asymptomatic patients, without any reference to plaque volume changes. Finally the possibility of 
publication bias cannot be excluded. 
 
Despite the above limitations 3D ultrasound may have a significant clinical potential for the 
identification of vulnerable carotid plaques. The fine reproducibility results that were presented above 
(Table 12.1) show that despite the current complexity of the involved image analysis methodology, 
measurements can be easily reproduced for most plaque features. However, there are still areas that 
need further investigation in order to evaluate the effectiveness of this novel approach. The accuracy 
of 3D measurements regarding internal carotid artery stenosis was excellent when compared with 
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 traditional 2D ultrasound or even angiography, though similar data regarding the accuracy in plaque, 
composition or morphology evaluations was rather limited. More studies are currently warranted 
evaluating the accuracy of 3D ultrasound in total plaque volume, morphology or composition 
measurements. In addition, more studies are needed comparing the differences of the above 
mentioned ultrasound features between 2D and 3D ultrasound measurements in patients with 
asymptomatic and symptomatic carotid plaque disease in order to identify their prognostic ability in 
the identification of vulnerable plaques. The potential effectiveness of this ultrasound modality for 
further stroke-risk stratification in symptomatic patients with less than 70% internal carotid stenosis 
should also be investigated in the future. 
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 12.5.Conclusion 
The current guidelines for the management of carotid plaque disease are based on the degree 
of stenosis and the presence of cerebrovascular symptoms. However, if patients with asymptomatic 
disease but higher risk could be identified, invasive treatment could only target patients at an 
increased risk. The good reproducibility of 3D ultrasound in the assessment of various plaque features, 
as well as the preliminary evidence which suggests increased sensitivity to identify plaque changes 
post-treatment indicate a significant clinical potential. However, the exact clinical applications of this 
approach remain undetermined since the existing evidence fails to provide solid data regarding the 
superiority of 3D ultrasound in comparison to the traditional 2D approach. More research is needed to 
demonstrate the cost-effectiveness and the exact sensitivity of this promising approach in the 
identification of the vulnerable plaque and the re-stratification of asymptomatic patients with carotid 
artery stenosis. 
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Chapter 13 
 3D ultrasound features versus stenosis for the identification of the vulnerable 
plaque  
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 13.1.Introduction 
Two dimensional (2D) ultrasound imaging and the degree of carotid stenosis have been for decades a 
powerful tool for the diagnosis and management of carotid plaque disease. Ultrasound imaging 
became soon after its first introduction a valuable asset for the vascular surgeon due to its non-
invasive nature, the low cost and its undoubted effectiveness to identify and evaluate the carotid 
anatomy and the associated pathologies such as the formation of an atherosclerotic plaque.  Even 
today in the era of high-tech imaging techniques such as angio-MRI and angio-CT  the 2D ultrasound is 
still surviving and represents our first choice for the initial investigation of a patient with peripheral 
arterial disease. 
 
Indeed, for a significant number of patients with carotid plaque disease the 2D ultrasound and the 
subsequent analysis of the information that is provided are sufficient in order to determine the best 
possible plan of patient care. However, 2D ultrasound can only provide us with a limited number of 
views (longitudinal and transverse) and certainly their quality and information that they contain can 
vary since it is an operator-dependant technique. In addition once the slices (2D) have been captured 
it is not possible to extract images of other planes from them, which prevent us from having the 
complete picture with regard to this plaque structure. 
 
The 2D ultrasound provides us with the same information as if we were taking an imaging “biopsy” of 
a certain part of the plaque, which then we consider as representative of the whole plaque. The 
reason behind this is that atherosclerotic plaques “grow” in a 3-dimensional environment in all 
directions both in the longitudinal and transverse axis of the artery. In addition, in the case of 
heterogeneous plaques the single depiction of a 2D ultrasound slice of the carotid plaque may be not 
really representative in terms of composition (as this can be evaluated by GSM and possible other 
texture features). Of course, as it was mentioned before, even this approach may be sufficient and 
cost-effective for a significant number of patients, however, the detrimental effects of cerebrovascular 
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 events urge for the investigation of every potential improvement in the diagnosis and management of 
the vulnerable carotid plaque. 
 
The development of angio-MRI and angio-CT has introduced a new era in the volumetric vascular 
imaging. Using highly sophisticated reconstruction software and following the acquisition of images 
containing volume information in three dimensions (in real time) we can visualize vascular structures 
in different planes from different angles acquiring more information about them. Nevertheless, these 
modalities have their own limitation such as: limited accessibility, increased cost, radiation, more 
invasive nature, increased patient inconvenience and of course they can be contraindicated when 
contrast has to be used in patient with allergic reaction to that or if renal impairment is present. 
 
Three-dimensional ultrasound could represent the solution in order to combine the advantages of 
volumetric vascular imaging with MRI or CT with those of ultrasound imaging (increased availability, 
non-invasive nature and decreased cost). The new volumetric acquisition techniques facilitate the 
storage of multiple, consecutive and equidistant views which are subsequently converted in a matrix 
of points which are representative of the volume scanned. The navigation and the 3D reconstruction 
of the underlying structures can be then performed by sophisticated software such as VOCAL® or Q-
Lab®. 
 
The application of three-dimensional ultrasound for the evaluation of carotid plaques is not new as it 
was demonstrated in the previous chapter (chapter 12). So far the majority of studies focused on the 
use of novel 3D ultrasound systems for the evaluation of carotid plaque volume and its association 
with cerebrovascular events. On the other hand there is not enough data regarding the use of 3D 
ultrasound for the evaluation of carotid plaque composition and texture. Plaque volume is only one of 
the features that characterise the carotid plaque but there are texture features such as the grey scale 
median (GSM) that have shown promise in the identification of the vulnerable plaque. 
 189 
  
Our hypothesis was that certain 3D volume and texture measurements would distinguish the 
symptomatic from the asymptomatic group, when used in a small sample sizes, better than the degree 
of stenosis alone. 
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 13.2.Methods 
13.2.1Study design 
A cross-sectional, case -control study evaluating the diagnostic effect of 3D volume –texture 
ultrasound on symptomatic and asymptomatic patients with carotid plaque disease was designed. 
Eligible patients attended one visit during which they had both the traditional 2D ultrasound imaging 
as well as the 3D ultrasound test (Figure 13.1). 
 
13.2.2Eligibility criteria 
i. Asymptomatic patients with no reported cerebrovascular events and internal carotid stenosis (ICA) 
>20% (ECST) 
ii. Patient with history of stroke, transient ischemic attack or amaurosis fugax within the previous 6 
months and ICA stenosis>20% 
iii. Patients presenting at the Vascular Non Invasive Diagnostic Centre (Weymouth 30, London, UK), 
Ealing Hospital, NHS Trust, London, UK , Charing Cross Hospital, NHS Trust, London, and University 
College of London Hospitals, UK for investigation of their carotid plaque disease. 
iv. Patients able to understand and sign the provided consent form. 
 
13.2.3.Exclusion criteria 
i. Patients with ICA stenosis <20% 
ii. Patients with extensive carotid plaque calcification and acoustic shadowing (not included in the 
analysis) 
iii. Patients with high carotid bifurcation (unable to scan due to the size of the 3D probe) 
 
13.2.4. Study Sites 
The recruitment of the study-subjects, the brief physical examination, the signing of the inform 
consent as well as the ultrasound examinations (2 and 3D) were performed within the premises of the 
Vascular Non-invasive Screening and Diagnostic Centre (CDER Trust, 30 Weymouth Street, London, 
W1G 7BS).  
 191 
  
The ultrasound scanning was blindly performed by Dr Maura Griffin who is an experienced clinical 
scientist without her being aware of the clinical status of the patient.   
 
Patients were also identified at the following centres: 
i. Outpatient clinic of Mr Geroulakos who is a consultant vascular surgeon at Ealing Hospital, NHS 
Trust, London, UK.  
ii. Stroke unit of Charing Cross Hospital, NHS Trust with the help of Dr P Bentley who is a consultant 
neurologist.  
iii. Vascular surgery department (Mr T Richards -consultant vascular surgeon at University College of 
London Hospital, FRCS), the Hyper Acute Stroke Unit and the neurology department (Professor M 
Brown) of the University College London Hospitals.   
 
13.2.5.Scanning technique and image analysis 
This was discussed at the Methods section of the thesis at Chapter 6. For the image analysis in this 
study we used thick slices of 2.5mm to assess the feasibility of performing volumetric measurement 
and assessment of plaque’s composition and ultrasound texture. Plaques with excessive acoustic 
shadowing or image degradation due to motion or other artefacts were excluded from the final 
analysis. The image analysis was performed blindly with regard to the symptoms of the patient.  
 
13.2.6.Statistical analysis 
The variables were explored regarding their pattern of distribution and when normal distribution was 
demonstrated then a t-test for dependant variables was used to compare the means between the 
symptomatic and asympomatic groups. To compare the means between 3 groups (i.e asymptomatics 
vs. TIA group vs. Stroke group) the ANOVA statistical test was used. When normal distribution was not 
the case then the variables where transformed using appropriate transformations. Finally the receiver 
operator curves were used to plot sensitivity and specificity of the various imaging features according 
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 to the presence of symptoms or not. The area under the curve was also calculated. The level of 
statistical significance was set to p<0.05.  The SPSS statistical package was used.  
 
13.2.7. Ethics 
Ethical approval for this was granted by the West London research ethics committee, UK 
(11/LO/0299).  
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Figure 13.1:  Flow chart diagram of the patient recruitment process.  
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 13.3.Results 
13.3.1. Patient Demographics 
In total 90 patients were identified and signed the informed consent form. They were all scanned with 
the new 3D probe as previously described.  The carotid plaque images from 21 of them were not 
suitable for further image analysis. The main reasons for exclusion were plaque calcification, high 
carotid bifurcation and motion artefact. As a result a number of 87 carotid plaques entered the final 
analysis. Males were the vast majority (80.2%) with 57 asymptomatic and 20 symptomatic cases (1:3 
ratio). The mean ECST carotid stenosis was 62% (SD: 19.52).  
13.3.2. Volumetric analysis using 3D 
The volumetric analysis consisted of measurements regarding the total plaque volume (mm3), the 
average plaque area (average of cross-section plane-mm2) and the total plaque area (mm2) that was 
imaged. Using 2.5mm sections for the image analysis of the plaques, we retrieved 62 complete 
measurements. When the volume and plaque area measurements were compared between the 
asymptomatic and the symptomatic group (both TIA/AF and stroke), respectively, the results were as 
follow: 
• Mean Plaque Volume(mm3): 238.3 (SD:107) vs. 200.9 (SD:125) , p=0.568 
• Plaque Area average (mm2): 16.3 (SD:6) vs. 14.7 (SD:5.9), p=0.809 
• Mean Plaque Area total (mm2): 95.4 (SD:42) vs. 81.8(48.4), p=0.648 
No statistical significance between the symptomatic and the asymptomatic group was identified for 
the three variables.  
In subgroup analysis we separated the group of symptomatics into those who had TIA/AF and those 
who had strokes only. By using the ANOVA statistical test we were able to compare the volumetric and 
plaque area means between the asymptomatic vs. TIA/AF group vs. stroke group as it is shown below.  
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 • Mean Plaque Volume(mm3): 238 (SD:107) vs. 260 (SD:130) vs. 148 (SD:101), p=0.081 
• Plaque Area average (mm2): 16 (SD:6) vs. 17 (SD:7) vs. 12 (SD:2), p=0.112 
• Mean Plaque Area total (mm2): 95(SD:42) vs. 104(SD:52) vs. 62 (SD: 37),  p=0.106 
In the subgroup analysis no statistical significance between the symptomatic and the asymptomatic 
group was identified for the three variables.  
Finally, ROC curves were used to compare the predictive ability of models that use as discriminating 
factor plaque volume vs. Plaque area vs. Stenosis (Figure 13.2).  The percentage of ECST degree of 
stenosis was also used, as it is currently the gold standard for the surgical planning.  The area under 
the curve was used to compare the predictive ability with regard to Stenosis vs. Plaque volume vs. 
Average plaque area (mm2) vs. Total plaque area, respectively: 
• 0.604 (SE:0.082) vs. 0.372 (SE:0.087) vs.0.397 (SE:0.086) vs 0.373 (SE:0.086), p>0.05 
The volumetric parameters failed to improve the diagnostic ability when compared to stenosis.(Figure 
13.2) 
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Figure13.2: ROC curves comparing stenosis vs. Plaque volume vs. Average plaque area vs. Total plaque area. 
Volumetric parameters failed to improve the diagnostic ability when compared to stenosis. 
 
(Abbreviations: area tot25: total plaque area measured with 2.5mm slices in 3D; area average 25: plaque area 
measured with 2.5mm slices in 3D; stenosis: measured in ECST degrees and in 2D; volume: plaque volume 
measured with 2.5mm slices in 3D) 
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13.3.3.Composition analysis using 3D 
The composition analysis consisted of measurements of the grey scale median (GSM) of the entire 
plaque and the juxtaluminal black area (JBA) using the 3 dimensional observations. Sections of 2.5mm 
thickness were obtained from 66 carotid plaques. After comparing the GSM and the JBA for entire 
plaque volume between the asymptomatic and the symptomatic group (both TIA/AF and stroke), 
respectively, the results were as follow: 
• GSM (entire plaque): 35.2 (SD: 14) vs. 33.5 (SD: 15.9), p=0.9 
• JBA (entire plaque-mm2): 3.2 (SD: 3.4) vs. 4.1 (SD: 3.5), p=0.35 
No statistically significant difference between the groups was identified for the GSM and JBA. In 
subgroup analysis, as previously, we separated the group of symptomatics into those who had TIA/AF 
and those who had strokes only. By using the ANOVA statistical test again we were able to compare 
the composition features (GSM and JBA) between the asymptomatic vs. TIA/AF group vs. Stroke 
group, respectively, as it shown below.  
• GSM (entire plaque):  35.2 (SD:14) vs. 39.5 (SD:19) vs. 28.3 (SD:11), p=0.305 
• JBA (entire plaque-mm2): 3.2 (SD:3) vs. 3.9(SD:4.1) vs. 4.1 (SD:3.1), p=0.722 
In the subgroup analysis no statistical significant difference between the groups was identified for the 
two variables. Finally, ROC curves were used to compare the predictive ability of models that use as 
discriminating factor GSM vs. JBA vs. Stenosis (Figure 13.3) . The percentage of ECST stenosis was 
again used, as it is currently the gold standard for the surgical planning.  The area under the curve was 
used to compare the predictive ability with regard to Stenosis vs. GSM vs. JBA  (mm2) , respectively: 
• 0.582(SE:0.081) vs. 0.446(SE:0.087) vs.0.562 (SE:0.086) p>0.05 
The plaque composition parameters failed to improve the diagnostic ability when compared to degree 
of stenosis. (Figure 13.3) 
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Figure 13.3: ROC curves were used to compare the predictive ability of models that use as 
discriminating factor GSM vs. JBA vs. Stenosis 
 
 
(Abbreviations: black ar 3D 25: Juxtaluminal black area measured with 2.5mm slices in 3D; GSM 25: Grey scale 
median with 2.5mm slices in 3D; stenosis: measured in ECST degrees and in 2D) 
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 13.4.Discussion 
This is the first study to assess the 3D songraphic changes between symptomatic and asymptomatic 
carotid plaques in terms of both plaque composition and volume. Two-dimensional ultrasound cannot 
provide us with volumetric information unless very laborious reconstructions are undertaken. In 
addition the composition information that we receive when we analyse 2D carotid images can be 
limited in cases of heterogeneous plaques since we only have an average measurement from a specific 
imaging angle. In theory this is the advantage of this new 3D technique; that we can relatively easily 
evaluate the entire plaque with one scan and simultaneously assess both the plaque volume and 
composition.  
 
Only one study was identified, as previously discussed, assessing the possible differences in 3D 
ultrasound features between patients with asymptomatic or symptomatic carotid disease. 
[Heliopoulos J,2009]  The studies investigated 110 cases of symptomatic and 104 asymptomatic 
patients using 3D ultrasound. They assessed the echotexture of the plaques by means of 3D imaging 
using the mean grey scale value of the whole plaque without any information regarding plaque 
volume or morphology changes. They concluded that, especially, at moderate degrees of ICA stenosis 
(less than 60-70%), lower mean grey values could be an important factor indicating plaque 
vulnerability and increased risk for a stroke. 
 
In this study we managed to obtain a number of 3D carotid images that were successfully analysed 
providing us with both compositional and volume information for the entire plaque volume.  For this 
study thick slices of 2.5mm were used to minimise the necessary time for computer processing and 
analysis of the sections.  Features such as the plaque volume, plaque area, grey scale median and 
juxtaluminal black area (JBA) were measured and compared within the two groups. Despite the fact 
that there seemed to be some differences between the volume or texture features of symptomatic 
versus asymptomatic plaques, these differences did not reach statistical significance. In addition they 
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 also did not seem to improve on the diagnostic ability currently achieved using the simple 
measurement of the degree of stenosis. 
The main limitations of this study is the small number of patients especially at the symptomatic group 
which is mainly due to the difficulty in accessing those patients before they have their operation which 
usually happens within the first 48 hours after the event. In the future we have already applied for an 
extension of our ethics approval in order to include more patients especially in the symptomatic 
group. Another possible limitation is the selection of slice thickness that has been shown to affect the 
accuracy of measurements. It is possible that the 2.5mm slice thickness was relatively thick to allow 
improvement on the prediction ability in comparison to the degree of stenosis or other traditional 2D 
ultrasound features. 
13.5 Conclusion 
The analysis of 3D carotid images using thick cross sectional slices did not significantly improve our 
ability to differentiate between symptomatic and asymptomatic plaque when compared to traditional 
2D ultrasound measurements.  
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Chapter 14 
3D ultrasound slice thickness and its effect on stroke prediction 
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 14.1. Introduction 
In the previous chapter we assessed the effectiveness of certain 3D ultrasound features in 
distinguishing between symptomatic and asymptomatic plaques. For the purposes of that analysis we 
used 2.5mm inter-slice distances (ISD) for the sectioning of the plaque. Unfortunately this approach 
did not result in the identification of more sensitive imaging markers for the identification of the 
vulnerable plaque. One of the possible limitations was the use of thick slices that may not accurately 
represent the entire plaque.  
 
Indeed, the effect of the ISD as well as the effect of the initial plaque size in the volume reproducibility 
measurements has already been assessed by 2 studies [Landry A,2004; Ludwig M,2008]. Both of them 
concluded that ISD might have an effect on measurement variability. More specifically they showed 
that volume measurement variability can be smaller for larger plaques, while Fenster et al., suggested 
a possible effect of the ISD on the observed variability. [Landry A,2004]  There were no studies though 
exploring the effect of ISD on the identification of the vulnerable plaque and stroke prediction.  
 
The purpose of this study was to assess if thinner 3D ultrasound slices will improve the predictive 
ability of the 3D measurements in terms of differentiating between symptomatic and asymptomatic 
plaques.  
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 14.2.Methods 
14.2.1.Study population and design 
The study population characteristics and the study design were discussed in the Methods section of 
Chapter 13. 
 
14.2.3.Image analysis 
All images from the 3-dimensional dataset from the eligible patients, that were analysed previously, 
ware cropped again using thinner sections of 1.5mm.  Again, the image analysis and cropping were 
performed blindly in relation to the symptoms of the patient and by the same operator (GCM).  
 
14.2.4.Statistical analysis 
The variables were explored regarding their pattern of distribution and when normal distribution was 
demonstrated then a t-test for dependant variables was used to compare the means between the 
symptomatic and asympomatic groups. To compare the means between 3 groups (i.e asymptomatics 
vs. TIA group vs. Stroke group) the ANOVA statistical test was used. When normal distribution was not 
the case then the variables where transformed using appropriate transformations. Finally the receiver 
operator curves were used to plot sensitivity and specificity of the various imaging features according 
to the presence of symptoms or not. The area under the curve was also calculated. The level of 
statistical significance was set to p<0.05.  The SPSS statistical package was used.  
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 14.3.Results 
 
A number of 67 carotid plaques were available for analysis using thinner slices. Using 1.5mm thickness 
slices we produced on average of 9.5 (95CI: 8.7-10.2) slices vs. 5.4 (95% CI: 5.07-5.92) that were 
produced by using 2.5mm inter-slice distance. 
 
14.3.1.Differences between 2.5mm and 1.5mm slice thickness 
We assessed the differences in the observed values in composition and volume features and 
compared them between the thinner (1.5mm) and thicker (2.5mm) slices protocols.  As it can be seen 
on table 14.1 there are statistically significant differences in all variables between the thin and thick 
slices group.  
 
14.3.2.Volumetric imaging with thinner slices vs. stenosis 
 
The volumetric analysis consisted of measurements regarding the total plaque volume (mm3), the 
average plaque area (average of cross-section plane-mm2) and the total plaque area (mm2) that was 
imaged. Using 1.5mm sections for the image analysis of the plaques we retrieved 76 complete 
measurements for 76 carotid plaques. By comparing the volume and plaque area between the 
asymptomatic and the symptomatic group (both TIA/AF and stroke), respectively, the results were as 
follow: 
• Mean Plaque Volume (mm3): 342.42 (SD:168) vs. 318.4 (SD:198), p=0.795 
• Plaque Area average (mm2): 22.3 (SD:8.72) vs. 23.47 (SD:8.14), p=0.752 
• Mean Plaque Area total (mm2):  229.33 (SD: 124) vs. 208.37 (SD:134), p=0.623 
 
No statistical significance between the groups was identified with the thinner slices for the three 
variables.  
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Table 14.1: Differences in the observed values in composition and volume features when compared 
between the thinner (1.5mm) and thicker (2.5mm) slices 
Pa ired Samples Test
114.25 132.19 16.15 82.01 146.50 7.075 66 .000
2.197 9.116 1.060 8.522E-02 4.309 2.073 73 .042
7.13 7.79 .95 5.23 9.03 7.500 66 .000
7.13 7.79 .95 5.23 9.03 7.500 66 .000
1.2071 3.8622 .4490 .3124 2.1019 2.689 73 .009
VOLUME15 - VOLUME25Pair 1
GSM3D15 - GSM3D25Pair 2
area average15 - area
average25
Pair 3
area average15 - area
average25
Pair 4
blackar3D15 -
blackar3D25
Pair 5
Mean Std. Deviat ion
Std. Error
Mean Lower Upper
95% Confidence
Interval of the
Difference
Paired Differences
t df Sig. (2-tailed)
 
  
Abbreviations: GSM3D15: Grey scale media with 1.5mm slices in 3D; GSM3D25: Grey scale media with 
1.5mm slices in 3D; blackar3D25: juxtaluminal black are with 2.5mm slices in 3D; blackar3D15: 
juxtaluminal black are with 1.5mm slices in 3D. 
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In subgroup analysis we separated the group of symptomatic patients into those who had TIA/AF and 
those who had strokes only. By using the ANOVA statistical test we were able to compare the 
volumetric and plaque area means between the symptomatic vs. TIA/AF group vs. Stroke group as it is 
shown below.  
• Mean Plaque Volume (mm3): 342.41 (SD: 168) vs. 359.30(SD: 219)  vs.  273 (SD:173), p=0.503 
• Plaque Area average (mm2):  22.3 (SD:8) vs. 25.9 (SD:8) vs. 20.78 (SD:6.67), p=0.385 
• Mean Plaque Area total (mm2): 229.3 (SD:124) vs. 236.9 (SD:146) vs. 176.6 (SD:119), p=0.492 
In the subgroup analysis no statistical significance between the groups was identified for the three 
variables.  
Finally, ROC curves were used to compare the predictive ability of models that use as discriminating 
factor plaque volume vs. Plaque area vs. Stenosis (Figure 14.1).  The percentage of ECST degree of 
stenosis was used, as it is currently the gold standard for the surgical planning.  The area under the 
curve was used to compare the predictive ability with regard to Stenosis vs. Plaque volume vs. Average 
plaque area (mm2) vs. Total plaque area, respectively: 
• 0.646 (SE:0.073) vs. 0.426 (SE: 0.076) vs. 0.543 (SE: 0.076) vs. 0.426 (SE:0.076) 
The volumetric parameters does not seem to improve the diagnostic ability when compared to 
stenosis even when thinner slices were used. 
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Figure 14.1: ROC curves comparing plaque volume vs. Plaque area vs. Stenosis regarding their use as 
tools for stroke risk prediction. 
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 14.3.3.Composition measurements with thinner slices vs. Stenosis 
 
The composition analysis consisted of measurements of the grey scale median (GSM) of the entire 
plaque and the juxtaluminal black area using the 3 dimensional observations. Sections of 1.5mm 
thickness were obtained from 66 carotid plaques. After comparing the GSM and the JBA for entire 
plaque volume between the asymptomatic and the symptomatic group (both TIA/AF and stroke), 
respectively, the results were as follow: 
• GSM (entire plaque): 36.25 (SD:13.8) vs. 35.2 (SD:18.2), p=0.116 
• JBA (entire plaque-mm2): 4.5 (SD: 4) vs. 6.03 (SD:5.2), p=0.099 
No statistical significance in the GSM and JBA values between the groups was identified.  
In subgroup analysis, as previously, we separated the group of symptomatics into those who had 
TIA/AF and those who had strokes only. By using the ANOVA statistical test we were able to compare 
the composition features (GSM and JBA) between the symptomatic vs. TIA/AF group vs. Stroke group, 
respectively, as it shown below.  
• GSM (entire plaque):  36.2 (SD:13) vs. 35.6 (SD:18) vs. 34.8 (SD: 18),p>0.05 
• JBA (entire plaque-mm2): 4.5 (SD:4) vs. 6.8 (SD: 5.5) vs. 5 (SD: 5), p>0.05 
In the subgroup analysis no statistical significance between the groups was identified for the two 
variables. Finally, ROC curves were used to compare the predictive ability of models that use as 
discriminating factors the GSM vs. JBA vs. Stenosis for the thinner slices (Figure 14.2).  The percentage 
of ECST stenosis was again used, as it is currently the gold standard for the surgical planning.  The area 
under the curve was used to compare the predictive ability with regard to stenosis vs. GSM vs.  JBA  
(mm2) , respectively: 
• 0.464(SE:0.8,p=0.068) vs. 0.464(SE:0.083, p=0.636) vs. 0.574 (SE:0.08, p=0.334) 
The composition features also failed to improve the diagnostic ability when compared to stenosis. 
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Figure 14.2: ROC curves were used to compare the predictive ability of models that use as 
discriminating factors the GSM vs. JBA vs. Stenosis for the thinner slices (1.5mm). 
 
(Abbreviations: Blackare3D15: juxtaluminal black area with 1.5mm sections in 3D; GSM3D15: Grey 
scale median with 1.5mm slices in 3D) 
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14.4.Discussion 
This study investigates for the first time the effect of thin 3D ultrasound slices on the identification of 
vulnerable carotid plaque plaques. After evaluating the effectiveness of 2.5mm in slices in (chapter 13) 
we repeated the entire process using thinner transverse sections (1.5mm) to see if we can improve 
the predictive ability of this approach.  Indeed, the overall measurements from the thinner and thicker 
slices were significantly different, which may have significant implications for future applications of 
the 3D ultrasound. Especially with regard to the selected interslice distance (ISD) it can alter the 
characterization of the plaque according to how heterogeneous the plaque is.  
The analysis of the thinner slices was obviously more time-consuming than then thicker ones since 
more transverse plaque sections were produced and which had to be manually cropped and analysed. 
The main question was if that extra time and effort would actually translate in diagnostic benefit in 
terms of identifying more vulnerable plaques when compared to the thicker slices.  Unfortunately that 
did not proved to be the case. The volume and composition features of the thinner slices again did not 
seem to perform better than the degree of stenosis in terms of stroke prediction.  
The effect of the inter-slice distance as well as the effect of the initial plaque size in the volume 
reproducibility measurements has been assessed in the past by only two studies [Landry A,2004; 
Ludwig M,2008]. Both studies concluded that volume measurement variability can be smaller for 
larger plaques, while Fenster et al., [Landry A,2004] suggested a possible effect of the ISD on the 
observed variability. More specifically Fenster et al., showed that carotid plaque volume measurement 
variability decreased with increasing plaque volume whereas it increases with ISD. In another study by 
Stumpe et al., it was also shown that both intra- and inter-reader variability of the measurement of 
carotid plaque volume were lower for larger than for smaller plaques. [Ludwig M,2008]. 
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 14.5 Conclusion 
The results from previous studies as well as from the current one indicate that the plaque volume and 
the inter-slice distance are important factors and have to be taken into account when analysing 3D 
images.  
 
Our study showed that the thickness of the analysed slice did not really affect the stroke risk 
predictive ability but this has to be verified by other studies with large sample sizes.  
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Chapter 15 
3D versus 2D ultrasound for carotid plaque assessment and risk for stroke  
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 15.1.Introduction 
Two-dimensional ultrasound has been for decades a powerful tool for the assessment of carotid 
atherosclerosis. The recent technological advances though, have provided us with opportunities to 
assess carotid plaques in all their 3 dimensions. Currently there are no studies comparing the 
traditional 2D versus the novel 3D ultrasound probes, in terms of their effectiveness in characterising 
carotid plaques.  Given the significantly higher price for a 3D probe, a cost effectiveness analysis would 
be reasonable to support or reject the wide implementation and switch of healthcare practitioners to 
the more expensive 3D probes.  
The main theoretical benefits from the use of 3D ultrasound versus the 2D are: 
• Automatic acquisition of the entire plaque volume, which may prove beneficial especially for 
the characterization of heterogeneous plaques  
• Possibilities for semiautomatic segmentation in different plains and orientation and off-line 
analysis with the possibility of various reconstructions. 
The main disadvantages on the other hand are: 
• Increased cost 
• Increased scanning time 
• Bulkier probes that make handling more demanding  
This is one of the first studies to investigate the effect of 3D ultrasound measurements in carotid 
plaque characterisation and stroke prediction versus the use of traditional 2D ultrasound. Our main 
objective was to determine if 3D measurements of traditional and novel features have better 
predictive ability compared to the 2D ones with regard to stroke risk assessment.  
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 15.2.Methods 
15.2.1.Study population and study design  
As discussed in the methods section of Chapter 15. 
15.2.2.Image analysis 
All eligible patients apart from a 3D ultrasound scan, also had a traditional 2D scan of the 
corresponding carotid plaque. The corresponding images to the 3D dataset were separately 
processed, cropped and analysed as it has been described in Part II, Chapter 6. The analysis of the 2D 
carotid views was performed at the longitudinal view of the carotid plaque in order to summarise the 
entire plaque. As before, images with extensive acoustic shadowing, calcification or motion artefact 
were excluded.  
We also calculated the values for all available novel texture features (second order statistics) that 
were discussed in chapter 4 from the 3D dataset. All the novel textures features were calculated both 
for the thin (1.5mm) and thick slices (2.5mm). The features from the 2D dataset were also extracted as 
previously described (chapter 4).  
15.2.3.Statistical analysis 
 Evaluation of the stroke predictive ability of 3D vs. 2D ultrasound features 
The predictive ability of traditional features such as degree of stenosis, grey scale median, and JBA 
were compared between the 2D and 3D measurements (thin and thick slices) using ROC curves and 
the area under the curve. Odds ratio for traditional texture features as well as novel ultrasound 
features (i.e second order statistics-APPENDIX I) were determined using unadjusted logistic regression 
for each variable separately. Continuous risk factors were transformed to an unskewed distribution 
where possible. Risk factors which were significant at p <0 .05 in these unadjusted models were then 
considered in multivariable logistic regression model. The ability of each feature to predict a 
cerebrovascular event was tested by using the ROC curve and the area under the curve The IBM SPSS 
statistical package (version 20, SPSS Inc, Chicago, Ill) was used for statistical analysis and construction 
of graphs 
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 15.3. Results 
15.3.1.Evaluation of the stroke-predictive ability of volumetric imaging: 2D vs. 3D 
There was no improvement in the stroke risk predictive ability between the 2D and 3D volume and 
plaque area measurements. The degree of stenosis appears superior in identifying the plaques with 
increased risk for stroke. The area under the curve for every variable can be seen on table 15.1. 
 
15.3.2. Evaluation of the stroke predictive ability of Composition measurements: 2D vs.3D  
There was no improvement in the stroke risk predictive ability between the 2D and 3D plaque texture 
analysis measurements either. No improvement over the percentage of stenosis alone was noted .The 
area under the curve for every variable can be seen on table 15.1. 
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 Table 15.1: Area under the curve for Composition and volume measurements in 2 and 3 dimensions for 
thin and thick slices 
 
 
 
Abbreviations: AREA_MM2: plaque area measured in 2D, AREA TOT 15: plaque area measured in 3D with 
1.5mm slice thickness, AREA TOT 25: plaque area measured in 3D with 2.5mm slice thickness, GSM: grey scale 
media in 2D, GSM3D15: GSM measured in 3D with 1.5mm slices, GSM3D25: GSM measured in 3d with 2.5mm 
slices,VOLUME25: plaque volume measured in 3D with the 2.5mm slice thickness, VOLUME15: plaque volume 
measured in 3D with 1.5mm slice thickness, Blackar3D15: juxtaluminal black area measured in 3D with 1.5mm 
slices, Blackar3D25: juxtaluminal black area measured in 3D with 2.5mm slices 
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 15.3.3.Evaluation of 2D and 3D novel texture features association with cerebrovascular events 
As we shown before (chapter 8) certain novel texture features can improve the identification of the 
vulnerable plaque. We sought to assess if that is case when using the 3D ultrasound measurements 
and if there would be any improvement over the corresponding 2D values of the same variables.  
 
The second order statistics (Appendix II) SGLD-VAR (1.5mm), SGLD_SVA (1.5mm), SGLD-DEN (2.5mm), 
SGLD_DVA (2.5mm), SGLD_DVA (2D), SGLD_DEN(2D), were the only significant factors at the 
univariate  logistic regression analysis which were associated with the occurrence or cerebrovascular 
events (table 15.2)  
 
However, in the multivariable logistic regression model with all the significant features from Table 
15.2 as covariates, only SGDL-VAR (1.5mm) and SGLD-SVA (1.5mm) were independent predictors of 
cerebrovascular events (Table 15.3). 
 
 The ROC curves from the resulting features SGDL-VAR (1.5mm) and SGLD-SVA (1.5mm) had an area 
under the curve of 0.498 (SE:0. 086, p=0.98) and 0.5 (SE:0.086, p=0.98) respectively, but without any 
improvement when compared to the degree of stenosis (figure 15.1)  
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 Table 15.2.Univariate logistic regression of all novel texture features and risk of stroke 
  B S.E. Wald df Sig. OR   
GSM3D15 .048 .030 2.520 1 .112 1.049   
VOLUME15 .005 .010 .223 1 .637 1.005   
AREAVR15 .080 .059 1.850 1 .174 1.083   
AREATOT1 -.014 .015 .829 1 .362 .986   
BLAKAR15 .171 .110 2.404 1 .121 1.186   
VOLUME25 .076 .169 .201 1 .654 1.079 
 
GSM3D25 .022 .031 .510 1 .475 1.023   
ARAVER25 -.053 .087 .374 1 .541 .948   
AREATO25 -.192 .423 .207 1 .649 .825   
BLAKAR25 .163 .135 1.454 1 .228 1.177   
STENOSIS .035 .018 3.907 1 .048 1.036   
GSM .016 .016 .989 1 .320 1.016   
AREA_MM2 -.008 .010 .601 1 .438 .992   
AGECOD -.007 .023 .080 1 .777 .993   
 
FPSFANG .000 .001 .002 1 .969 1.000   
FSFANG15 .002 .002 1.884 1 .170 1.002   
FSFANG25 -.001 .002 .536 1 .464 .999   
FPSFRAD .000 .001 .015 1 .901 1.000   
FSFRAD15 -.001 .001 1.602 1 .206 .999   
FSFRAD2 .001 .002 .400 1 .527 1.001   
GLDCON15 -.032 .034 .925 1 .336 .968   
GLDCON25 .006 .026 .047 1 .829 1.006   
 
GLDMENE -36.828 80.1 .207 1 .649 .000   
GDMENE15 -58.426 65.5 .794 1 .373 .000   
GLDMENE25 1.601 1.397 1.312 1 .252 4.957   
GLDMENT -.767 8.2 .009 1 .926 .464   
GDMENT15 -.402 5.689 .005 1 .944 .669   
GLDENT25 -14.810 10.8 1.848 1 .174 .000   
SGLDEN25 -13 9.769 1.807 1 .029 .930 
GLDHHOM -1.212 3.331 .133 1 .716 .297   
GLMHOM15 -2.954 29.38 .010 1 .920 .052   
GLDHOM25 -.634 23.8 .001 1 .979 .530   
GLDMMEA .009 .090 .010 1 .919 1.009   
GDMMEA15 -2.783 2.739 1.032 1 .310 .062   
GLDMEA25 -.269 .419 .412 1 .521 .764   
 
RUNLGLD -.002 .004 .256 1 .613 .998   
RUNGLD15 -1.228 .801 2.351 1 .125 .293   
SGLDDEN -.8 1.948 .188 1 .045 .430 
RUNGLD25 .303 .519 .340 1 .560 1.354   
RUNLLRE .077 .178 .188 1 .665 1.080   
RUNLRE15 1.033 3.052 .114 1 .735 2.808   
RUNLRE25 -1.732 3.191 .295 1 .587 0.177   
RUNLRLD .000 .000 .115 1 .734 1.000   
SGLDVA25 .02 .049 .238 1 .035 1.024 
RUNRLD15 -.001 .003 .169 1 .681 .999   
RUNRLD25 -.003 .004 .855 1 .355 .997   
RUNRP15 .664 2.023 .108 1 .743 1.942   
RUNRP25 2.526 2.931 .743 1 .389 12.506   
 
RUNSRE15 1.8 15.656 .014 1 .907 6.181   
RUNSRE25 -5.3 15.715 .114 1 .735 .005 
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   B S.E. Wald df Sig. OR 
SGDCON15 -.05 .037 2.241 1 .134 .946   
SGLDDVA .14 .088 2.584 1 .018 1.151 
SGLCON25 .033 .023 1.947 1 .163 1.033   
SGLDCON .024 .025 .886 1 .346 1.024   
 
SGLSVA25 -.05 .024 2.094 1 .148 .966   
SGDVAR15 -.23 .143 3.128 1 .041 .777   
SGLVAR25 .136 .096 2.016 1 .156 1.145   
SGDSVA15 .06 .036 3.221 1 .053 1.067   
SGLSVA25 -.03 .024 2.094 1 .148 .966   
SGDSVA15 .1 .056 3.998 1 .046 1.118 
SGLVAR25 .13 .096 2.016 1 .156 1.145   
Abbreviations: Please see Appendix II 
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 Table 15.3: Multivariate logistic regression of significant features from table 15.2 and risk of 
stroke. 
 
  B S.E. Wald df Sig. Exp(B)   
SGDVAR15 -.4 .223 3.964 1 .046 .642   
STENOSIS .03 .022 1.062 1 .303 1.023   
SGDSVA15 .11 .056 3.998 1 .046 1.118   
SGLDEN25 -13 9.769 1.807 1 .179 .000   
SGLDVA25 .02 .049 .238 1 .625 1.024   
SGLDDVA .14 .088 2.584 1 .108 1.151   
SGLDDEN -.8 1.948 .188 1 .665 .430   
Abbreviations: Please see Appendix II. 
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Figure 15.1. ROC curves for the selected variables from the multivariate regression model of table 
15.3. 
 
(Abbreviations: SGLDSVA3D15: SGLD_SVA measurement with 1.5mm slices in 3D; SGLDVAR3D15: 
SGLD_VAR measurement with 1.5mm slices in 3D; GSM: Grey scale median measured in 2D.) 
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 15.4.Discussion 
The grey scale median (GSM) has been for decades one of the few texture features that has been used 
for the characterization of carotid plaque lesions with promising results [ref]. However, it remains 
more of a research tool rather than a feature used in the daily clinical practice. The plaque volume is a 
similar example with reasonable support in the literature but also very few actual clinical applications. 
This study is one of the first studies to simultaneously assess these features in a study where a 
symptomatic and asymptomatic group are compared using measurements both from a 2D and a 3D 
ultrasound probe. Another novelty of our study is the evaluation of other texture features apart from 
GSM, which has been shown to be useful for the identification of the vulnerable plaque (chapter 8). 
In the first part of this study we assessed the risk of stroke predictive ability of traditional features 
such as GSM, plaque area and plaque volume, to evaluate if there is any additional benefit from the 
use of these features with 3D ultrasound imaging. Then we compare the finding with those from 2D 
ultrasound imaging.  Our study showed that there was not  significant improvement from the use of 
the 3D measurements of the above variables in terms of stroke prediction. The 2D ultrasound imaging 
and the assessment of texture and plaque area appeared to be equivalent to the more expensive and 
time consuming 3D imaging, however, without offering the possibility for volume measurements.  
At the second part we attempted to reassess the previous studied, novel second order statistics for 
plaque analysis (chapter5) but this time using the measurements obtained by the 3D ultrasound 
probe. Fenster and his colleagues have previously suggested [Fenster A, 2004] that these features can 
be more sensitive in the detection of plaque-related pharmacological changes than volume 
measurements. Some of these features have been previously associated with ipsilateral embolic brain 
infraction [Kakkos SK, 2010]. We managed to identify novel features that appeared to be associated 
with the presence of symptoms. However, again they did not appear to improve on the predictive 
ability achieved by the degree of stenosis alone or the GSM values from the 2D ultrasound.  
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 15.5 Conclusion 
There was no additional benefit from the use of 3D ultrasound in risk of stroke stratification when 
compared to traditional and novel 2D ultrasound measurements. However, due to the relative small 
sample size of our cohort, larger studies are needed in order to confirm the above statement. 
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PART V 
Introduction to carotid plaque motion analysis 
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Chapter 16 
Introduction to carotid plaque motion analysis  
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 16.1. Introduction 
Plaques develop in a dynamic environment and may rupture not only as a result of inherent instability, 
but also due to the excessive mechanical forces during the cardiac cycle. In a study by Meairs et al., it 
was suggested that plaque surface motion analysis maybe able to distinguish between high and low 
risk plaques. [Meairs S,1999] The approach was based on reconstructions of plaque motions using 
temporal 3-D ultrasound. This study found significant differences in the maximal discrepant surface 
velocity motion between patients with and without symptoms. Similarly, Murillo et al., utilised a multi-
scale plaque motion approach to estimate 2D plaque motion to help differentiate between 
symptomatic and asymptomatic plaques. [Murillo S, 2012] 
In this chapter will test the image analysis methodology for quantifying discordant plaque motion that 
was previously described in Part II of this thesis. Discordant motion is the phenomenon of different 
parts of the plaque moving in different directions with different velocities during the cardiac cycle. On 
the other hand, concordant plaque motion is the phenomenon of all carotid plaque parts moving in 
the same direction and with the same velocity. Naturally, discordant motion is believed to be 
associated with higher strain whereas concordant motion is linked to lower strain values.  
The main objective of this chapter is to assess if it is feasible to classify and quantify the carotid plaque 
motions in order to help clinicians differentiate between plaques that are likely to rupture. 
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 16.2.Methods 
16.2.1. Ultrasound video acquisition and visual classification 
Video loops of ultrasound images of 35 carotid bifurcation plaques were obtained from 4 symptomatic 
and 31 asymptomatic patients with carotid bifurcation atherosclerosis. Ethics Committee approval had 
been obtained by the local research ethics committee. These images were collected for the purposed 
of the 3D study (Part IV of this thesis). The video loops were anonymised first and studied without 
knowledge of the presence or not of symptoms. The ultrasound videos were of size 568x448 pixels at 
a frame rate of 40 frames per second (fps).  
From each video loop, we extracted a series of 8-10 consecutive cardiac cycles that did not include any 
motion artefacts such as carotid movement due to neck movement or swallowing.  Video loops were 
classified visually as mechanically concordant or discordant.  
16.2.3. Video motion estimation and relevant parameter selection 
This has been previously discussed in detail in chapter 7 of this thesis. 
16.2.4.Plaque motion visualization 
Statistical analysis of the estimated motion vectors is performed over the region of the plaque. A 
limitation of the current version of the software comes from the fact that we are not tracking the 
motion of the plaque boundary throughout the cardiac cycle. 
To visualize the motion, the user can select the spacing between the estimated motion vectors 
(𝑀𝑀𝑜𝑜𝑡𝑡𝑖𝑖𝑜𝑜𝑛𝑛 𝑉𝑉𝑒𝑒𝑐𝑐𝑡𝑡𝑜𝑜𝑟𝑟𝑠𝑠 𝑆𝑆𝑝𝑝𝑎𝑎𝑐𝑐𝑖𝑖𝑛𝑛𝑔𝑔) and can also magnify the display of the motion vectors (𝑀𝑀𝑜𝑜𝑡𝑡𝑖𝑖𝑜𝑜𝑛𝑛 𝑉𝑉𝑒𝑒𝑐𝑐𝑡𝑡𝑜𝑜𝑟𝑟𝑠𝑠 
𝑀𝑀𝑎𝑎𝑔𝑔𝑛𝑛𝑖𝑖𝑓𝑓𝑖𝑖𝑐𝑐𝑎𝑎𝑡𝑡𝑖𝑖𝑜𝑜𝑛𝑛).  
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 16.2.5. Statistical Analysis 
The discrimination between concordant and discordant motions is based on estimating the motion 
velocity spread over each video frame, over the entire video. To determine the motion spread we 
used the orientation-histogram to determine the angular spread that reaches 50% of the peak 
orientation (half-peak spread). For each video frame, we have an estimate of the angular spread 
(𝑤𝑤𝑖𝑖𝑑𝑑𝑡𝑡ℎ) and the 𝑚𝑚𝑒𝑒𝑑𝑑𝑖𝑖𝑎𝑎𝑛𝑛_𝑣𝑣𝑎𝑎𝑙𝑙𝑢𝑢𝑒𝑒 summarized as a single point: (𝑤𝑤𝑖𝑖𝑑𝑑𝑡𝑡ℎ, 𝑚𝑚𝑒𝑒𝑑𝑑𝑖𝑖𝑎𝑎𝑛𝑛_𝑣𝑣𝑎𝑎𝑙𝑙𝑢𝑢𝑒𝑒). A collection 
of all of the points over the entire video is used to generate a scatterplot. 
The maximum fan-width for each median value was defined using the following: 
𝑀𝑀𝐴𝐴𝑋𝑋𝐹𝐹𝑊𝑊(𝑚𝑚𝑣𝑣𝑎𝑎𝑙𝑙)=max𝑚𝑚𝑒𝑒𝑑𝑑𝑖𝑖𝑎𝑎𝑛𝑛_𝑣𝑣𝑎𝑎𝑙𝑙𝑢𝑢𝑒𝑒=𝑚𝑚𝑣𝑣𝑎𝑎𝑙𝑙𝑤𝑤𝑖𝑖𝑑𝑑𝑡𝑡ℎ. (1) 
The maximum fan-width measures the maximum angular spread (in degrees) for a fixed motion 
magnitude. For this study we ignore the motion magnitudes for integer-valued motions 𝑚𝑚𝑣𝑣𝑎𝑎𝑙𝑙 = 2, 3, 4, 
and 5 pixels. The sum of the maxima over several integer motions is defined using 
𝑆𝑆𝑀𝑀𝐴𝐴𝑋𝑋𝐹𝐹𝑊𝑊(𝑚𝑚𝑣𝑣𝑎𝑎𝑙𝑙=𝑖𝑖,…,𝑗𝑗)=Σ𝑀𝑀𝐴𝐴𝑋𝑋𝐹𝐹𝑊𝑊(𝑚𝑚𝑣𝑣𝑎𝑎𝑙𝑙)𝑚𝑚𝑣𝑣𝑎𝑎𝑙𝑙=𝑗𝑗𝑚𝑚𝑣𝑣𝑎𝑎𝑙𝑙=𝑖𝑖.(2) 
To differentiate between concordant and non-concordant motions, the sum of the motion spreads as 
expressed by (2) was studied. For this study the basic idea was that larger spreads would characterise 
non-concordant motions. [G. Farnebäck,2002] 
 
 
 
 
 
 
 229 
 16.3.Results 
To differentiate between concordant and disconcordant motions, we collected ultrasound videos from 
35 patients as previously described. These videos were visually classified into concordant p (n=22) and 
discordant (n=13) plaques. 
Figure 16.1 is a comparative example between a stable and an unstable carotid plaque. The 
orientation histogram of the visually classified as concordant plaque of Fig. 16(a), shows a narrow fan 
width of 6o degrees at the peak of the cardiac systole. Then figure 16(b) shows the orientation 
histogram for the visually classified as discordant plaque. In this case, the orientation spread is 
approximately 84o degrees at the peak systole.  
We compared the scatterplots for all cases. In Figure 16.2  the MAXFW and SMAXFW for the different 
cases described in (1) and (2) are presented. From the boxplots, we can see that SMAXFW(i=3,4,5) 
provides the best separation between stable and unstable plaques.  
The sum of maximum fan widths for the median pixel motions 5 to 3 (SMFW5to3) had a median value 
of 100 degrees and inter-quartile range (IQR) of (80, 110) degrees for the concordant plaques and 270, 
(230, 430) for the discordant plaques (P < 0.001). 
 Thus, a possible new tool for objective differentiation between concordant and discordant plaques 
has been produced. 
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(a) 
 
 
 
 
 
 
 231 
 (b)                           
 
 
Figure 16.1: Carotid bifurcation plaque motion analysis. (a) Plaque with concordant motion at peak systole.  The histogram 
plot shows the magnitude and orientation. The motion-spread scatterplot for is characteristic of a concordant plaque.  (b) 
Plaque with discordant motion at peak systole. The histogram plot shows the magnitude and orientation. The motion-spread 
scatterplot for is characteristic of a non concordant plaque.  (Reproduced with permission from Pattichis etl. IEEE 2012) 
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Figure 16.2. Boxplots of the maximum fan-width (MAXFW in (8)) and the sum of the maximum fan widths (SMAXFW in (9)) for different, integer pixel motions. Here, “0” refers to stable plaques and “1” refers to “unstable” plaques. (a) Boxplot for MAXFW(5). (b) Boxplot for MAXFW(4). (c) Boxplot for MAXFW(3). (d) Boxplot for MAXFW(2). (e) Boxplot for SMAXFW(i=2,3,4,5). (f) Boxplot for SMAXFW(i=3,4,5). Boxplot Legend. Q1/Q3: 1st/3rd quartile or 25th/75th percentile shown as the lower/upper hinge of the box. M: median shown as a line segment across the box.  IQR: interquartile range is the box height from Q1 to Q3. Lower/Upper Whisker: The smallest/largest observed value within 1.5×IQR below/above the Q1/Q3.  S-Outlier: Suspected outliers shown by unfilled circles are between 1.5×IQR to 3×IQR below/above Q1/Q3. Outlier: Outliers shown by 5-pointed stars are 3×IQR or more below/above the Q1/Q3. The outliers are labelled by the identifying numbers. (Reproduced with permission from Pattichis etl. IEEE 2012)  
 233 
 16.4. Discussion 
We developed a real-time motion analysis system that can estimate velocities between consecutive 
video frames. The spread of the motion orientation around the dominant orientation over each video 
frame was measured. The spreads of the motion orientations for different motion magnitudes were 
calculated for each video. These motion-spread measurements were also useful in quantifying 
discordant movement.  
Our study showed that it is possible to objectively quantify and study carotid plaque motion using 
plain 2D ultrasound and customised software. There was no extra cost and no inconvenience for the 
patient. All the analysis was performed with a personal computer at a later stage. There were no 
special requirements for the patients and obtaining a video loop proved to be a relatively simple task, 
which was not adding to the duration of examination. 
This can be used in the future to assess if plaque motion can be used to differentiate between stable 
and unstable plaques adding more dynamic information on carotid plaque characterizations. At the 
moment we are at the process of analysing all the available video loops obtained during the course of 
the 3D study and we will report on the results soon. 
The evaluation of carotid plaque has so far been limited to static measurements of the volume, 
composition or degree of stenosis. It is possible that the combination of these measurements with the 
dynamic information obtained by our plaque motion software may improve the identification of the 
vulnerable carotid plaque. Obviously, further clinical research is warranted to standardise the 
technique and provide solid evidence regarding the cost effectiveness of this approach. 
Finally it is possible that this approach can have important applications in the calculation of 
biomechanical stresses on the plaque surface simplifying the otherwise very complicated process of 
plaque surface strain analysis. As shown by a recent review of the literature by our group [Makris et 
al., 2010] there is preliminary evidence suggesting that the combined effect of the various types of 
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 stress acting on the carotid plaque may help us to distinguish between high and low risk plaque. 
However, the current methodologies are based on complicated simulations that make this type of 
analysis clinically impractical. The use of our software might be able to simplify this process by 
providing real time data for the stress wall analysis models but again further research is warranted. 
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 16.5. Conclusion 
Using customised software and B-Mode video loops it is possible to objectively quantify carotid plaque 
motion. Further research is currently in progress to determine if this approach can provide us with 
useful information for the improvement of carotid plaque characterisation and the reliable 
identification of the high risk for stroke individuals. 
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PART VI 
 
Chapter 17 
 
Discussion 
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 17.1. Background 
In 2008, cardiovascular disease (CVD) was the primary cause of 811,940 of all 2,471,984 deaths in the 
United States [Roger VL, 2012]. The prevalence of CVD among American adults is greater than 1 in 3. 
The total direct medical costs of CVD are estimated to triple from $273 billion to $818 billion within 
the next twenty years and this is despite the fact that the death rate by CVD has declined to 30.6% 
within the past decade. About half of this decrease is attributed to the increased use of best medical 
therapy and 44% to environmental and life style changes. In 2008, there were 795,000 cases of new or 
recurrent stroke which accounted for 1 of every 18 deaths in United States. Among the survivors of 
ischemic stroke who were older than 65 years, many experience long-term disabilities [Roger VL, 
2012]. Carotid plaque associated stroke is, thus, a source of significant mortality and morbidity. For 
years now the identification of that patient group that will benefit more from surgical interventions to 
prevent a stroke has become the “Holy Grail” in carotid vascular surgery. As it was pointed out in the 
introduction of this thesis, if we only use the traditional approach, which depends almost exclusively 
on the degree of stenosis, we need 20 CEA operations to prevent one stroke. 
 
For more than decade now research groups from around the world have been focusing on new 
imaging techniques that would make the selection process more sensitive. In other words, techniques 
that we would enable us to identify those patients that despite the currently available best medical 
treatment are more likely to suffer a stroke. This problem has been proven to be more complicated 
than we originally imagined. Carotid plaques are dynamic structures growing in a complicated and 
constantly changing environment with many possible parameters affecting their structural abilities to 
resist fatigue and rupture. 
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 Two-dimensional ultrasound has been for years the method of choice for the screening of patients 
with cerebrovascular events. It is cheap, relatively easy to use and can provide us with a usually 
straightforward answer.  However, it has become evident that ultrasound and especially the use of the 
degree of stenosis alone as a sole indicator of disease severity is not enough. [Nicolaides AN, 2010] For 
many researchers this did not come as a surprise since there are many other factors that appear to 
have an effect on carotid plaque stability.  Factors such as the presence of fibrous cap, the presence 
and the size of the lipid core, the overall composition of the carotid plaque, the presence of neovessels 
within the plaque and the amount of biomechanical forces that apply on the plaque surface due to the 
blood flow, can affect the carotid plaque stability and risk of stroke as it is becoming increasingly 
evident by emerging data [Abbot A, 2009]. 
 
In this thesis we tried to identify novel ultrasound features to differentiate between stable and 
unstable plaques. Firstly, we used the previously developed methodology by our group to objectively 
analyse carotid plaque images from the large ACSRS cohort study. This was in order to identify novel 
2D ultrasound features of plaque composition, such as features of plaque texture heterogeneity, 
which were not previously studied during the course of that study. In addition, and recognizing the 
possible limitations from two dimensional ultrasound imaging, we developed a unique methodology 
for 3D ultrasound image acquisition, composition and volume analysis that we subsequently applied to 
a prospective, cross-sectional study that we designed and run. Finally, in collaboration with the 
University of New Mexico we developed software for the objective quantification of carotid plaque 
motion that can be useful for the further characterization of this dynamic structure.  
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 17.2. New methodologies for carotid plaque characterization 
The use of 3-dimensional ultrasound has been so far limited to the plaque volume measurements. Our 
group aimed to investigate if it is possible to use the 3-dimensional ultrasound in order to obtain 
information regarding the composition of the entire plaque as well as its volume. In order to achieve 
this we combined two different types of software. One for the semi-automated sectioning of the 
plaque volume (Q-lab) and another for the texture analysis of every provided slice (Incosoft Plaque 
analysis software). This way and after using special formulas we showed that it is feasible to evaluate 
specific texture features such as GSM for the entire plaque and at the same time calculate the plaque 
volume. This can have significant implications for future studies and for the way we assess carotid 
plaque characteristics. 
 
Another challenging problem was to develop a way of assessing carotid plaque motion in an objective 
way. It has been suggested that the carotid plaque motion during the cardiac cycle may have 
implications on its structural properties due to the tensile and shear forces that are being applied. 
With the invaluable help of the team from the University of New Mexico, we showed that it is 
possible, using ultrasound and dedicate software, to objectively quantify plaque motion and measure 
its possible effect on the carotid plaque. To our knowledge this is one of the first studies to present 
such a methodology that does not required complicated reconstructions or MR imaging. 
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 17.3. Novel 2D ultrasound features and the ACSRS study 
 17.3.1.Novel texture features for plaque composition analysis 
The current ultrasound evaluation of carotid plaque composition is based on the image analysis of 
specific texture-features and especially grey scale median. Each plaque is digitally represented as a 
block of black and white pixels in various combinations, according to the proportion of the contained 
lipid or fiber tissue. A pixel is a square, small element with standardized dimensions that occupies a 
certain 2-dimensional space. Each pixel is characterized by specific properties such as intensity of the 
signal (brightness), which is the amplitude of the received echo and determines the black or white 
contour. The ratio of the black and white pixels depends on the type of plaque. [Geroulakos G, 1993] 
An objective approach for the evaluation of the plaque texture -features can be achieved using digital 
image analysis and specialized software [Kakkos SK, Stevens JM,2007]. Certain measures such as the 
first and second order statistics may provide us with a description of the digital properties of the 
corresponding image (Appendix I). 
The first order statistics (FOS) describe the distribution of the grey levels of pixels without taking into 
consideration the spatial dependence between the pixels. They are based on the histogram of the 
frequency of grey tones distribution (x-axis) as a function of the pixel count (y-axis). The grey scale 
median (GSM) belongs to this group of characteristics and describes the middle gray level above and 
below which 50% of the overall observations are spread. Despite the descriptive information provided 
by FOS the potential spatial, within matrix dependence is ignored [Kakkos SK, Nicolaides AN,2006; 
Wilhjelm JE,1998].  
Second order statistics (SOS) address the pixel distribution considering at the same time the spatial 
dependence and they are indicative of image homogeneity. In other words SOS like Spatial Gray Level 
Dependence Matrices (SGLDM), Gray level difference statistics (GLDS), Gray level run length statistics 
(RUNL) and the Fourier power spectrum (FPS) (Appendix I) describe both the distribution of the pixels’ 
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 grey level as well as their relative positioning with respect to each other [Haralick RM,1973; Kadah 
YM,1996; Wilhjelm JE,1998]. So far carotid plaque composition was mainly assessed using means of 
FOS and especially GSM which is representative of how echolucent or how echogenic a carotid plaque 
is. Indeed, the correlation of GSM and cerebrovascular events has been significant and it was the 
beginning of a new era for carotid plaque characterization analysis [Kakkos SK, Stevens JM,2007]. 
However the importance of image homogeneity as this can be quantified by objective means such as 
the SOS measures was largely underreported.  
Our study showed that the combination of such features for computerized characterization of 
asymptomatic carotid plaques might enable us to identify a low and high risk of stroke group of 
patients who can benefit from different treatment strategies. This may suggest that if such a group of 
patients with asymptomatic carotid plaque disease but with a higher risk of stroke can be identified 
then maybe carotid endarterectomy can still be justified. 
Finally, the size of the lipid core without obvious thin fibrous cap and its effect on risk of stroke was 
evaluated using the same cohort. Histology studies have shown that the symptomatic plaques were 
more often associated with a juxta-luminal location of the lipid core compared to the asymptomatic 
one [Bassiouny HS,1997] In clinical studies JBA in carotid plaque was imaged by ultrasound and was 
more often found in symptomatic than asymptomatic plaques [Pedro LM,2002] In addition a thin, 
ruptured or absent fibrous cap has been more frequently noted in carotid plaques causing 
cerebrovascular symptoms (Pedro LM,2000; Demarco JK,2010). Obviously in those initial stages the 
determination of the JBA or the echogenic cap was subjective because monitor brightness can alter 
the results of the visual assessment (Kakkos SK, Nicolaides AN, 2011). Our group developed image 
normalization of ultrasound images and colour mapping. This technique was employed in JBA 
evaluation (Sztajzel R, 2005) so that echo-poor areas near the plaque vessel lumen could be well 
delineated with reproducible measurements of their area, without the subjectivity of the previously 
mentioned visual assessment (Kakkos SK, Nicolaides AN, 2011). 
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 In chapter 11 of this thesis we actually demonstrated that the presence of a JBA without a visible 
fibrous cap was linked to ipsilateral neurological events in patients with asymptomatic carotid artery 
stenosis. This link was still significant after adjusting for other significant factors associated with 
plaque vulnerability. This is an important finding and in combination with other emerging imaging 
features can be a significant aid towards the more accurate characterization of the carotid plaque. 
Further support to our hypothesis is also provided by previous studies, which have shown a good 
agreement between carotid ultrasound and plaque histology (Snow M,2007; Hatsukami TS,1994). The 
presence of a thin or ruptured fibrous cap on carotid MRI in patients with moderate asymptomatic 
stenosis was a strong predictor of future cerebrovascular events (Takaya N,2006).  Moreover, in 
patients with TIAs and carotid plaques causing mild to moderate stenosis, the presence of juxtaluminal 
hemorrhage/thrombus on MR has been shown to be a strong predictor of TIA recurrence (Teng 
Z,2011). Whether risk index or stratified GSM are better than JBA size determination in predicting 
future stroke in patients with asymptomatic carotid stenosis remains to be determined.  
The use of the dedicated “Incosoft Plaque analysis” software has made the objective analysis of 
carotid plaques more straightforward thanks to its friendly user interface and the many provided 
measured variables including first and second order statistics as well as total plaque area and 
juxtaluminal black area. At the moments this is the only commercially available software for carotid 
plaque evaluation which provides automatic plaque classification according to the “Geroulakos 
Classification” and which has been tested in a large prospective study such as the ACSRS one. 
(Geroulakos G, 1993) 
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 17.3.2.  Carotid plaque progression and its value for stroke risk stratification 
The evaluation of the change of certain plaque features during ultrasound follow-up is another 
promising approach, especially for the asymptomatic patients and in order to identify those at a high-
risk for stroke. Patients with asymptomatic carotid disease are more likely to undergo more than one 
carotid ultrasound scans during the progress of their disease. However, during these scans its usually 
only the degree of stenosis that is being assessed with usually no attention paid to any possible 
composition or morphology changes. As we know carotid plaques develop in a dynamic environment 
and so far there is limited evidence regarding their change in time with regard to their composition 
and volume. It is also largely unknown if this change has any effect on the risk of stroke and if it can be 
used to identify a high risk for stroke groups of patients. 
To answer these questions we used the ACSRS cohort and retrospectively evaluate the changes in 
plaque composition, when the degree of stenosis is constant, in a subgroup of the ACSRS participants. 
We also evaluated the change in the degree of stenosis through time in the entire ACSRS cohort 
aiming to assess the predictive ability of the change in the degree of stenosis.  In both studies it was 
shown that useful information could be obtained by the recording of the follow-up measurements of 
certain plaque texture features as well as of the degree of stenosis, which can be used to identify the 
high-risk individuals. It was also suggested, that these changes in the composition and size of the 
plaque can be used as outcome measures to evaluate response in various treatments.   
Previous studies have demonstrated links between echolucent plaques [Liapis C, 2000] contralateral 
stenosis or ipsilateral stenosis and ipsilateral carotid stenosis progression [Sabeti S, 2007]. In our 
study elevated levels of creatinine, hypoechoic plaques, male gender, sever ipsilateral or contralateral 
stenosis were associated with progression to occlusion. On the other hand the age of the patient and 
the presence of discrete white areas were associated with a decreased incidence of regression. It was 
difficult to interpret these findings since older patients may have more calcified plaques or plaques 
with more collagen, which are obviously less likely to regress. Finally, the presence of discrete white 
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 areas, possibly indicates neovascularisation within the plaque as shown by carotid plaque perfusion 
studies [Shah F,2007], which can also be resistant to regression. This may have implications for the 
need of more aggressive medical therapy in patients with DWA-rich plaques but further research is 
warranted.  
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17.4. Current data on 3D ultrasound for the investigation of carotid plaque disease 
Our recent systematic review of the literature supports the good reproducibility of 3DUS on the 
evaluation of carotid plaque volume, however, with high heterogeneity between studies [Makris et al, 
2011]. In contrast to the relatively large number of studies evaluating the use of 3DUS to assess plaque 
volume in this review, there was a limited number of  studies evaluating the composition of the entire 
plaque by grey scale means. Heliopoulos et al. showed that lower plaque echogenicity is more likely to 
be observed in symptomatic than in asymptomatic patients with moderate degree of carotid stenosis, 
indicating that it is a significant factor for the production of cerebrovascular symptoms [Heliopoulos 
J,2008]. During the review of the literature no studies were identified evaluating the use of 3DUS to 
assess both the composition and the volume of the entire plaque.  
In part IV of this thesis we presented for the first time a simple, semi-automated methodology based 
on commercially available computer software and 3D ultrasound that enable us to obtain 
simultaneous information on volume and composition for the entire plaque.  We tested this 
methodology on a prospective study in more than 80 patients with both symptomatic and 
asymptomatic disease. This study showed that 3D measurements of certain plaque features, such as 
GSM for the entire plaque, do not improve the stroke predictive ability when compared to the 
traditional measure of degree of stenosis. This did not change even when we analysed an even larger 
number of sections of the same plaque by using thinner slices. In addition, when the 3D plaque 
measurements were compared to the corresponding 2D ones there was no statistically significant 
difference in the risk of stroke predictive ability.  
Currently there is no evidence from our study to support the use of 3D ultrasound probes for the 
evaluation of carotid plaque disease since they are more expensive, more difficult to use (bulkier) and 
without any apparent clinical benefit. However, we should keep in mind that further improvements in 
3D ultrasound technology are already on their way and they are more likely to improve the resolution 
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 and lower the cost of these probes.  We secured approval for the continuation of the 3D study and we 
will expand the sample size in order to increase the power of it.  
Finally, even if a diagnostic benefit was not established by the use of 3D ultrasound in our study, the 
developed methodology may have significant applications in other areas of carotid plaque analysis. In 
collaboration with the Bioengineering department of Imperial College and Professor Y Xu we have 
started a joined project where the images from the 3D imaging will be used to produce biomechanical 
stress maps of the carotid plaque surface. The preliminary data from this collaboration suggests that 
the obtained 3D ultrasound reconstructions of the plaque can simplify the process of carotid stress 
map creation making further analysis feasible. [Wang Z., 2012] If 3D ultrasound can provide us with 
reliable data as a basis for such complicated biomechanical reconstructions then another potential 
application of it may have just been revealed. This research is still on going. 
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 17.5. Biomarkers and contrast enhanced ultrasound for the further characterisation of carotid 
plaque disease. 
High-sensitivity C-reactive protein (CRP) is one of the most common biomarkers mostly used in 
research studies and it has been shown potential in stroke risk prediction. It is still unclear if CRP is 
directly causal to the plaque rupture, however the association with clinical events appears to be clear. 
[Staub D., 2013] Apart from CRP there are many other systematic biomarkers that have shown 
promise but have not been thoroughly tested. Some of them include myeloperoxidase, secretory type 
II phospholipase A2 , oxidized low-density lipoprotein , pregnancy-associated plasma protein A and 
lipoprotein-associated phospholipase A2.  In addition there are several common genetic variations 
that have been reproducibly correlated to with cerebrovascular event risk.  Some characteristics 
examples include, each copy of the risk allele at 9p21, which seems to increase CAD risk by more than 
25%. Recently, a multistage genome study identified a number of genetic variants associated with 
early-onset myocardial infarction and stroke. [Staub D, 2013] Three of these are newly identified 
(21q22, 6p24, and 2q33) whereas 6 (9p21, 1p13, 10q11, 1q41, 19p13, and 1p32) are replicated from 
previous observations. To evaluate the cumulative effect of these single nucleotide polymorphisms on 
the risk of cardiovascular events, a genotype score from 9 single-nucleotide polymorphisms was 
generated. Patients with scores in the top quintile had a twice as many chances of suffering a 
cardio/cerebrovascular event when compared with those in the last quintile [Verhoeven EL,2011] 
An important potential use of biomarkers is to guide the use of non-invasive and/or invasive imaging 
procedures. In 1,004 asymptomatic Korean patients who underwent coronary CTA imaging as part of a 
health screening, individuals with C-reactive protein ≥2 mg/l had a much higher prevalence of 
coronary plaque and mixed calcific plaque compared with those with lower C-reactive protein levels 
[Villanueva FS,2008] 
Carotid enhanced ultrasound (CEUS) is a relatively novel invasive approach to image atherosclerotic 
plaques and it is currently the subject of rigorous research. CEUS has shown to precisely demonstrate 
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 carotid stenosis of more than 70 %. [Fleg JL., 2012] The degree of carotid luminal narrowing on CEUS 
imaging correlated strongly with magnetic resonance imaging studies and conventional angiography. 
In addition certain studies have shown that CEUS imaging maybe useful to detect occlusion and 
distinguish it from tight stenosis. CEUS has also shown promise for the assessment of restenosis post 
interventional carotid artery stenting. [Garcia-Garcia HM.,2009] 
 In a study evaluating the use of CEUS for follow-up after carotid stenting showed that CEUS provides a 
reduction in intra-stenotic flow artefacts providing better visualization and detection of the full length 
of the stenosis when compared with colored Doppler. [Rogers IS., 2010] 
Carotid CEUS may also enhance the visualization of wall irregularities such as dissections, echolucent 
plaques and , surface ulcers. [Kugiyama K., 1999]. In a study of 100 asymptomatic vasculopaths, 
standard carotid ultrasound demonstrated atherosclerotic plaques 77 % when the CEUS detected 
atherosclerotic plaques in 88 % with a statistically significant difference. [Elesber AA.,2006].  The 
vulnerable, hypoechoic atherosclerotic plaques were more likely to be detected by CEUS and not with 
standard carotid ultrasound, which shows the potential of CEUS in high-risk symptomatic or 
asymptomatic patients.  
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 17.6. Future studies 
The work started in this thesis will be continued in the future with the aim to improve even further the 
predictive ability of ultrasound based imaging in carotid plaque disease. 
The 3D ultrasound study will be expanded and more patients will be included, as ethical approval to 
do so has been granted.  In addition, the correlation of the 3D ultrasound findings with plaque 
histology that has started with this thesis (analysis not finished) will be completed providing us with 
further insight regarding the correlation of 3D ultrasound findings with the actual plaque sample. It is 
also planned to correlate 3D imaging findings with plaque motion data in order to establish possible 
links between plaque composition and certain plaque motion patterns that may predict plaque 
rupture.  
Finally a prospective study to evaluate the effect of combination treatment with omega 3 fatty acids 
and statins has been designed and ethical approval has also been granted. The hypothesis is that the 
addition of pharmacological doses of fish oil to standard statin therapy will cause regression of carotid 
plaque characteristics associated with the development of ischemic stroke. The use of 3D ultrasound 
for measurements of plaque volume and texture in this study has advantages over older methods such 
as intima-medial thickness (IMT). Firstly the biological correlates are different, IMT represents mainly 
hypertensive changes in the arterial wall, whereas carotid plaque volume is biologically more relevant 
to the disease process of ischemic stroke; secondly plaques progress along vessel walls more quickly 
than they thicken so that methods measuring change in plaque volume are more sensitive to change 
in plaque biology over time. The full details of the protocol can been found in Appendix III.  
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 Appendix I 
Texture features of carotid plaque echogenicity and heterogeneity: 
A.  First order gray level parameters  
The features mean gray level, variance, median (GSM), mode (expresses the most frequent value), 
kurtosis, skewness, energy and entropy belong to this category. In this category the parameters are 
derived directly from the gray level histogram. They describe the gray level distribution without 
considering spatial independence; as a result they can only describe echogenicity of texture and the 
overall variation characteristics within the region of interest (ROI).  
 
B.1. Second order statistics- The Spatial Gray Level Dependence Matrices (SGLDM)  
The features that belong to this category are : Angular Second Moment (ASM), Contrast, Correlation, 
Variance (Sum of squares), Inverse Difference Moment (IDM) – Homogeneity, Sum Average, Sum 
Variance, Sum Entropy, Entropy, Difference Variance, Difference Entropy, Information Measure of 
Correlation-1 (IMC-1) and Information Measure of Correlation-2 (IMC-2).  
 
The SGLDM algorithm is based on the assumption that texture properties of an image are contained in 
the overall or ‘‘average’’ spatial relationship between the gray levels in the image. SGLDM is based on 
the estimation of the second order conditional probability density f(i,j;d,q). Each value f(i,j;d,q) 
represents the probability that two different resolution cells which are in the direction specified by an 
angle q and have distance d, will have gray level values i and j respectively.  
 
ASM is a measure of homogeneity of the image. Homogeneous images have very few dominant gray-
tone transitions, which result into higher readings. Contrast is a measure of the contrast or the 
amount of local variations present in an image. Images with large neighbouring gray level differences 
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 are associated with high contrast. Correlation is a measure of gray-tone linear-dependencies in the 
image and heterogeneity. Heterogeneous images have higher correlation values. 
 
B.2. Gray level difference statistics (GLDS)  
The GLDS algorithm is based on the assumption that useful texture information can be extracted using 
first order statistics of an image. The algorithm is based on the estimation of the probability density pd 
of image pixel pairs at a given distance d ¼ (Dc,Dy), having a certain absolute gray level difference 
value. Coarse texture images, result in low gray level difference values, whereas, fine texture images 
result interpixel gray level differences with great variances. The parameters used from this category 
are: Entropy, Contrast, Mean, Angular Second Moment e Homogeneity, Energy. 
 
B.3. Gray level run length statistics  
This technique is based on grey level run length of the image. If we examine the points that lie along 
some given direction (run lengths), we will occasionally find runs of consecutive points that all have 
the same grey level. In a coarse texture relatively long runs occur more often, whereas, fine texture 
contains primarily short runs. In a directional texture, the run lengths that occur along a given line 
should depend on the direction of the line. The parameters used from this category are: Short Run 
Emphasis (SRE), Gray Level Distribution (GLD), Run length distribution (RLD), Long Run Emphasis (LRE), 
Run Percentage (RP).  
 
 
C.  The Fourier power spectrum (FPS)  
The estimation of the power spectrum of an image using Fourier transform provides useful 
information about texture. Coarse texture will produce results concentrated near the transformation 
origin, while in images with smooth texture values it will be more spread out. 
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 APPENDIX II 
1.1. Investigating for multi-collineatirity among the 51 ultrasound texture features 
Multi-collinearity within the data was reduced to the minimum using the technique, which was 
described, in the methods’ section of Chapter 5. As a result the following 22 texture features were 
included in the following analysis (table 1).  
1.2 Linear transformation of the variables 
The non-normally distributed variables were linearly transformed using appropriate logarithmic or 
other arithmetic transformations and approximate normal distribution in most of them apart from the 
variables col_9 and Kurtosis. The resulting variables are sqcol6, sqcl_bel20, sqcl_bel30, lgskew, 
lgsgldasm, lnsgldcon, lglgsgldcor, lglgsgldMlnM2, lglgrunl_sre, sqsgldvar, lggldmhom, lggldmcon, 
sqfpsfrad, lnrunlgld, sqrunlrld, bel_30, col_2, sgldlnM1, lggsm40, sqareamm where the initials ln, lg 
and sq stand for logarithmic and square root transformations, respectively. (Table 2) 
1.3. Factor Analysis 
Factor, principal component analysis with Varimax orthogonal rotation was used in order to eliminate 
redundant variables. The correlation R matrix determinant value was 7.456E-19  and the KMO and 
Bartlett's test of Sphericity were .794 and 46282.827 (df: 231, p<0.0001) respectively (Table 3).  
Principal component analysis of the transformed textural features extracted 5 factors with eigenvalues 
of more than 1 (appendix Figure 1 and appendix Table 4). Only the variables with loading factors 
above 0.8 were considered: 
-Factor 1 accounted for the 29.5% of the total variability. The features: bel_30,  lggsm40 and lgsgasm 
(logarithmic form of GSM and SGLD_ASM respectively) correlated strongly with factor 1 (loading factor 
0.908, -.0902 and 0.883).  
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 -Factor 2 accounted for the 20.5% of the total variability. The features: lnsgldcon, lggldmcon 
(transformed forms of SGLD_CON and GLDM_CON) correlated with factor 2 with loading factors of 
0.846 and 0.845 respectively.  
-Factor 3 accounted for 13.3% of the total variability. Two features strongly correlated with this factor 
and these were: sqrunlrld (LF: 0.954) and sqareamm (LM: 0.950). These are the transformed foms of 
RUNL_RLD and plaque area. 
-Factor 4 accounted for almost 12% of the total variability.  Only Sqclbel3 correlated strongly with this 
factor with a LF: 0.961 which is the transformed version of CL_bel30. 
-Finally the last factor was responsible for the 11.3 % of the total variation and in combination with the 
previous 4 factors was explaining a cumulative 87.2% of the cumulative variation. The L2gsgcor and 
Sgldinm1 features correlated strongly with the last factor (LF: 0.852 and 0.876 respectively). These 
variables represent the transformed versions of the features SGLD_COR and SGLDINM1. 
The remaining features had loading factors of less than 0.8 and thus were decided not to be included 
in the final analyisis.  
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 Descriptive Statistics
48.217963 25.816679 1118
23.144310 10.097955 1118
2.907897 3.192944 1118
.469694 1.029530 1118
12.428970 6.853990 1118
11.163337 5.261138 1118
2.205323 1.255096 1118
35.870149 24.421165 1118
1.439813 .979354 1118
46.6891 28.6515 1118
2.78E-02 8.11840E-02 1118
77.793478 93.999539 1118
.968418 3.10628E-02 1118
1360.347 943.341117 1118
-.397157 4.98302E-02 1118
.976563 2.85545E-02 1118
.317691 .138471 1118
72.336547 76.797083 1118
3170.804 1650.724426 1118
.912515 3.88612E-02 1118
209.0777 166.848069 1118
11883.13 7231.274280 1118
BEL_30
COL2
COL6
COL9
CL_BEL20
CL_BEL30
KURT
MEDIAN
SKEW
AREA_MM2
SGLD_ASM
SGLD_CON
SGLD_COR
SGLD_VAR
SGLDINM1
SGLDMINM
GLDM_HOM
GLDM_CON
FPS_FRAD
RUNL_SRE
RUNL_GLD
RUNL_RLD
Mean Std. Deviation Analysis N
 
Table 1: The resulting 22 texture feature after multi-collinearity reduction 
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 Descriptive Statistics
1.4068 .9641 1118
34.5101 13.0213 1118
3.3688 1.0397 1118
54.4140 14.4951 1118
104.2250 31.9560 1118
6.5397 1.9813 1118
3.2354 .8344 1118
1.0570 3.396E-02 1118
-2.4376 .8206 1118
1.6823 .4067 1118
-.5345 .1758 1118
1.8583 .1376 1118
3.8937 .9686 1118
5.0591 .7876 1118
-1.9768 .2762 1118
-2.1239 .2921 1118
-1.4758 .1702 1118
48.217963 25.816679 1118
23.144310 10.097955 1118
.469694 1.029530 1118
2.205323 1.255096 1118
-.397157 4.98302E-02 1118
SQCOL6
SQSGLVAR
SQCLBEL2
SQFPFRAD
SQRUNRLD
SQAREAMM
SQCLBEL3
LGSKEW
LGSGASM
LGGLCON
LGGLHOM
LGGSM40
LNSGCON
LNRNGLD
L2GSGCOR
LLGSGLNM
LLRUNSRE
BEL_30
COL2
COL9
KURT
SGLDINM1
Mean Std. Deviation Analysis N
 
Table 2: Descriptive statistics after the linear transformation of the texture variables 
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 KMO and Bartlett's Test
.794
46282.827
231
.000
Kaiser-Meyer-Olkin Measure of Sampling
Adequacy.
Approx. Chi-Square
df
Sig.
Bartlett's Test of
Sphericity
 
Table 3: KMO and Bartlett’s test from of the resulting factor analysis and PCA 
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 Scree Plot
Component Number
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Figure 1: Scree plot- Factors with eigenvalues>1 were selected 
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 Rotated Component Matrixa
     
     
     
     
  .954   
  .950   
   .961  
     
.883     
 .846    
     
-.902     
 .845    
     
    .852
     
     
.908     
     
     
     
    .876
SQCOL6
SQSGLVAR
SQCLBEL2
SQFPFRAD
SQRUNRLD
SQAREAMM
SQCLBEL3
LGSKEW
LGSGASM
LGGLCON
LGGLHOM
LGGSM40
LNSGCON
LNRNGLD
L2GSGCOR
LLGSGLNM
LLRUNSRE
BEL_30
COL2
COL9
KURT
SGLDINM1
1 2 3 4 5
Component
Extraction Method: Principal Component Analysis.  
Rotation Method: Varimax with Kaiser Normalization.
Rotation converged in 6 iterations.a. 
 
Table 4:  Principal Component Analysis of the 22 texture features. The Varimax rotation method was used with 
Kaiser Normalization and 5 factor components were retrieved. Only the variables with loading factors above 0.8 
were included in the final analysis. 
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 Appendix III 
Study protocol 
The efficacy of omega-3 fatty acids plus statin therapy vs. statin therapy alone in carotid plaque 
stabilization and reduction of circulating inflammatory markers. A Pilot trial combining 2 and 3 
dimensional ultrasound. (OMEGA 3 TRIAL) 
Introduction 
Pooled data from two large meta-analyses provide significant evidence illustrating the beneficial effect 
of statin-treatment. [1, 2] The relative risk reduction rate for stroke was 21% [(OR) 0.79 (0.73-0.85)] 
with no heterogeneity between studies [2] while the 5-year incidence of major coronary events, 
coronary revascularization and stroke was reduced by about one-fifth per mmol/l reduction in LDL 
cholesterol [1]. In addition in the most recent meta-analysis –of statins combined with other 
preventive strategies for stroke prevention which included 165 792 individuals, there was a reduction 
in relative risk for stroke of 21.1% (95% CI 6.3-33.5, p=0.009) for every 1 mmol/L decrease (39 mg/dl) 
in LDL cholesterol. [3]   
Reduction rates of 16% and 26% for fatal/ non-fatal strokes and total vascular events respectively 
were observed after intensive treatment with atorvastatin by the only randomized trial (SPARCL-
Stroke Prevention by Aggressive Reduction in Cholesterol Levels) which included patients who had 
suffered stroke or transient ischemic attacks (TIA) but without manifestations of heart disease and a 
median follow-up of 4.9 years. [4]  
The role of statins in peripheral arterial disease (PAD) 
The effect of statins on peripheral artery disease and particularly on carotid plaque disease has been a 
matter of increasing importance due to the socioeconomic burden which arises from the development 
of stroke or TIAs. Two systematic reviews of the available literature indicate that there is clinical 
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 evidence supporting the beneficial effect of statins on the development of PAD, though the quality of 
the evidence was insufficient as most of the studies were non-randomized. [5,6] In parallel, 
preliminary evidence is documented with respect to the potential reductions of perioperative 
morbidity and mortality in patients undergoing non-cardiac vascular surgery though further 
appropriately designed trials are warranted in order to establish the true effect and define the proper 
duration and dosage of statin treatment needed to achieve maximum benefit. [6]  
Plaque progression and vulnerability are invaluable prognostic markers of cerebrovascular events 
irrespectively of the studied vascular bed. Nevertheless the majority of studies are currently focused 
on the coronary system. The REVERSAL (Reversal of Atherosclerosis with Aggressive Lipid Lowering) [7] 
and ASTEROID (A Study to Evaluate the Effect of ROsuvastatin on Intravascular Ultrasound Derived 
Coronary Atheroma Burden) trials [8] are only two of several randomized studies which concluded 
that the atheroma volume within the coronaries can be significantly reduced by statin therapy.  
The effect of other lipid-lowering agents in atherosclerotic plaque disease 
Nevertheless, apart from controlling LDL levels with statins, it has been suggested that targeting 
higher HDL levels and/or lower triglyceride levels could prove beneficial in terms of stroke prevention -
as it was indicated by two large systematic reviews. [9, 10] This effect could be partly anticipated since 
the atherosclerotic process is not only associated with LDL levels but also with the function and levels 
of HDL and triglycerides which are also considered major determinants of cardiovascular risk. [11, 12] 
Niacin, fibrates and omega-3 fatty acids are the main agents that could be considered for combination 
treatment with statins in order to establish better total lipidaemic control -not just of LDL levels. There 
is accumulating evidence that indeed combined lipidaemic treatment with niacin [13], fibrates [14] 
and/or omega-3 fatty acids –which is a well-known triglyceride –lowering agent [15,16] -may result in 
even more stable plaques thus potentially reducing the rates of stroke. Currently, there is a small 
number of studies investigating the direct effect of combined treatment with statin and niacin/or 
fibrates [17, 18] on the carotid plaque composition, although, no studies could be identified with 
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 regard to the combined effect of omega-3 fatty acids and statins in terms of carotid plaque 
morphology.    
There is preliminary evidence regarding the beneficial effect of omega-3 fatty acids to the 
cardiovascular system. They are associated with reduced the risk of cardiovascular related death, 
reduced nonfatal coronary events and suppression of cardiac arrhythmias [19]. Moreover higher 
intake of fish oil has been associated with a decreased risk of embolic infarction, primarily among 
women who are not on aspirin regularly [15] and elderly individuals [20].,Omega-3 fatty acids can be 
incorporated in the atherosclerotic plaques inducing structural changes towards potentially more 
stable forms [21, 22]. Most trials in secondary prevention of casdiovascular event showed significant 
reduction in stroke rates whereas the evidence from primary prevention trials evaluating the effect of 
fish oil on stroke was inconsistent- as it was shown in a recent systematic review of the literature-with 
only minor adverse events [23]. However, so far the exact role of combined therapy with statins and 
omega-3 fatty acids on the carotid plaque composition and size remains basically unknown. 
Hypothesis 
The combined effect of statins and omega-3fatty acids (fish oil) will improve the overall plaque 
stability and decrease the atherosclerosis-related inflammation in men.                                                                                                                                                            
Rationale for the proposed research 
1. Lack of evidence regarding the combined effect of statins and omega-3 fatty acids (fish oil) to 
carotid plaque morphology and stability.[24] 
2. Limited number of studies with regard to the application of advanced 2D and 3D ultrasound 
imaging and analysis in carotid plaque morphology. [25] 
3. Limited evidence regarding the effect of combined lipid-lowering treatment on the wall stress 
patterns of the carotid plaque. [26] 
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 4. Novel, proposed serum, inflammatory markers to be measured and correlated with the 
potentially, observed changes in plaque morphology. 
Methods 
Study design 
This will be a pilot, randomized, double-blind, placebo-control, study. The patients will be screened at 
their initial visit for the presence of asymptomatic or symptomatic carotid regardless of the degree of 
the stenosis. Those with the symptomatic disease will only be eligible if they do not require any 
surgical intervention and providing they are not too disabled to be able to consent or attend scanning 
centre (see Screening Criteria). After their initiation visit and randomization the patients will be 
followed up for a total of 12 months.  The number of follow-up visits will be 3; every four months post-
randomization. The total duration of the patients’ involvement to the study will be 1 year. 
Study population 
Screening Criteria 
The following patient groups attending appointments at Ealing and Charing Cross Hospital’s 
outpatient’s arterial clinic will be screened. Patients with: 
• Peripheral Artery Disease (without indication for revascularization) 
• Coronary Artery Disease  
• Stroke or Transient ischemic attacks (without indication for revascularization) 
• Diabetes Mellitus II (newly diagnosed or in chronic treatment) 
• Hypercholesterolemics (newly diagnosed or in chronic treatment) 
 and generally patients on statin therapy or statin-naïve patients of the above groups. 
In addition patients from the Stroke Units of both Ealing and Charing Cross Hospital will be screened 
for eligibility 
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 Inclusion Criteria: 
• Patients with  any degree of asymptomatic carotid plaque disease (plaque type I-III according 
to Geroulakos Classification)  
• Patients with any degree of symptomatic carotid plaque disease  (plaque type I-III according to 
Geroulakos Classification) who had recently suffered from Transient Ischaemic Attack (TIA), or 
mild-to-moderate strokes (NIHSS score < 10) who are able to consent and practically 
participate in the trial.   
• Patients on simvastatin or statin naive patients who are suitable for simvastatin 
administration. 
• Patients with adequate mobility. 
• Patients who are able to understand and sign the informed consent form. 
Exclusion Criteria: 
• Intolerance to statins (for statin naives) 
• Intolerance to fish ingredients such as omega-3 fatty acids 
• Previous treatment with omega-3 fatty acids products 
• Haemorrhagic disorders  
• Hepatic impairment  
• Pregnancy and breast-feeding 
• Chronic or current acute bacterial/viral infections (within the previous two weeks) 
• Active rheumatologic disease  
• Patients with cancer disease or in chemotherapy 
• Immunosuppressed patients 
• Physical, geographical  or social factors that may preclude appropriate compliance to study 
requirements  
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 • Receipt of any investigational treatment within the previous 30 days 
Total expected number of patients: 100 
Investigation Location 
The recruitment of the study-subjects, consent, physical examination, some of the ultrasound test and 
the blood sampling will be performed within the premises of Ealing and Charing Cross Hospital NHS 
Trust, London, UK. Additional ultrasound tests will be performed at the Vascular Non-invasive 
Screening and Diagnostic Centre (28 Weymouth Street, London, W1G 7BZ).   
The laboratory analysis for the serum inflammatory profile of the included patients will be performed 
at the Loyola Medical University, Chicago, USA. 
Research Network 
1. Imperial College, University of London, UK  
 -Dep’t of Vascular Surgery, Ealing Hospital (Mr Geroulakos): Will be responsible for the project design 
and setup, recruitment of the patients and will have the full co-ordination of the study. 
- Imperial College Cerebrovascular Research Unit, Charing Cross Hospital (Dr P Bentley): Screening and 
recruitment of patients with symptomatic carotid plaque disease. 
 -Dep’t of Chemical engineering (Dr Xu): Will perform the stress-wall analysis. 
2. Vascular Centre, CDRES trust, UK. (Prof Nicolaides): Within its premises the majority of the 2-
dimensional (2D) and 3-dimensional (3D) ultrasound scanning will be performed. In addition the 
analysis of the acquired, anonymized images will be also performed by experienced associates of the 
Trust. 
3. Loyola University, Chicago, USA (Prof Fareed). It is there where the analysis of the inflammatory 
profile will take place in their highly specialized laboratories. 
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 4. Institute of Science and Technology, Cyprus (Prof Patichis). The friendly-user computerized 
algorithm and software for plaque analysis will be further developed and provided by this group for 
the purposes of the trial. Plaque motion analysis will be also part of their contribution.  
5. Pronova Company, Norway (Omacor); Financial Support (pending) and omacor supplier. 
Study Objectives 
The primary endpoint will be: 
To evaluate the effect on carotid plaque ultrasound characteristics (volume and composition) between 
the two treatment groups in the acute (after 4 months of treatment) and chronic phase (after 12 
months of treatment). 
The secondary endpoints will be: 
a. The effect on the inflammatory status as evaluated by changes in the levels of the following 
markers: endothelin, selectin p and e, tissue factor, NO, ADMA, hsCRP, CRP, MCP1, CD40L,vWF, 
microparticles and serum amyloid A.  
b. Correlations between 2D and 3D ultrasound characteristics of the analyzed plaques. 
c. The changes in biomechanical stress- patterns/and plaque motion patterns between the two groups 
during the study period and how this can be affected by the combined lipid-lowering treatment. 
d. The correlation between the changes in specific inflammatory markers and plaque characteristics 
between the two groups. 
Research treatment 
Treatment Arms 
[(statin treatment) and (placebo)] versus [(statin treatment) and (fish oil)] 
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 Route of administration 
  Both regimens will be administered orally 
Dosage and type of regimen 
-For statins: 
The type of statin will be Simvastatin according to NICE guidelines.  
-For fish oil: 
The proposed form is omega-3 acid ethylesters in the form of Omacor® (Pronova): 1 g of 
omega-3-acid ethyl esters 90 contains eicosapentaenoic acid 460 mg and decosahexaenoic acid 380 
mg. The proposed dosage scheme is 4 capsules per day (4g/day) with food. 
Randomisation and allocation to treatment 
Each patient will be allocated to a number which will be produced by dedicated computer software. 
This number will be the number of the allocated treatment box. Both placebo and actual fish oil 
capsules will be of the same shape, colour and taste (as much as possible) and will be delivered in 
randomly numbered white boxes. The real content of each group of boxes will be in a separate sealed 
envelope which will be opened at the end of the study or in case of serious adverse events which will 
require the discontinuation of the participation of the particular subject in the trial. 
Safety considerations 
There is clinical evidence confirming that a significant number of patients do not achieve the LDL 
targeted levels with intitial statin monotherapy.  [27, 28] The recently completed COMBOS study 
(Combination of Prescription Omega-3 with Simvastatin) confirmed that combined prescription of 
simvastatin and omega-3 fatty acids succeeded in significantly improving a range of other lipid 
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 indicators apart from the LDL primary target, including lipoprotein particle size, non-high density 
lipoprotein cholesterol and triglycerides [29].  
Omega-3 f.a (OM3FA) alone have been associated with significant reductions in triglycerides and 
significant increase in HDL and LDL cholesterol [30].Clinical data with OM3FA suggests that their 
administration is tolerated with minor adverse events such as fishy odour and aftertaste in the mouth, 
nausea, and gastrointestinal discomfort with belching and bloating, diarrhea, and flatulence while it 
was not correlated with hepatic or renal impairment, rhabdomyolysis, hyperglycemia, or bleeding 
disorders [19, 31]. In addition even when OM3FA where co-administered with a statin no undesirable 
effects on glycemic control or LDL cholesterol levels were observed. [19, 32]  The COMBOS study –
which so far is the largest trial of this kind – also showed no statistically significant differences in 
adverse events or LDL control [29]. Finally there is recent evidence from pharmacological studies that 
the co-administration of statins with omega-3 fatty acids does not affect the pharmocokinetics of 
simvastatin and that the combination appears well tolerated [33].  
 
Imaging modalities 
a. Two dimensional (2D) ultrasound imaging (Commercial model applied) 
b. Three dimensional (3D) ultrasound imaging by Phillips (Experimental probe) will be provided by 
Vascular Non-invasive Screening and Diagnostic Centre (CDER Trust) 
 
Features for analysis: 
• 2D U/S:  plaque type, Grey Scale Median, Juxtaluminal black area and total plaque area.  
• 3D U/S: plaque volume and volume texture 
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 Software for image analysis  
The latest version of the “Plaque Texture Analysis Software” (Incosoft International Ltd,PO BOX 172, 
Greenford, London UB69ZN,UK ) which is a dedicated research software package will be applied. 
Software and methodology for wall stress analysis: 
They will be provided by department of Chemical Engineering of Imperial College, London which will 
be in close collaboration during the whole duration of the project. The –anonymized- ultrasound 
images acquired during the treatment and follow-up period will be gathered and sent for blind 
analysis in order to create maps of biomechanical stress distribution on the carotid.   
Methodology for plaque motion analysis 
As described above the digitalized copies of the collected images will be sent –anonymized first- to the 
digital laboratories of the Institute of Science and Technology in Cyprus where after proper blind 
image analysis, maps of plaque motions distribution will be created 
Image Capture  
The following technical ultrasound settings will be observed for 2D and 3D to ensure optimum image 
quality for texture analysis. Maximum dynamic range will be used to ensure the greatest display of 
gray scale values. Persistence will be set on low and frame rate on high ensuring good temporal scale 
values. The time gain compensation curve (TGC) will be sloping through the tissues but vertical 
through the lumen of the vessel so that the brightness of the anterior and posterior wall will be 
similar. The overall gain will be adjusted to minimize but not abolish noise in the blood. The ultrasound 
beam will be at 900 to the arterial wall. The minimum depth will be used so that the plaque will 
occupy a large part of the image. The above settings are essential prerequisites for plaque texture 
analysis, Images (both with color Doppler or power Doppler and gray scale) will be saved on DVD in 
TIFF and DICOM format. 
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 Image analysis 
The “Plaque Texture Analysis Software” version 3.2 (Iconsoft International Ltd, POBox 172, Greenford, 
London UB6 9ZN, UK) will be used. Image normalization will be performed using linear scaling with 
blood (gray scale value assigned: 0) and adventitia (gray scale value assigned: 190) as reference points 
as previously published (20). The normalized image will then be standardized to a pixel density of 20 
pixels per mm using the bicubic method provided by the software. Plaque segmentation will be 
performed by outlining the plaque in comparison to the corresponding color image and saving it as a 
separate file. Using the “Feature extraction” module of the software texture features will be 
automatically extracted by the software. They include gray scale median (GSM), GLD_SEN, RUNL_RP, 
Entropy and SGLD_DEN and plaque area. The presence and size of a juxtaluminal black area will be 
measured manually. These features used in combination have been shown to discriminate between 
symptomatic and asymptomatic carotid plaques in cross-sectional studies (82% correct classification) 
and to be highly predictive of stroke in a prospective follow-up study of 1121 patients with 
asymptomatic carotid stenosis (Odds ratio for different features was 3-8). All texture features are 
automatically saved in a database for easy access and statistical analysis. 
3D Image analysis 
The 3D plaque images will be initially analysed by “QLAB” the software provided by Philips. Color and 
gray scale images will be sectioned transversely at 1 mm intervals. Images will be saved in TIFF and 
DICOM format. Each pair of transverse images (Colour and gray scale) will be analysed as described 
above for 2D images using the “Plaque Texture Analysis Software”. Thus, instead of plaque area in 
mm2 we shall measure volume in mm3 and texture features will be averaged for all the transverse 
sections and will become volume texture measurements. 
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 Serum marker evaluation 
At each follow-up visit –apart from the 3rd - two blood samples will be taken. One sample will be kept 
for analysis at Ealing Hospital (Full blood count, lipid, liver and renal profile AND coagulation profile) 
and the other one will be temporarily stored at the pathology department of Ealing Hospital until they 
are shipped to the laboratories of Loyola University.  
The more specialized analysis of the inflammatory and coagulation profile the frozen, anonymized 
blood samples will be shipped –every 4 months- on dry ice, in a container in batches to the following 
address: Hemostasis &Thrombosis Laboratories of Loyola University Medical Centre where they will be 
properly analyzed for the indicated inflammatory markers (endothelin, selectin p and e, tissue factor, 
NO, ADMA, hsCRP, CRP, MCP1, CD40L, vWF, microparticles and serum amyloid A). The samples will be 
appropriately destroyed after the analysis. 
Follow up assessment 
After their initiation visit and randomization the patients will be followed up for a total of 12 months. 
During this period 3 follow-up visits are anticipated every 4 months. Each follow-up visit will consist of 
1 hour at the Hospital for physical examination, assessment of concordance, dispensing of study 
medication and blood sampling and 1 ½ hour at the CDER Trust for the 2 and 3D ultrasound scanning 
(apart from the 3rd visit during which only physical examination will be performed at Ealing Hospital). 
The ultrasonographer will be blinded to the allocated treatment. These two visits can take place on 
the same day or separately, but within one week. The patient’s travel expenses will be reimbursed at 
the end of each visit.  
At the end of the study patients are free to return to their normal treatment without the omega-3 
fatty acids (apart from those who are currently indicated from NICE guidelines.The reason for all 
premature departures will be recorded as per CONSORT guidelines [34]. 
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 Statistical considerations 
Population analyzed: All efficacy analysis will be based on all randomized patients, irrespective of 
whether the patient actually received omega-3 FA or the placebo capsule.  
Sample size estimation: This is the first study investigating the potential effect of combined lipid-
lowering treatment with statins and omega-3 FA. Previous studies have investigated the effect of 
statin therapy alone versus placebo on carotid plaque morphology –using 2D ultrasound 
characteristics and various serum inflammatory markers [35-37]. For 3D ultrasound characterization of 
carotid plaques there is evidence from a previous study that plaque volume measurement can show 
the effects of treatment on atherosclerosis even after only 3 months of treatment [25]. A major 
advantage of using 3D ultrasound to measure carotid plaque volume is that this technique is more 
sensitive to change compared to using 2D ultrasound. This increases the sensitivity of the study to 
establish a treatment effect. 
Change in plaque volume: A previous study [25] using 3D ultrasound showed a decrease in plaque 
volume of 90 mm3 in subjects treated with atorvastatin only compared to an increase of 33 mm3 in 
placebo group (treatment difference 123 mm3) after 3 months. Assuming that the proposed 
intervention strategy is only 50% as effective over the full study period of one year, this will give a 
mean treatment difference of 55 mm3, SD 80, with a study power of 90% (p=0.05) requires 45 
subjects in each arm (total subjects =90). 
Plaque echogenicity using 2D ultrasound and grey scale median: A previous study using this technique 
has shown a treatment difference of 4 (SD 6) in plaque echogenicity between statin-treated and 
placebo subjects. A study power of 90% (p=0.05) requires 48 subjects in each arm (total subjects = 96).  
The acquired data will be analysed using both parametric and non-parametric statistics and SPSS 
software. During the analysis, variables such as age, sex, diabetic and smoking status will be taken into 
consideration.  Because of the small number of patients, this will be performed by allocating subjects 
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 to groups using a process called minimisation, which attempts to balance the groups against measured 
characteristics. This method is considered more suitable than multivariate analysis when small sample 
sizes are studied. 
Ethics, data and safety 
This protocol was approved by the Ealing & West London Research Ethics Committee. Consenting 
participants will be denied the choice of which treatment they will receive.  Patients will only be 
known by their study number.  Information linking their name to their study number will be held on a 
secure hospital network drive accessible only from the members of the research team and will remain 
strictly confidential.  All the research files will be kept in the Josef Pflug vascular laboratory at Ealing 
Hospital. All blood samples sent to the laboratory in the USA will be fully anonymized. 
MHRA approval: Following communication with this agency it was decided that our study will not be 
considered as a Clinical Trial of an Investigational Medicinal Product (IMP) as defined by the EU 
Directive 2001/20/EC 
Project management 
Every 6 months internal review meetings will be performed in order to evaluate the progress of the 
project and ensure that milestones are achieved in a timely manner.  All members of the research 
team and the R&D manager of the hospital will participate to these meetings to provide feedback for 
the research progress. In addition, an advisory committee will be formed by Professor Farreed 
(Hemostasis & Thrombosis Laboratories of Loyola University Medical Centre, USA), Dr Bentley (Senior 
Lecturer Imperial College and consultant neurologist, Charing Cross Hospital) and Professor Xu 
(Bioengineering dept, Imperial College, London, UK). This committee has already provided the 
research team with useful feedback with regard various issues during the design of the project and 
they will also participate in the review meetings. Mr Geroulakos and Professor Nicolaides will be the 
Project managers and will be responsible for the smooth running of the trial and the delegation of 
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 duties during the trial. This multidisciplinary approach will enable us to resolve any potential future 
issues and improve the interpretation of the results.  
Patient and public involvement 
The R&D manager and a variety of people from various administrative posts (non-physicians) at Ealing 
Hospital NHS Trust have been consulted during one-off meetings. They provided the research team 
with useful feedback regarding different aspects of the proposed design and management of this 
research project. We plan to continue this collaboration though "Clinical Governance" meetings, which 
are regularly arranged, at Ealing Hospital for educational purposes.    
However, we do realize the importance of further public involvement in every research effort and thus 
motivated individuals will be selected through local support groups for people with cardiovascular 
disease and/or with the help of related charities such as the Stroke association and the British Heart 
Foundation. These individuals will help us in the production of the patient's information packs and 
consent forms in order to make the information -related with our study- accessible for everyone. 
In addition during and at the end of the study a brief report of our progress will be send to the 
participants of our study in order to keep them updated. In addition we plan to organize regular 
meetings with the public -end especially with the local community in collaboration with the above 
mentioned support groups and charities-in order to provide information about our research effort and 
answer questions regarding research methodology, carotid plaque disease and stroke. It is possible 
that we will also involve available patients and member of the public to present some of the findings 
or even share the experience of collaborating with us so we can also further improve as a team. 
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 Appendix IV 
Permissions 
For the use of published material originating from our own group, permission was obtained when 
necessary: 
1. Licence number :3318840504197 
Jan 30, 2014 
Elsevier 
Atherosclerosis 
Three-dimensional ultrasound imaging for the evaluation of carotid atherosclerosis 
2. Licence number :3318840294796 
Jan 30, 2014 
Elsevier 
Journal of Vascular Surgery 
The size of juxtaluminal hypoechoic area in ultrasound images of asymptomatic carotid plaques 
predicts the occurrence of stroke 
3. License number: 3318841219105 
Jan 30, 2014 
Elsevier 
Atherosclerosis 
The effect of statins on carotid plaque morphology: A LDL- associated action or one more pleiotropic 
effect of statins? 
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